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This study has shown that three species of BardeteIJa, B. bronchlsepUca, 
B. avium  and B. parapertussis, are capable of growth in vertebrate 
tracheobronchial washings (TBW), while B. pertussis is not. A total of nine 
samples of TBW from man, horse, mouse, rabbit, sheep, dog and chicken 
exhibited differences in growth-sup porting abilities as judged from colony 
counts on Bordet-Gengou (BG) agar plates (from inocula of about 2000 
CFU/ml). Single samples of TBW from horse and mouse gave higher 
stationary-phase counts of B, bronchlseptlca and B. avium, than any of the 
other TBW. However additional samples would have to be tested to 
determine whether this is a consistent species effect or is due to 
between-sample variation. With human TBW, where three samples were 
tested, there was considerable between-sample variation.
As regards the differences between the bordetellae, B. bronchlsepUca 
strain 5376 (Eldering strain) grew in all species of TBW, except that one out 
of three human specimens appeared to be bactericidal. The 
stationary-phase viable counts (colony forming units ; CFU) with the other 
samples were all in the 12-fold range 7.9 to 9.1 (Log|Q CFU/ml). B, avium
strain P4091 behaved, in general, very similarly to B. bronchlseptlca 
except that the average final viable counts were slightly lower. Thus 
although B. avium  is exclusively an avian parasite, its growth in chicken 
TBW was not greater than in mammalian TBW; in fact, it grew least well in 
the avian fluid.
With the two human bordetellae, B. pertussis (strain 183344 showed no 
evidence of growth in any of the TBW, although there was consistent and 
extensive growth in the control fluid, CL medium, where counts of 10.0 
log IQ CFU/ml were reached from inocula of around 3.3 log|Q CFU/ml. B.
X X X
parapertussis (strain 10520) was the organism that exhibited the greatest 
variation of growth in the different TBW. Thus, it grew to levels of 5.5-6.7 
log IQ CFU/ml in TBW from chicken, sheep, rabbit, mouse and two human
samples, while it failed to grow in the horse and dog TBW which had 
supported extensive growth of B. bronchlseptlca and B. avium. In Cl 
medium, B. parapertussis reached counts of 9.5 log|Q CFU/ml i.e. slightly
lower than B. pertussis.
With B. pertussis, an attempt was made to determine whether the 
failure to grow in TBW (rabbit was chosen) was due to lack of nutrients or 
to the presence of inhibitors. This was explored by comparing growth in a) 
TBW, b) CL medium, c) a 1:1 mixture of TBW and CL medium and d) TBW 
and MeBCD (methylated cyclodextrin). The observed growth in (b) and (c) 
but not in (a) or (d) suggested that lack of nutrients, rather than the 
presence of inhibitors was the likely explanation.
Since amino acids are primary nutrients of bordetellae in laboratory 
culture media, it was necessary to analyse TBW for their amino acid 
content. This was done by the ninhydrin method. All samples of TBW had 
readily detectable amounts of amino acids, the concentrations ranging from
0.1 to 0.81 mM, expressed as leucine equivalents. The 0.81 mM is 
approximately 1/200 the level of amino acids in CL medium, yet it 
supported growth of B. bronchlseptlca to a level only 2-fold lower than CL 
medium. There was a statistically significant correlation between the 
amount of growth and the amino acid concentration with B. bronchlseptlca 
and B. avium  in TBW; but this was not so with B. parapertussis.
Nicotinic acid was likewise readily detected in TBW by microbiological 
assay with LactobacilluspJantarum. Values ranged from 0.2 to 1.06 ug/ml.
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which was about 20-fold less than in conventional BordeteJJa media. As 
with the amino acid values, there was some correlation between the 
nicotinic acid content of TBW and the level of stationary-phase CFU/ml of 
B. bronchlsepUca and B. avium, but not of B. parapertussis.
The possibility that nutrients in TBW had originated from blood 
contamination was explored by haemoglobin analysis. This showed that 
TBW was never contaminated by more than 0.22 % by volume of blood and 
that the levels of amino acids and nicotinic acid contributed by the blood 
were small compared with those intrinsic to the TBW.
During the growth experiments with TBW samples it was noticed that 
both B. bronchlseptlca and B. avium  showed an increase in viable count 
when incubated in the non-nutrient control fluid, PBS. Thus from an 
inoculum of 2 x 10^ CFU/ml washed cells of B. bronchlseptlca, there 
developed 2.7 x 10^ CFU/ml after 48h at 37“C. This 1000-fold increase 
corresponded to about 10 cycles of cell division in the PBS. In addition, B. 
bronchlseptlca also grew in reagent-grade water, and in local lake and 
pond waters, all without added nutrients. Within 48 to 72h at 37T in PBS 
and in lake and pond waters, stationary-phase populations of around 2.7 x 
10*^  CFU/ml developed from washed B. bronchlseptlca inocula of around 2 
X 10^ CFU/ml. Much smaller increases, in the order of five- and eightfold 
respectively, were observed in reagent-grade water and in seawater from 
the same inocula.
The possibility that carry-over of nutrients was responsible for growth 
in PBS was discounted by showing successful serial transfer of B. 
bronchlseptlca in PBS under conditions in which Escherichia coll, tested in 
parallel, rapidly died out. During long-term incubation in both PBS and lake 
water B. bronchlseptlca maintained viability for at least six months at 37“C
X X X ]
and 10 T.
The ability of B. bronchiseptica strain no. 5376 to grow in these 
low-nutrient fluids was extended to five other strains of this species, 
including the type strain no, 452, a rabbit strain isolated in the 1950‘s and 
three recent clinical isolates from a pig, horse and a dog. Two strains of 
PasteureJIa haemolytlca, tested similarity, failed to grow in either PBS or 
lakewater, but gave extensive growth in the control fluid, brain heart 
infusion broth.
This work therefore reveals two novel observations:
1. Tracheobronchial washings from various vertebrate 
sources are capable of supporting the growth of BordeteJJa species, but 
with variability according to BordeteJJa species and the source of TBW, and
2. B. bronchJseptJca is able to grow and survive for long 
periods - in the order of months - in low-nutrient fluids such as lake 
waters and may therefore exist in the natural enviroment.
I N T R O D U C T I O N
Part 1. The Genus BordeteJJa.
The focus of this research was a study of the growth of BordetelJa 
species in tracheobronchial washings from various vertebrate sources. The 
introduction to the thesis is designed to provide the reader with general 
information about the genus BordeteJJa and also to describe in some detail 
those aspects of direct relevance to this study. For this reason emphasis is 
placed on the growth and nutrition of the bordetellae and on the collection 
and chemical composition of respiratory tract secretions.
The opening section of the Introduction (Part 1) contains 
information about the historical, clinical and biochemical backgrounds of 
the four species of bordetellae. The main section (Part 2) deals fully with In 
vJvo and In vitro growth of the genus and their nutritional requirements, 
while the final section (Part 3) concentrates on information available on the 
collection and chemical composition of respiratory tract secretions.
Where certain aspects have been dealt with sparingly, the reader 
will be referred to the appropriate review articles which contain more 
detailed information and primary sources.
Discovery of the bordetellae
Diseases which may , in retrospect, be attributed to members of the 
BordeteJJa date long before the isolation and identification of the 
disease-causing organism.
BordeteJJa pertussJs , the aetiological agent of whooping cough, was 
first isolated and described by Bordet and Gengou in 1906. However, the 
first mention of a whooping cough-like disease was by Guillaume de Baillou 
in the Mirror of Health in 1540 (cited by Lapin, 1943). This is generally 
accepted as the first clear description of epidemic whooping cough:
At the close of summer almost the same diseases prevailed as 
before Principally that common cough.... Serious are the symptoms of
this. The lung is so irritated by every attempt to expeil that which is 
causing the trouble it neither admits air nor again easily expells it. The 
patient is seen to swell up and as if strangled holds his breath tightly in the 
middle of his throat... For they are without the troublesome coughing for 
the space of four or five hours at a time then this paroxysm of coughing 
returns, now so severe that blood is expelled with force through the nose 
and through the mouth. Most frequently an upset stomach follows... For we 
have seen so many coughing in such a manner, in whom after a vain 
attempt semi-putrid matter in an incredible quantity was ejected 
(Linneman, Jr, 1979).
It was suggested that the disease was introduced into Europe in the 
Middle Ages by travellers form other parts of the world (Linneman, Jr,
1979) and was well recognized by the mid 18^^ century. The disease was 
reported from diverse regions; Switzerland (1755), Island of Oeland (1763), 
Germany (1769), Brunswick (1770) and Milan (1815). It was Sydenham in 
1769 (see Lapin, 1943) who gave the name "Pertussis" to this disease. For a 
more detailed historical description see Lapin (1943).
BordeteJJa parapertussis causes a milder form of whooping cough 
and went unrecognised until its isolation by Eldering and Kendrick in 1938 
from cases of whooping cough. Linneman and Perry (1977) suggested that 
severe cases of whooping cough were mixed infections with B. pertussis, 
but now both diseases are believed to be distinct (Connor, 1986).
B. bronchlseptlca causes a respiratory tract infection in a variety 
of domestic and wild animals (see review by Goodnow, 1980). It was 
originally isolated by Ferry in 1911 from the respiratory tract of dogs with 
a distemper-like disease. As with B. pertussis, previous reports of similar 
diseases could be attributed to this organism (review by Goodnow, 1980). 
A respiratory disease of swine was reported by Franque in 1830 and was 
the first mention of what is now known as atrophic rhinitis (see Rutter,
1985). Switzer demonstrated laboratory-induced swine atrophic rhinitis 
with a pure culture of B. bronchlseptlca, thus establishing its role in the 
disease and this was verified by other workers (see review by Goodnow,
1980). Thompson et aJ (1974), Bemis ^z/(1977a) and McCandlish e t aJ 
(1978) have all shown that B. bronchJseptJca was responsible for kennel 
cough in dogs. Reviews on B. bronchJseptJca and the diseases it causes 
include those by Thompson e t a l (1974), Bemis e t z^/{ 1977a), Goodnow 
(1980), and Rutter (1985). '
BordeteJJa avJum is a pathogen of birds responsible for a disease 
in turkeys called turkey coryza. It was first studied and described 
definitively by Kersters e t aJ (1984) although the disease had been 
reported previously (Hinz and Kunjura, 1977). Filion e t aJ (1967) 
incorrectly blamed an upper respiratory tract infection of turkeys on B. 
bronchJseptJca. In the late 1970's Hinz et ^ (1 9 7 8 ) reported a similar 
disease in Germany. Simmons et aJ (1984), blamed AJcaJJgenes faecaJJs for 
turkey coryza and other reports of the disease were recorded in 1931, 
1932 and 1934 (see Hinz and Kunjura, 1977).
Laboratory characteristics
The BordeteJJa are minute Gram-negative, coccobacilli, 0.2-0.5 pm 
in diameter and 0.5-2.0 pm in length. They are strictly aerobic, 
chemoorganotrophic bacteria which are parasites or pathogens of the 
respiratory tract of man and other animals. B. pertussis and B. 
parapertussis are non-motile while B. bronchlseptlca and B. avium  are 
motile. Colonies on Bordet-Gengou medium are described as "smooth, 
convex, pearly, glistening and nearly transparent". Those of B. pertussis, B. 
parapertussis and B. bronchlseptlca are surrounded by a zone of 
haemolysis (Pittman and Wardlaw, 1981 ).
Table 1 outlines the main characteristics within the genus. B, 
parapertussis, B. bronchlseptlca and B. avium, but not B. pertussis, utilize
Table 1 : Differentiation betw een B. p e rtu ssis , B. parapertussis, 
B. bronchisep tica  and B. avium, (modified from Pittman, 
1984)
Characteristics B. pertussis B.para-
pertussis
B. bronchl- 
septlca.
B. avium
Motility. P- +
Growth on Bordet-
Gengou medium:
1-2 days. — - -
3-6 days. + b
Growth on peptone
agar;
Phase I. _ + -
Phase IV. + -
Browning. — f — —
Growth on Mac-
conkey agar. — f - -
Citrate utilisation. _ ¥ -
Nitrate reduction. __ — + c +d
Urease. — +e
Oxidase. _ - +f
Mol% of G+C of
DNA(Tm) 67-70g 66-70g 68.9h 6i .6i
a Symbols : +, typically positive; - .  typically negative 
b Blank space indicates no information
c Regularily positive in nitrate medium supplemented with nicotinamide 
adenine dinucleotide (NAB) and serum. Exceptions occur in conventional 
nitrate-test medium 
d Only in medium supplemented with NAD and serum 
e Positive within 4h
f Ko vac's test positive after 48-72 h incubation 
g Johnson! cited by Johnson & Sneath. 1973) 
h Type strain 
i Strain 591/77 of Hinz
citrate as a soie carbon and energy source and are capable of growth on 
peptone agar and MacConkey agar [B. pertussis phase IV organisms also 
grow on peptone agar). Of the four species, only B. parapertussis has the 
ability to produce a browning from the tyrosine in the peptone agar.
Both B. bronchiseptica and B. avium , but not B. pertussis or B. 
parapertussis reduce nitrate and show a positive oxidase reaction. B. 
bronchiseptica and B. parapertussis are urease positive while the other 
two bordetellae show no activity. The DMA base ratios lie within the range 
61-70 mole % (G+C).
The BordeteJJa also produce a wide range of toxins and other 
virulence factors (see reviews by Weiss and Hewlett, 1986 and Wardlaw, 
1988). Table 2 shows the virulence determinants and their sharing by the 
four bordetellae. All four species possess heat-labile toxin (HLT), tracheal 
cytotoxin (TCT) and agglutinogens (AGG). The three mammalian bordetellae 
have filamentous haemagglutinin (FHA), adenylate cyclase toxin (ACT) and 
haemolysin (HLY) activities, whereas B. avium  is deficient in all of these. 
B. pertussis is the only member of the genus to produce pertussis toxin 
(PT); however both B. parapertussis and B. bronchiseptica possess 
transcriptionally silent PT genes (Arico and Rappuoli, 1987). The virulence 
factors are under the control of a single genetic sequence known as the vir 
or bvg  locus. For more detailed information about the virulence factors 
and their control, the reader is referred to Coote and Brownlie (1988) and 
other chapters in the book by Wardlaw and Parton (1988), and Coote 
(1991).
Taxonomy
The similarities and characteristics of the BordeteJJa and some 
closely related genera are shown in Table 3. All species within the 
BordeteJJa have, at some time, been placed in other families. B. pertussJs, 
B. parapertussis and B. bronchiseptica were finally assigned to the genus
Table 2 : Virulence factors of the genus BordeteJJa. (modified
from Wardlaw, 1988)
Virulence Factor B .p ^ B. p ^ B .b fi B  ê
Heat Labile Toxin (HLT) + + +
Tracheal Cytotoxin (TCT) + + + +
Lipopolysacchaddes (LPS) + + + +
Agglutinogens (AGG) + + + +
Filamentous Hemagglutinin (FHA) + +
Adenylate Cyclase Toxin (ACT) + + +
Haemolysin (HLY) + +
Pertussis Toxin (PT) + - - -
 ^ B. pertussis-, ^ B. parapertussis-, ^B, bronchiseptica-, ^ B. avium-, 
^ activity demonstrated;  ^no activity recorded 
A blank space indicates no information available.
Table 3 : Differential characteristics of the genus BordeteIJa and 
other morphologically and physiologically similar 
genera  ^ (modified from Pittman, 1984)
Characteristic Bordetella Alcaligenes Brucella Haemophilus
Strictly parasitic.
Saprophytic. — - -
Localise on respiratory cilia — —
Strictly aerobic. - —
Growth requirement : 
Thiamine.
Nicotinamide. —
X and/or V factor. _
Ferment carbohydrates. — — -
Nitrate reduction. D D
Litmus milk, alkaline. + +
Oxidation of amino acids +
Tétrazolium reduction. f b
Growth on 320mg 
potassium tellurite per litre >
Citrate utilised. D _
PAGE resemblance.*' _
Mol% G-C of DNA. 6l-70!Tin) 56-70(Tni) 55-58(Tfli) 38-44(Tm)
a Symbols ; positive reaction ; - , no reaction ; D, variable 
b Blank space indicates no information 
c PAGE patterns are distinct for each genus
BordeteJJa by Moreno-Lopez in 1952, and B. avJum was added at a later 
date (Kersters et aJ, 1984). B. pertussis was originally a member of the 
HaemopJiiJus, B. parapertussis was placed in both HaemopJiiJus and 
Acin/tobacter, and B. bronchiseptica was placed successively in BaciJJus, 
AJcaJigenes, BruceJJa and then HaemophiJus, before being allocated to 
BordeteJJa Even B. avJum was formerly assigned to AJcaJJgenes
A comprehensive, numerical taxonomic study by Johnson and 
Sneath (1973) helped establish B. pertussis, B. parapertussis and B. 
bronchiseptica as individual species within the one genus, supporting the 
stance taken by Moreno-Lopez in 1952. Differentiation between the 
HaemophiJus and the BordeteJJa was relatively simple as the BordeteJJa 
species were obligate aerobes whereas the HaemophJJus were facultative 
anaerobes. The guanine plus cytosine ratios also differ, the bordetellae 
being in the range 61 to 70% and the haemophili 38 to 44% (Table 3). It 
was more difficult to separate the BordeteJJa from some other genera, 
especially considering the close similarities between B. bronchiseptica and 
AJcaJigenes faecaJis (Johnson and Sneath, 1973. Ulrich and Needham, 
1953).
The BruceJJa and BordeteJJa differed in that the former 
metabolized alanine and DL-asparagine, whereas the BordeteJJa prefered 
glutamic acid and proline. In DNA hybridization studies, Hoyer and 
McCullough (1968) found no detectable pairing between BruceJJa and 
BordeteJJa species. The essential requirement for nicotinic acid (Proom, 
1955) displayed by the BordeteJJa also differentiated them from other 
genera. B. avium  was classed as a member of the BordeteJJa when 
Berkhoff and Riddle (1984) distinguished between it and the species 
within AJcaJJgenes, and Kersters et aJ (1984) listed its major 
characteristics.
It appeared that B. pertussis, B. parapertussis, B. bronchiseptica
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and B. avium  were independent species classed within a single genus 
based on their nutritional requirements (Proom, 1955, Berkhoff and Riddle, 
1984 and Kersters et aJ, 1984), enviromental niche (respiratory tract of 
man and animals), DNA base ratios and the nature of the several virulence 
factors that they share.
More recent studies have focussed on genetic diversity to 
distinguish between the Bordetella and other closely related genera and 
also between species within the BordeteJJa. De Ley et aJ (1986) showed 
the closeness of the relationship between the bordetellae by DNA base 
compositions and DNA-rRNA hybridization studies. Their results indicated 
that B. pertussis, B. parapertussis and B. broncJiiseptica could not be 
differentiated genotypically in terms of their Tm(e) values of their 
DNA-rRNA hybrids i.e. the temperature at which one half of the DNA-rRNA 
hybrid is denatured. The calculated mean G + C contents of their genomic 
DNA was almost identical. These findings agreed with those of Kloos e t at 
(cited by De Ley ^  1986).
The Tm(e) values for the B. avium  strains tested put it in close 
vicinity of B. pertussis, B. parapertussis and B. broncJiiseptica and a study 
of 147 phenotypic features of B. avium  have shown it to resemble most 
closely B. parapertussis and then B. broncJiiseptica (90% and 82% 
relatedness respectively) (De Ley et aJ, 1986).
The same workers also found that some strains from the genus 
AJcaJigenes were very close to the bordetellae in terms of DNA-rRNA 
hybridization and they proposed a new family - the AJcaJigenaceae - to 
encompass both genera (De Ley et aJ, 1986).
Other studies in this area included the work of Musser et aJ (1986) 
involving electrophoretic mobilities of certain metabolic enzymes of the 
four bordetellae. These investigations indicated that B. pertussis, B. 
parapertussis and B. broncJiiseptica were very similar. In fact, these
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workers claimed that recognition of the bordetellae as separate species 
could only be justified if based on pathogenicity considerations. However B. 
avium  was found to be genetically distinct enough to warrant status as a 
separate species (Musser e t aJ 1986).
In 1987 Musser and coworkers, in studies similar to those 
performed in 1986, reported that within strains of B. bronchlseptlca there 
was only limited genetic variation.
Other evidence which supported the grouping of B. pertussis, B. 
parapertussis and B. bronchiseptica as members of a single independent 
genus was the fact that both B. parapertussis and B. bronchiseptica 
contained transcriptionally silent copies of the pertussis toxin operon which 
is active in B. pertussis (Arico and Rappuoli, 1987). However no such genes 
were found in B. avium  or in members of the genus AJcaJigenes (Arico 
and Rappuoli, 1987).
More details of the taxonomy of the bordetellae can be found in the 
review by Johnson and Sneath (1973) which deals with the three 
mammalian bordetellae, and Kersters et aJ (1984) describe in detail the 
properties of B. avium  . The papers of interest dealing with the genetic 
approach to taxonomy are those of De Ley et aJ (1986), Musser e t aj 
(1986, 1987) and Arico and Rappuoli, 1987).
BordeteJJa : The Diseases
The bordetellae cause a variety of different diseases which affect 
man, animals and birds. Table 4 shows some of the characteristics of these 
diseases.
B. pertussis is a respiratory tract pathogen of man that is 
responsible for whooping cough, or pertussis. A similar but less severe 
form of the infection is caused by B. parapertussis B. bronchiseptica 
causes kennel cough in dogs (reviewed by Thompson et aJ, 1974; Bemis ei 
aJ, 1977a, and McCandlish e t aJ, 1978), atrophic rhinitis in swine (review
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Table 4 : Characteristics of the diseases caused by B ordetella  
species
Organism
Characteristic
B,p B-pA B. bron .’' B . r
Name Whooping cough, 
Pertussis
Atypical 
whooping cough
Kennel cough. 
Atrophic rhinitis
Infectious coryza,
Rhinotracheitis, 
Bordetellosis, 
Turkey coryza
Reservoir Man Man. Sheep Dogs, pigs and various Turkeys, chickens 
wild animals and other birds
Transmission Aerosol droplets Aerosol droplets Aerosol droplets Aerosol droplets
and infected feed, 
litter and water
Symptoms Catarrhal, paroxysmal As with B.p 
and convalescent stages
Nasal atrophy and Exudative 
snout deformation conjunctivitis. 
Coughing, sneezing, Sneezing and
Ocular and nasal serous discharge
discharge. Reduced Tracheal rales,
weight gain Reduced feeding.
Site of Cilia of respiratory
infection epithelium
As with B.p Nasal and respiratory Respiratory
epithelial c ilia  epithelial c ilia
Carriers None None Dogs, cats, rats, swine Not known
Immunity Solid after infection 
Short-lived with 
immunization
As with B.p As with B.p Not known
Duration Several months As with B.p Up to 14 weeks About 12 weeks
Treatment No effective treatment As with B.p As with B.p As with B.p
Table 4 (continued)
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Characteristic
Organism
B.p B pp B. bron. B. a
Vaccine Whole cell 
Acellular
None Whole cell 
Acellular
Whole cell
 ^ Information on B. pertussis (Bp) gathered from: Connor (1986); Friedman (1988); 
Ptfcbffiïwi and Wardlaw (1981) and Wardlaw and Parton (1988)
 ^ Information on B. parapertussis (Bpp) gathered from; Eldering and Kendrick 
(193S); Linneman and Perry (1977); Connor (1986); Chen (1989)
 ^ Information on B, bronchiseptica (B.bivn) gathered from; Thompson etaJ WlA): 
Bemis e ta l (1977a); McCandlish e ta l Goodnow (1980); Rutter (1985); Papasian
(1987)
Information on B, avium (B.aJ gathered from; Hinz and Kunjara (1977); Kersters ei 
(1984); Simmons etaJ. (197g^ M%(^ )
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by Rutter, 1985) and respiratory tract infections in a variety of other 
domestic and wild animals (review by Goodnow, 1980). The avian pathogen 
B. avium  is responsible for a disease which, in turkeys, has had a number 
of names: rhinotracheitis, bordetellosis, infectious coryza and turkey coryza 
(see Kerster s etaJ, 1984).
The reservoir of infection for the four species varies. All are 
thought to be obligate respiratory tract pathogens restricted to colonization 
of cilia on the nasal and tracheal epithelium. They are generally 
transmitted by aerosol via infected droplets expelled whilst speaking, 
coughing or sneezing and are therefore very contagious within 
populations. With B. pertussis and B. parapertussis it is possible that hand 
to mouth transmission may occur via infected objects such as 
handkerchiefs (Nicholl and Rudd, 1989), while with B. avium  infected feed, 
litter and water are possible disease vectors (Simmons e t al, 1984).
While B. pertussis appears to be strictly a human pathogen, B. 
parapertussis has recently been isolated from sheep (Chen et aJ 1989). 
The two animal and bird pathogens infect a variety of other mammals and 
birds respectively. B. bronchiseptica has been isolated from dogs, pigs, 
cats, seals, rabbits, monkeys, foxes, skunks, raccoons, koala bears and lesser 
bushbabies (Goodnow, 1980). It has also been isolated from man and some 
evidence of zoonotic transmission was recorded (Goodnow, 1980; Byrd et aJ,
1981). B. avium  is most commonly isolated from turkeys, but chickens, 
geese and ducks are also susceptible (Kertsers et aJ 1984). B. avium  did 
not initiate respiratory tract infection on mice, guinea pigs and hamsters 
under laboratory conditions (Simmons e ta l  1984).
Different symptoms present themselves in the various disease 
states. In whooping cough, the symptoms vary in severity, with cases of B. 
pertussis and are generally milder ^ ith  B. parapertussis, although this is 
not always the rule (Lautrop, 1971) After about 7-10 days of incubation
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the catarrhal stage begins. This is the most infectious stage of the disease 
with symptoms similar to many upper respiratory tract infections i.e. 
irritation of the mucous membranes, cough and fever. This usually lasts a 
further 7-10 days after which the paroxysmal stage ensues with bouts of 
sometimes severe paroxysmal coughing followed by the characteristic 
whoop. The convalescent stage then follows and a return to normal activity 
and development without complications is completed. (Connor, 1986).
Animals infected with B, bronc±Jseptjca show a variety of 
symptoms. In swine, atrophic rhinitis is characterized by nasal atrophy and 
snout deformation (Rutter, 1985) and with all B. bronchlseptica infections 
it is usual to find coughing, sneezing and discharge from the eyes and nose. 
A reduction in weight gain is also expected (Goodnow, 1980). Symptoms 
presented by birds infected by B, avJum include reduced feed 
consumption, exudative conjunctivitis and sneezing with serous discharge 
from the nose. ( Hinz e t al, 1978; Kersters e t al 1984 and Simmons e t al,
1984).
A major difference between the diseases caused by the two human 
pathogens and those by B. bronchlseptica is that in the latter the presence 
of live organisms is required for symptoms to continue, whereas in the 
former cases the disease persists even if no bacteria can be recovered 
(Bemis e t al, 1977a).
Only B. bronchlseptica appears to have a carrier state where the 
infected animals are asymptomatic. This has been observed in dogs, cats, 
rats, guinea pigs and swine (review by Goodnow, 1980). B. bronchJseptJcâ 
has also been isolated from humans (Ghosh and Tranter, 1979 and Byrd ei 
2/1981).
With the three mammalian bordetellae immunity is usually solid 
after natural infection whereas it is short-lived after immunization 
(Connor, 1986: Rutter, 1985 and Goodnow, 1980). No evidence of immunity
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in B. avJum infections has been reported. In all of the diseases caused by 
the four BordeteJJa species antibiotic treatment is ineffective and once 
initiated the disease usually runs for the whole course. With B. 
parapertussis no vaccine has been used to date. It has also been shown 
that immunization against B, pertussis does not confer resistance to 
infection by B, parapertussis (Lautrop, 1971 and Connor, 1986). Whole ceil 
pertussis vaccines and acellular vaccines have been used for immunization 
against whooping cough. The whole cell vaccines have been in general use 
throughout the world except in Japan, where the use of acellular vaccines 
has been more common place (Parton, 1991). FT. FHA and agglutinogens 2 
and 3 all have protective activity in both mice and man, while ACT has 
protective activity in mice. More detailed information about vaccines can 
be found in the review by Parton (1991). Similarily with B. bronchlseptica 
both whole-cell and subcellular (cell wall material) or bacterins have been 
used with varying measure of success (Rutter, 1985 and Goodnow, 1980). 
With B, avium  whole cell vaccines have been tested (Hofstad and Jeska,
1985) however no substantial body of work exists at present.
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Part 2. Growth and nutritional requirem ents. 
BordeteJJa p ertu ssis
Growth in the vertebrate host. Ethical constraints dictate that 
In vivo growth studies of B. pertussis can not be done in the natural host, 
man, and that animal models should be sought. A notable exception was a 
study of whooping cough in four young children in which all were infected 
intr anas ally with-^. pertussis (MacDonald and MacDonald, 1933). Two of 
the children had already been vaccinated against whooping cough and 
remained uninfected. The remaining two became infected , with B. 
pertussis colonizing the respiratory tract and being recovered on cough 
plates during the period of infectivity.
Nowadays more convenient animal models have been investigated. 
These have included puppies, monkeys and chimpanzees (Bradford, 1938), 
mice (Dolby e t a j 1961; Sato e t a i 1980), rabbits (Preston et a i 1980; 
Ashworth e t ai 1982) and more recently rats (Woods e t a i 1989). A novel 
method for the study of in  vivo growth of B. pertussis was the 
intraperitoneal diffusion chamber (Coleman and Wetterlow, 1986), as used 
previously with staphylococci (Day e t a i 19SO).
Of these experimental animals the most utilized has been the 
mouse. Only two sites of infection have been used in the mouse namely the 
lungs and the brain (Standfast and Dolby, 1961) and both intranasal and 
intracerebral infections have been studied extensively (Fisher, 1955: Dolby 
et ai 1961; Dolby and Standfast, 1961; Standfast and Dolby. 1961; Dolby, 
1962 and Alonso et ai 1987). Intranasal infection involves the instillation 
of a measured volume of standardised bacterial suspension into the nasal 
cavity of anaesthetized mice and intracerebral is simply an injection into 
the brain of the mouse (Standfast and Dolby, 1961).
Standfast and Dolby (1961) made a comparison between the two
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methods of infection drawing a number of conclusions from their study. 
The terminal viable count in the lungs and brain was always 10^ CPU with 
death occuring on the 4^^ or 5^^ day after infection. In the lung sublethai 
infections could be observed with challenge doses of less than 10^ CPU 
where numbers increased steadily to lO'  ^ to 10^ until the 10^^ to 14^^ day 
after infection and then slowly declined over some weeks or even months 
until the lung became sterile. This was in contrast to brain 
infections where there was,no such thing as a sublethai infection. In fact in 
the brain, regardless of initial inoculum, numbers consistently increased to 
10^ CPU with death ensuing. It appeared that probably a single cell, if it 
became lodged in the brain, could and would grow to a critical level (Dolby 
and Standfast, 1961). With large initial inocula there was an initial die-off 
followed by an increase in viable count to the critical level in both 
infections.
Sato ei aJ (1980) claimed that aerosol infection of mice with B. 
pertussis gave a more accurate and reproducible inoculum. In this system 
the mice were placed on a mesh screen in a glass chamber fitted with a 
nebulizer. The animals were exposed to an aerosol for 30 minutes by 
spraying 0.4 ml of bacterial suspension per minute at a nebulizer pressure 
of 1.5 kg/cm^. From a bacterial concentration of 2 x 10^ CPU/ml an initial 
delivered inoculum of 2 x 10^ CPU/lung was obtained. This reached a 
maximum of 10^ CPU/lung in 14 days (Figure 1), after which the viable 
count decreased. Sato e t aJ (1980) observed the same growth and 
infectivity pattern as Standfast and Dolby (1961). Again the lethal dose 
was found to be 10^ CPU/lung.
A novel method of studying the growth and toxin production of B. 
pertussis in vivo was introduced by Coleman and Wetterlow (1986) 
following work with staphylococci (Gladstone and Glencross, 1960; Houser 
and Berry, 1961; Day et al 1980). It involved the use of a small sterile
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Figure 1 lu  vivo  growth of B, p ertu ssis  in the lung of a 
mouse, (from Sato et aJ, 1980 and reproduced with 
permission).
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chamber, bounded by 0.22 \im. membrane filters, which was inoculated 
with Â pertussis , sealed and surgically implanted into the peritoneal 
cavity of mice. The mice were killed at intervals and viable counts 
performed on the contents of the chambers. A comparison was made 
between growth in the chambers {In vivo) and in Cohen and Weeler (CW) 
medium {In vitro) and is shown in Figure 2. From the Figure it can be seen 
that the viable counts for B. pertussis strain 1392 were greater in the 
implanted chambers reaching over 10^ CFU/mL Four widely different 
strains all showed the same growth characteristics in the chambers. 
Another observation, consistent with the findings of previous 
workers on growth of B. pertussis in mice (Dolby et a l 1961), was that a 
steady-state bacterial concentration of around 10^ CPU/ml (not presented 
in Figure 2} was always reached. This was also regardless of the size of the 
initial inoculum. If the inoculum was small the viable count increased to 
the maximum value in 6-7 days and if large inocula (>10^) were used the 
viable count decreased quickly until the steady state was reached (three 
weeks). These workers found that it was possible to initiate an infection In 
vivo with less than 10 organisms per chamber. They also showed that 
virulent strains of B, pertussis were able to outgrow avirulent strains 
when implanted in the same chamber.
Another animal model which has received recent attention 
attention is the "coughing rat model" which closely parallels the human 
infection with respect to the clinical and physiological changes seen in the 
human infection, including the paroxysmal cough (Woods et a l 1989). This 
work was based on a previous model involving the infection of rats with 
Pseudomonas aeruginosa (Cash et a l 1979). With the virulent Tohama I 
strain a reproducible infection, similar to the human disease was produced 
in the rat with colonization of the lung observed. Organisms were 
recovered 21 days after infection.
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Figure 2 Comparison of in  vivo  growth (intraperitoneal 
chambers; #) and in  vitro  growth (CW medium; o) of 
B, pertu ssis, (from Cole men and Wetterlow, 1986 and 
reproduced with permission).
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Growth on laboratory media. Most of the literature dealing 
with the development of culture media for the BordeteJJa concentrated on 
work with B. pertussJs, although similar media have been used for the 
other members of the genus. In the following sections that deal with 
members of the genus other than B. pertussJs only information additional 
to that already provided will be presented and the reader will be referred 
to the appropriate sections of the text for details of other media. Since most 
of the media for B. pertussJs have been used for more than one purpose 
e.g. Regan and Lowe (1977) medium has been used for the isolation,
Ê.
transport and propagation of B. pertussJs, some rep/tition is unavoidable in 
this section.
Iso la tio n  a n d  tra n sp o rt m edia. B. pertussJs was first isolated 
in 1906 by Bordet and Gengou using a medium which consisted of 
glycerinated potato extract and sheep or human blood solidified with agar. 
Since then many workers have tried to improve upon this recipe in their 
attempts to create more efficient isolation mediator B, pertussJs (Table 5).
Various isolation media have been used directly or in conjunction 
with transport media to facilitate the recovery of B. pertussJs from scantily 
populated specimens. In 1954, Lacey described a complex selective 
medium containing 4:4 diamidinodiphenylalanine hydrochloride, penicillin 
and sodium fluoride in a partially defined base which was successful in the 
isolation of B. pertussJs Most of the other recipes have involved the 
incorporation of selective antibiotic agents to suppress the nasopharyngeal 
flora present in samples. Benzyl penicillin and penicillin have been used 
often (Sutcliffe and Abbot, 1972; Stauffer e t aJ 1983 and Fareeduddin and 
Calder, 1984). Other selective agents have included lincomycin (Hoppe and 
Schwaderer, 1989), methicillin (Morrill e t aJ, 1988), anisomycin (Kurzynski 
e t aJ, 198g) and cephalexin (Regan and Lowe, 1977). Of all the antibiotics 
tested, cephalexin at a level of 40 pg/ml proved to be the most successful.
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Table 5 : Isolation media for B. pertussis
Medium Main Constituents R e fe r e n c e (s )
BG glycerinated potato extract + 50% (v/v) Bordet and Gengou, 1906 
horse blood + agar
Lacey's*
New Zealand agar, potato starch, glycerol, 
dl- alpha alanine, /-glutam ic acid, sodium 
fluoride, sodium chloride, potassium chloride, 
tap water, aconitic acid, fumaric acid, malonic 
acid, /  or (//-cyste in e  hydrochloride, d istilled  
water, magnesium hydroxide, 4:4' diamidinodi- 
phenylamine hydrochloride, penicillin  and 
defibrinated horse blood (dhb)
Lacey, 1954
Modified charcoal 
blood agar*
a) Charcoal agar, 10 % (v/v) horse blood 
1 % (w/v) proteose peptone, 0.25 U
benzyl pen icillin  Sutcliffe and Abbot, 1972
b) a, plus cephalexin (40 pg/ml) to 
replace benzyl pen icillin
Regan and Lowe* Oxoid charcoal agar, 10 %(v/v) dhb, 
cephalexin (40 pg/ml)
Regan and Lowe, 1977
Jones-Kendrick (JK) 
charcoal agar with 
cephalexin /penicillin
JK charcoal agar, cephalexin (40 pg/ml) 
or pen ic illin  (0.5 U/ml) Stauffer et at, 1983
BG agar/ benzyl 
p en icillin
BG agar base, 20 % (v/v) dhb, benzyl Fareeduddin and Calder, 1984 
p en ic illin  (0.25 U/ml)
Charcoal agar/ 
benzyl pen ic illin
Charcoal agar base, 10 % (v/v) dhb, Fareeduddin and Calder. 1984 
benzyl p en icillin  (0.3 U/ml)
Cyclodexirin agar Stainer-Scholte base, casamino acids. 
MeOCD, 1.8 % (w/v) agar
Aoyama et al. 1986 
Morrill et ai, 1988
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Table 5 (continued).
Medium Main Constituents Reference(s)
Modified BG agar* BG agar base, 20 % (v/v) dhb. 
cephalexin (40 pg/ml). anisomycin 
(20 pg/ml)
Kurzynski et at, 1988
Modified RL agar* RL charcoal agar, cephalexin (40 pg/ml), 
anisomycin (20 pg/ml)
Kurzynski et at, 1988
BG agar/fflethicillin BG agar base, 1 % (v/v) glycerol, 15 % (v/v) 
dhb, m ethicillin  (2.5 pg/ml)
Morrill et at, 1988
SS/ MeUCD Stainer-Scholte base, MeOCD (1 g) W irsingvon Koenig et at, 
1988
* also used for B. parapertussis
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Another additive, Me BCD has also been used for the successful isolation of 
B. pertussis (Aoyama e t aJ, 1986; Morrill et aJ, 1988 and Wirsing von 
Koenig et aJ, 1988).
Transport media (Table 6) used for B. pertussis had to be able to 
maintain the viability of the organism during its journey from the sampling 
point to its isolation in the laboratory. For this reason some of the transport 
media, like the isolation media, were enriched and contained certain 
selective agents (antibiotics) to improve the chances of B. pertussis 
isolation.
Amie s transport medium (Amies, 1967) was one which had been 
used successfully for the isolation of not only B. pertussis but for B. 
parapertussis and B, bronchlseptica It was a modification of Stuart's 
transport medium (Stuart, 1946) in which the glycerophosphate was 
replaced with an inorganic phosphate buffer and charcoal was added to the 
medium.
The isolation medium described by Regan and Lowe (1977) was 
also used as a successful transport medium. It was used directly by later 
workers (Kurzynski, 1988) while others made some minor modifications of 
the basic recipe (Morrill e t aJ, 1988).
In 1988, Morrill and co-workers studied three transport media; 
modified Regan-Lowe, beef extract agar and charcoal yeast-extract agar. 
They found that B. pertussis survived best when the modified Regan-Lowe 
with cephalexin and amphotericin B was employed.
L a b o ra to ry  p ro p a g a tio n  m edia. Both solid and liquid media 
have been used for the successful propagation of B. pertussis in the 
laboratory. Early work was reviewed by Rowatt (1955. 1957a and 1957b).
Table 7 shows the various solid media used for the post-isolation 
cultivation of B. pertussis.
BG agar, which was used for the first isolation of B. pertussis
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Table 6 : Transport media for B. pertussis
Medium Main Constituents Reference
Stuart's* Bacto agar, thioglycollie acid, sodium 
glycerophosphate, calcium chloride, 
methylene blue
Stuart, 1946
Amies*
Charcoal pharmaceutical neutral, 
sodium chloride, sodium hydrogen 
phosphate, potassium chloride, sodium 
thioglycollate. calcium chloride, 
magnesium chloride, agar No 1
Amies, 1967
Regan and Lowe* 
(RL)
Charcoal agar (1/2 strength), 10% (v/v) Regan and Lowe, 
defibrinated horse blood (DHB), 1977 
cephalexin (40 pg/ml) Kurzynski etal, 1988
Modified RL RL with amphotericin B (50 pg/ml) Morrill etal, 1988
Beef-extract
agar
Beef-extract, meat peptone, soluble starch 
charcoal, sodium chloride, nicotinic acid, 
agar, cephalexin (40 pg/ml) amphotericin 
B (50 pg/ml)
Morrill etai, 1988
Charcoal
yeast-extract
agar
Buffered charcoal yeast-extract agar, 1% 
(w/v) al pha- keto glu tarate. lincomycin 
(3 Pg/ml) anisomycin (80 pg/ml)
Morrill etai. 1988
* also used for B, parapertussis
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Table 7 : Solid media for the cultivation of B. pertussis
Medium Main constituents Reference
BG glycerinated potato extract 
+ 50% (v/v) horse blood + agar
Bordet and Gengou, 
1906
Barksdale and 
Simpson
nutrient agar + potato extract Barksdale and 
Simpson, 1934
Cruikshank and 
Freeman
proteose peptone + heart extract 
+ 20% (v/v) laked horse blood with 
13% (v/v) horse serum
Cruikshank and 
Freeman, 1937
Silverthone and 
Cameron
aqueous extract of beef liver  ^
salt + agar + 33% (v/v) citrated 
sheep blood
Silverthorne and 
Cameron, 1942
Modified Cohen- 
Wheeler(CW)
CW + agar+ charcoal Powell e ta i, 
1951
Charcoal agar CW + agar + charcoal + catalase 
preparation
Mazloum and 
Rowley, 1955
Regan-Lowe charcoal, cephalexin  ^
defibrinated horse blood
Regan and Lowe, 
1977
2S
(Bordet and Gengou, 1906), has also been useful in its cultivation. Other 
workers modified BG medium by using heated blood (Krumwiede, et aJ, 
1923) or lower concentrations of blood (Debre, et a l 1928) but they failed 
to notice that the organisms produced varied antigenically from Bordet and 
Gengou s bacillus. Leslie and Gardner (1931) explained this phenomenon 
when they reported that there were four phases of B. pertussis i.e I, II, III 
and IV.
Most modifications to BG medium were either by addition or 
removal of medium constituents or an increase or decrease in the 
concentration of some component. Dawson e t æ/(195D stated that the 
glycerol used in the medium, either added after potato extraction (Mackie 
and McCartney, 1953) or used in potato extraction (BG medium), was 
unnecessary and omitted it altogether. They also found most peptones to 
be inhibitory and that glutamate and aspartate improved growth, 
suggesting that amino acids may be responsible for the effect of the potato 
extract. Povitsky (1923) noticed that pH was important and that better 
growth could be obtained on media with a slightly acid reaction. Various 
other workers used lactate to improve growth (Madsen, 1925: Leslie and 
Gardner, 1931; Lacey, 1954).
Eldering and Kendrick (1952) made a modification to BG and this 
was used for routine diagnostic purposes. It contained 17% sheep blood, no 
peptone and penicillin was added. The medium described by Lacey (1954) 
and presented earlier as an effective isolation medium (Table 5) was also 
useful in the propagation of B, pertussis. However it was not a preferred 
medium for routine use due to the complexity of its formulation .
Blood was a possible source of many contamination problems and 
several attempts were made to replace it. Pollock (1947) effectively 
substituted charcoal, serum and serum albumin and suggested that the role 
of the blood was to absorb inhibitors, such as fatty acids, an effect also
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shown with M. tubercuJosis (Davis and Dubos, 1946). Powell, Culbertson 
and Ensminger (1951) produced a medium used for the growth of vaccine 
strains consisting of Cohen and Wheeler medium plus agar and charcoal 
suitable for growth from large but not small inocula. Others used charcoal 
(Mazloum and Rowley, 1955; Mishulow, Sharpe and Cohen, 1953) but again 
growth was only obtained from large inocula. In 1953 Ensminger et aJ mdi 
study on the growth of B. pertussis on charcoal agar found that the 
optimum concentration of charcoal was 0.2 %, which gave a cell count of 
184 billion/ml and that the optimal incubation period was 48h. They also 
found that Charcoal agar compared favourably with BG medium and could 
replace it in all of its uses.
Mazloum and Rowley (1955) combined CW medium agar, charcoal 
and a catalase preparation. The catalase was incorporated to counteract the 
inhibition by peroxidases. Mucin was also found to have a similar effect to  
charcoal (Miyamota e ta i 1954).
Regan and Lowe's (1977) enrichment medium, which was also used 
as an isolation and transport medium (Table 5 and 6), was successful in the 
propagation of B. pertussis from small populations.
Other research focussed on liquid media (Table 8) for the 
cultivation of B. pertussis Some workers believed that there could be no 
growth without blood (Lawson, 1939) or tissue extract (Toomey and 
McClelland, 1933-34). However in 1939 Hornibrook described a medium 
containing hydrolysed casein, soluble starch, salts, cysteine and yeast 
extract. In 1940, Hornibrook described another medium containing amino 
acids, starch and nicotinamide i.e Modified Hornibrook Medium. Other 
modifications to Hornibrook s recipe were made by various workers 
(Verwey and Sage, 1945; Wilson, 1945, Farrell and Taylor, 1945; and Cohen 
and Wheeler, 1946).
CW medium was recommended by the WHO for preparation of
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Table 8 : Liquid media for the cultivation of B. pertussis
Medium Main constituents Reference
Hornibrook hydrolyzed casein, soluble starch, 
yeast extract and salts^
Hornibrook.1939
Modified Hornibrook soluble starch, glutamic acid, 
L-tyrosine, glycine. L-proline, 
L-histidine, arginine and salt^
Hornibrook, 1940
Cohen-Wheeler casamino acids, soluble starch, 
cysteine hydrochloride, yeast dialysate 
and salts^
Cohen and Wheeler, 
1946
Stainer-Scholte DL-alanine, L-arginine, DL-aspartic acid 
L-glutamine, glycine, DL-histidine, DL-serine 
L-proline. L-glutamic acid, L_cystine,
adenine, ATP(Di Na salt),guanine. Stainer and Scholte,
hypoxanthine, thymine, activated charcoal, 1971
tris buffer, liver co-enzymes (CoA, DPN, TPN) 
ascorbic acid, niacin, glutathione,
2-deoxyribose and salts'^
Cyclodextrin (CL) 
medium
sodium L-glutamate, L-proline, tris, 
L-cysteine, niacin, glutathione, 
ascorbic acid, casamino acids, 
methylated 13-cyclodextrin and salts®
Imaizumi e ta l 1983
a NaCl, KCi. CaCl2 (anhydrous), Na2C0  ^(anhydrous), MgCl2(6H2Û), K2HPO4 
b as in a except no Na2C0  ^ (anhydrous) 
c as in d except no KCI
d as in b except add KH2P0  ^instead of K2HP0  ^ and add FeSO^ . 7H2O and CuSO^ . 5H2O 
e as in d except no MgCl2(6H20)
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pertussis vaccine. Verwey et aJ in 1949 compared a liquid medium they 
had prepared with Hornibrook's and other modified liquid media that were 
in use at that time. Basically, what they did was adjust the amount of the 
components in the medium or omitted some of them completely. Verwey 
and his coworkers also examined the optimal conditions for the growth of 
B. pertussJs. They claimed that their medium gave better growth than the 
others tested and that the vaccines that were produced using this medium 
were comparable to those prepared from BG medium. Verwey also made 
an agar form of this medium and, although on its own it was unsatisfactory, 
when 10-20 % blood ceils were added claims were made that it gave better 
results than the BG medium tested in parallel.
Anion exchange resins have also been shown to support the growth 
of virulent strains of B. pertussis as an alternative to starch or carbon 
(Kuwajima e t aJ, 1957). A liquid medium containing an anion-exchange 
resin was described in 1961 by Sutherland and Wilkinson and they were 
also able to produce a solid medium that compared favourably with BG 
medium. The anion-exchange resin was thought to remove inhibitors from 
the medium and inhibitors produced during growth.
D efined m edia and sm all Inocula. With defined media came a 
better understanding of the nutritional requirements of B. p ertu ssis. The 
replacement of starch and casein hydrolysate by activated charcoal and an 
amino-acid mixture, respectively, was undertaken by Wilson in 1963 in his 
search to produce a defined medium. His medium contained amino acids, 
glutamine, glutathione, inorganic salts, niacin, ascorbic acid, ATP, coenzyme 
A, DPN. TPN and nucleic acid derivatives.
Some workers described chemically defined media which were 
more useful for studying the nutritional requirements of the organism 
(Ungar e t ai 1950; Jebb and Tomlinson, 1955, 1957; Wilson, 1963). In 
1971, Stainer and Scholte produced a simple chemically defined medium
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consisting of sodium glutamate, cystine, proline, salts and growth factors, 
suitable for the large scale production of phase I B. pertussis
In most, if not all of the media described above, growth of B. 
pertussis could be obtained with large but not small inocula. In 1983, 
Imaizumi et aJ discovered the novel growth stimulant for B. pertussis 
heptakis (2,6-0-dimethyl)13-cyclodextrin (MefiCD). This was added to a 
complete synthetic medium such as SS and the same number of individual 
colonies and growth rates as with BG were obtained. As well as supporting 
growth from small inocula, the MeBCD was found to prevent the growth of 
other nasopharangeal flora (Aoyama e t a i 1986).
Cyclodextrin medium was initially used as an agar, with a basal 
medium similar to Stainer-Scholte, to which was added a supplement 
(Imaizumi e t a l 1983). GSM has been compared with BG medium and it is 
as good, if not better for the isolation and cultivation of B. pertussJs 
(Aoyama e t aJ, 1986). When 5{ig of cephalexin was added to GSM it 
increased its specificity for B. pertussis and made it a better clinical 
isolation medium than BG medium. It could also be used as a liquid 
medium. However the major restriction is that the MeBGD used in the GSM 
is expensive.
B. parapertu ssis
Growth in  th e  v e r te b ra te  host. B. parapertussis infections 
have been reproduced experimentally in mice (Ghen e t al, 1989). Natural 
infections have been noted in both humans (Linneman, 1979) and sheep 
(cited by Ghen et al, 1989). Very few studies have dealt quantitatively 
with the growth of this species within the confines of the animal or human 
host.
One study which examined some of these points was that of Ghen 
e t al, (1989) who induced an experimental pneumonia in mice using six 
strains of B. parapertussis which had been isolated from sheep
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bronchoaiveoiar washings. The inoculum (27 x 10^ CFU/ml) was instilled 
intranasally into three week old mice and sampling times over a period of 
29 days were used. The number of viable bacteria colonizing the lung at 
each sampling time was determined by plate counts and scored 
semi-quantitatively i.e. large numbers (+++), small (++), very small (+) and 
none (-). During the study period the viable count of B. parapertussis 
increased within the first couple of days when large numbers of bacteria 
were recovered from the lungs. The viable count then decreased and 
remained constant up until day eight. The numbers subsequently 
decreased to zero after day 14. There are no other reports similar to that of 
Chen et aJ (1989).
Growth on laboratory culture media. In general, media used 
for the isolation and culture of B. pertussis have been reported as also 
being suitable for use with B. parapertussis (Wardlaw, 1990).
Iso la tio n  a n d  tra n sp o rt m edia . Of the transport media 
described in Table 6 for B. pertussis three have also been employed for 
the primary isolation of B. parapertussis. These were Stuart's transport 
medium (Stuart, 1946), Amies transport medium (Amies, 1967) and the 
isolation and enrichment medium of Regan and Lowe (Regan and Lowe, 
1977). Mishulow, Sharpe and Cohen, in 1953, described a charcoal agar 
slope containing penicillin for transport of B. parapertussis to the 
laboratory before isolation.
Both BG agar (Lautrop, 1960) and modified BG agar (Kendrick and 
Eldering, 1969) have been used for the isolation of B. parapertussis from 
human specimens. In 1974, Gopaul and Yu used two media for the isolation 
of B parapertussis The first was BG agar containing 4 pg/ml of penicillin 
and the second contained the selective agent described by Lacey (1954). It 
consisted of a charcoal agar base with 10 % defibrinated horse blood and 2 
pg/ml of MScB 938. To this was added a further 40 pg/ml of cephalexin.
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Both media were used successfully for the isolation of B. parapertussis.
L a b o ra to ry  p ro p a g a tio n  m edia. Those media presented in 
Tables 7 and 8 are also capable of supporting the growth of B. 
parapertussis Being less fastidious than B. pertussis, B. parapertussis can 
be cultivated on MacConkey s agar and nutrient agar or in nutrient broth 
(Topley and Wilson, 1975). When B. parapertussis is grown on nutrient 
agar it causes a browning of the medium due to its ability to utilize 
tyrosine (see Table 1),
For references to the other media used for the cultivation of B. 
parapertussis the reader is referred to the previous section for B. 
pertussis.
B. b ro n cb isep tica
Growth in  th e  v e r te b ra te  host. Like B. parapertussis, there 
have been few studies of experimentally-induced infection of laboratory 
animals with emphasis upon quantitating the levels of bacterial growth in 
the animal's tissues.
In 1970 Shimizu and co-workers infected hysterectomy-derived, 
colostrum-deprived piglets, 5-6 days old, intranasally with a strain of B. 
bronchiseptica.T\i^ strain had been freshly isolated from the turbinate of a 
pig belonging to a herd with an acute rhinitis problem. The investigators 
attempted to recover B. bronchlseptica from the animals at 37 days and 
three months of age. No viable count was reported at time zero although 
reference was made to an inoculating suspension of 1 mg/mi (0.5 ml given) 
B. bronchlseptica. Upon sampling at 37 days over 50 CFU were recovered 
on a plate culture when a swab was taken of the mucosal surfaces of the 
turbinate and ethmoid, 10-49 CFU from the bronchi and 1-9 CFU from the 
lungs. After three months only a few bacteria were recovered from the 
ethmoid (10-49 CFU) and none was recovered from the turbinate, bronchi 
or the lung. Shimizu e t a l (1970) concluded that B. bronchlseptica
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multiplies in the aforementioned anatomical sites, causes damage and then 
decreases in numbers, disappearing from the respiratory tract of pigs three 
months after exposure.
Koshimizu e t aJ (1973) reported similar findings with intranasally 
infected conventional pigs aged 5-6 days of age. A volume of 0.5 ml of an 
initial inoculum of about 10^ CFU/ml was instilled and samples were taken 
at intervals of 1-2 weeks. At three weeks of age, B. bronchJseptJca was 
recovered from the nasal cavity, ethmoid, trachea and lung with greater 
than 100 colonies per plate from a single swab. The viable count remained 
constant for about 12 weeks (16 weeks in some cases) and then decreased, 
with no cells recovered after 22-24 weeks.
Other workers reported similar findings but no quantitation was 
recorded. Kemeny (1972) re-isolated B. bronchlseptica from young pigs 
al'ter intranasal inoculation of crude nasal washings from swine with 
atrophic rhinitis and also with a tryptone phosphate broth culture of a B. 
bronchlseptica strain isolated from the nasal washings. A similar inoculum 
to that of Koshimizu e t a l was used i.e. 1.5 x 10^ CFU/ml of which 4
ml was delivered with an atomizer.
Burek e t al (1972) successfully re-isolated B. bronchlseptica from 
the trachea, nasal cavity and lung of conventional and germ-free rats after 
aerosol infection, while Meyer and Beamer (1973) did likewise with 
intranasally infected germ-free swine. In this study B. bronchlseptica was 
also isolated from the intestinal tract. Brassinne e t a l (1976) intranasally 
infected gnotobiotic pigs with a strain of B. bronchlseptica isolated from 
the nasal cavity of a pig with atrophic rhinitis. He witnessed sneezing and 
coughing and re-isolated the bacterium from the ethmoid, turbinates, 
trachea and pneumonic lesions.
Similar findings have been reported in dogs infected by an aerosol 
of B. bronchlseptica (Thompson et al, 1976). B. bronchlseptica was
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recovered from the nasal cavity, trachea, bronchi and lung of the infected 
animals.
In none of these studies was reference to quantitation made. 
Growth on lab o ra to ry  cu ltu re  m edia. The media that are used for the 
isolation of B. bronchlseptica can generally be employed for the further 
cultivation of the organism.
Isolation and transport media. A number of different isolation 
and transport media have been assembled in Table 9.
Blood agar and MacConkey s agar appear to be the most popular 
isolation media (Thompson e t al, 1976. Be mis e ta l 1977b and Smith and 
Baskerville, 1979). Other workers modified MacConkey's to give better 
results and less contamination by the other bacteria of the respiratory 
tract. Farrington and Switzer (1977) added furaltadone and nystatin to 
double strength MacConkey's with 2 % dextrose. Be mis e t a l (1977b, 
1977c) used Levine eosin methylene blue agar for the successful isolation 
of B. bronchlseptica from both nasal and tracheal swabs from infected 
dogs.
In the study of Smith and Baskerville (1979) with pigs, two types 
of modified MacConkey's agar were used; 1) MacConkey's agar plus 1 % 
(v/v) glucose and 20 % MacConkey’s agar plus 1 % glucose and 20 pg/ml 
furaltadone. During this study a number of other isolation media were 
employed. In ajjdition to the modified MacConkey's medium and blood agar 
two other media were described for the selective isolation of B. 
bronchlseptica from pigs. Peptone agar was used which consisted of 
bactopeptone, glucose, lactose, sodium chloride, bromothymol blue and agar 
and a new medium named G 20G agar was also described. This medium 
was based on peptone agar with added penicillin, furaltadone and 
gentamicin. In these studies the anti-fungal agent fungizone was added to 
all of the agars described. G 20G medium proved to be the most successful
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Table 9 ; Isolation and transport media for B. bronchiseptica
Medium Reference(s)
Blood agar Thompson at a l,\^ l y  Be mis et al, 1977a; 
Smith and Baskerville, 1979
.MacConkey's agar Thompson e ta l 1976
Levine eosin methylene blue agar Be mis etal, 1977b, 1977c
Fisk and Soave, 1973
Modified MacConkey's agar Farrington and Switzer, 1977 
Smith and Baskerville, 1979 
De Jong and Borst, 1985
G 20 G agar Smith and Baskerville, 1979
Peptone agar Smith and Baskerville. 1979
Modified BG agar Rutter, 1981
Pasturella mu I  to d  da and De Jong and Borst, 1985
B. bronchlseptica selective agar
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in the isolation of B. bronchJseptlca.
Antibiotics have been used by other workers, for example, Fuzi 
(1973) used penicillin, streptomycin and vancomycin as selective agents. 
Nystatin and penicillin were used by Woode and McLeod (1967), 
furzoiidine by Koshimizu and co-workers (1973) and furaltadone and 
nystatin by Farrington and Switzer (1977).
A selective BG medium containing furaltadone, penicillin, 
amphotericin B, streptomycin sulphate and spectinomycin was used during 
an investigation of atrophic rhinitis in pigs (Rutter, 1981).
Amie s transport medium is usually the choice for B. bronchJseptIca 
(Bemis e t aJ, 1977b) when direct inoculation onto an isolation medium is 
not practicable.
L a b o ra to ry  p ro p a g a tio n  m edia. The culture media used for 
the other bordetellae (Tables 7 and 8) are also useful for laboratory 
maintenance and cultivation of B. bronchiseptJca Usually MacConkey's agar 
and blood agar are routinely employed and Brucella agar has also been 
used (Bemis e t al 1977c). The media described in Table 9 should be 
suitable as propagation media in addition to isolation and transport, as 
most are multi-purpose,
B. a viu m
Growth in the vertebrate host. Arp and McDonald (1985) 
produced a detailed study on the effect of temperature on the growth of B. 
avium  in turkeys. They reported viable counts in the tracheas of turkeys
f  'y
which were inoculated with 10^"^ CFU/0.5mi and then either heat-stressed 
140"C) or cold-stressed 135X or less). Figure 3 was reproduced from the 
original paper, in all cases there was an increase in viable count of B. 
avium  strains 78 and 838. The counts were expressed as log^Q CFU/cm
trachea. Seven to fourteen days after challenge, Arp and McDonald (1985' 
reported that colonization of cold-stressed turkeys was significantly less
39
Figure 3 : Growth of B. a viu m  in  vivo . Effect of temperature on 
growth of B. avium  strains 75 and 838 in turkey tracheas at 
35°C and 40°C. (from Arp and Me Donald. 1985 and 
reproduced with permission).
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than that in heat stressed birds i.e log^Q CFU/cm values of 6 and 6.5 in
cold-stressed birds (strains 78 and 838 respectively) compared to 5-5 and 
5 for heat-stressed birds (78 and 838 respectively). However by 21 days 
there was no significant difference between the two types of bird. 
Comparing numbers of bacteria in the upper and lower trachea of the 
turkeys the investigators found that in cold-stressed birds there were 
more organisms present in the upper than the lower portion of the trachea. 
The counts from the upper and lower trachea of heat-stressed turkeys 
were not significantly different. Observations after 21 days were not 
reported.
No other reports similar to this one or dealing with increases in 
viable counts within the avian host have been uncovered despite extensive 
searching.
Growth on la b o ra to ry  cu ltu re  m edia. The growth and isolation 
media used for B, avJum are the same as those for B, bronchsseptlca 
although other media which are only used for B. avium  are also described.
Isolation and transport media. In 1979, Simmons and 
co-workers isolated B. avium  from turkey polls using chocolate agar 
fortified with Iso Vitale X enrichment and included chloral hydrate to 
prevent the swarming of motile contaminating bacteria. The same workers 
used MacConkey's agar with 5 % agar to serve a similar purpose as the 
chloral hydrate. Simmons et a i (1984) used MacConkey's agar to isolate B. 
avium  from turkey poults as did Hofstad and Jeska (1985) and Blackall 
and Farrah (1985). In the study of Blackall and Farrah (1985) other 
isolation media used included blood agar and Salmonella-Shigella agar.
Laboratory propagation media. The media used for the 
isolation of B. avium  also serve as good cultivation media. For example, the 
isolation media used by Blackall and Farrah (1985) were employed as 
growth media in the same study. Kersters et al (1984) recommended the
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use of blood agar containing Columbia agar base and 7 % defibrinated 
ox-biood or veal infusion agar for the cultivation of B, avium.
During a study of the physical, biochemical and pathological 
properties of B. avium. Simmons and coworkers (1979) used brain heart 
infusion broth and agar for the cultivation of the bacteria. In 1983, Rimler 
and Simmons grew B. avium  on a number of different media including 
bovine blood agar, MacConkey's agar. Salmonella-Shigella agar and 
Simmons Citrate agar. Arp and McDonald (1985) used brain-heart infusion 
broth while Hofstad and Jeska (1985) employed dextrose-starch agar slants 
for cultivation.
In addition to the solid media described B. avium  should grow in 
the liquid media described for the other bordetellae.
Nutritional requirem ents of BordeteJIa
Early work on the nutritional requirements of this group dealt with 
B. pertussis. B, parapertussis and B, bronchiseptica (Proom, 1955, Rowatt, 
1955 and Jebb and Tomlinson. 1955, 1957). Later Kersters et ai (1984) 
detailed the requirements of B. avium
The BordeteiJa have relatively simple nutritional requirements 
with some similarities between species. All species have an absolute 
requirement for nicotinic acid and utilize amino acids as their primary 
carbon and energy source (Proom, 1955, Rowatt, 1955 and Kersters e t aJ. 
1984). Table 10 shows the minimal amino acid requirements of B. 
pertussis. B. parapertussis and B  bronchiseptica presented in a detailed 
study by Proom (1955). His results have been confirmed by other workers 
(Rowatt, 1955, Jebb and Tomlinson, 1955, 1957).
Glutamic acid appears to be the prefered amino acid and in simple 
amino acid mixtures is the first to be utilized by B. pertussis. B. 
parapertussis and B. bronchiseptica (Rowatt, 1955, Jebb and Tomlinson, 
1955, 1957; Goldner et a l 1966). B. bronchiseptica has the simplest needs
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Table 10 : M inim al n u tr itio n a l req u irem en ts  of B. p e r tu ss is , B.
p a ra p e rtu ss is  and B, b ro n ch isep tica . (modified from 
Proom, 1955)
Medium B,p Bpp B.jbr.
OL
L ABSM + complex amino acid (aa) 
mixture + nicotinic acid (NA)
2. Medium 1 without NA
3. ABSM + 7aa mixture
4. Medium 3 without glutamic 
acid
5. Medium 4 with alpha- 
ketoglutaric acid
6. ABSM + NA + glutamic acid + 
proline + leucine
7. Acetate citrate + NA
8. ABSM + NA  ^either alpha- 
ketoglutaric acid, acetate, 
citrate, glucose, glutamic 
acid or pyruvate
_c
d
a. Old lab strains 
are + with all 
but glucose
b. Fresh animal 
strains are + with 
lactate or citrate 
only
^ Ammonia Basal Salt Medium;  ^ phase I required starch;  ^with cystine; 
^ with cystine; ® with cystine and methionine
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and can grow in a mixture of glutamic acid, proline and leucine. Proom 
(1955) suggested that B, parapertussis required added cysteine and 
methionine and B. pertussis required in addition alanine, asparagine and 
serine for good growth (Prooml955). However Stainer and Scholte (1971) 
grew B. pertussis in a mixture of glutamate, proline and cystine.
None of the BordeteJIa utilize carbohydrates (Proom, 1955; Rowatt, 
1955; Jebb and Tomlinson, 1955, 1957; Xersters e t aJ, 1984) although B. 
bronchiseptica can use the organic acids lactate and citrate as alternative 
carbon and energy sources (Proom, 1955). This also is the case with B. 
avium  (Kersters e t a l 1984). Proom (1955) noticed that alpha-ketoglutaric 
acid could replace glutamic acid as the primary nutritional factor, even in 
the case of B. pertussis, if cystine was also added. B, pertussis appears to 
have an essential requirement for cystine, presumably as a sulphur source 
(Proom, 1955).
B. avium  has been the subject of least investigation and to date 
little work on the nutritional requirements has been undertaken. Its 
requirements appear to be similar to those of B. bronchiseptica with which 
it shares a number of other traits (see Table 2). B. avium  can utilize 
organic acids as a substitute for amino acids and in a simple amino acid 
mixture it used similar acids to those of B. bronchiseptica For information 
about B. avium  see Kersters etai{\9S4) .
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Part 3; Respiratory tract and its secretions
A natom y of the  re sp ira to ry  tra c t
For purposes of this thesis, the respiratory tract may be regarded 
as a system of branching tubes that fuse with the main airway and whose 
surface supports the growth of the bordetellae.
The trachea is a thin-walled tube composed of connective tissue 
strengthened at intervals by incomplete, C-shaped rings of cartilage which 
prevent collapse. It branches into the two main bronchi, whose structure is 
similar to that of the trachea and which is retained through the many 
successive branchings within the lungs, to the alveoli. The bronchi are 
supplied with blood by bronchial arteries and some of the deoxygenated 
blood is drained by bronchial veins. The lining of the tracheobronchial 
system protects the lungs from dehydration and invasion by foreign 
particles, including microorganisms.
The lungs develop at the ends of the bronchi, each lobe being 
served by an internal bronchus. The functional lungs are elastic spongy 
organs, consisting of several lobes, that occupy the thoracic cavity. Each is 
covered with a membrane, the pulmonary pleura, which forms a 
continuous sac, enclosing the lung and continuing as the parietal pleura of 
the chest cavity. The potential space between the pleurae is the pleural 
cavity and each lung is enclosed in a separate pleural cavity. The function 
of the lungs is gas exchange.
R esp ira to ry  tra c t flu ids.
Mucus and respiratory tract secretions arise from two sites, the 
submucosal glands and epithelial surface (goblet) cells. The collection and 
the composition of these secretions will be the main focus of attention for 
this section as it will be from the secretions that the bordetellae derive 
their nutrients during infection. Although there are reviews on respiratory
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tract fluids (Yeager ,1971, Boat and Cheng, 1980, and Richardson 1988) 
none contains information on potential BordeteJIa nutrients.
M ethods of Collection. Attempts to collect respiratory tract 
fluids date back to 1882 when Rossbank used blotting paper to dry the 
exposed tracheal mucous membrane of cats and dogs during his research 
into mucus replenishment (cited by Boyd, 1954). Table 11 summarizes 
early work on respiratory tract fluids.
Many of the early experiments used ai^sthetized animals with an 
indwelling tracheotomy tube, the system being brought to physiological 
temperature and humidity i.e. Boyd technique (Boyd, 1954). Another 
method, of use in short-term studies only, involved severing the trachea 
completely and fixing the transected ends inside a plastic cylinder, the 
secretions being collected from the cylinder (Hildlng, 1966). Figure 4 shows 
a few devices used for the collection of respiratory tract fluids. The " 
tracheal pouch " technique was described in dogs (Wardell, et a l 1969). 
With this method a 5-6 cm segment of trachea was isolated by transections 
above and below, the isolated segment having an intact blood and nerve 
supply. The two ends of the remaining airway were then anastomosed and 
healed satisfactorily. The proximal end of the isolated tracheal segment 
was then brought to the exterior and sutured to subcutaneous tissue in the 
neck. The distal end of the segment was ligated. The system remained 
sterile and the mucosa appeared normal by light microscopy. Repeated 
collection of secretions were made over a period of months with the dogs 
unanesthetized.
Most studies on human tracheobronchial secretions have been 
carried out on expectorated sputum from patients with chronic bronchitis, 
making the secretions abnormal from the beginning (see review by Yeager, 
1971).
Bronchoscopy was a common method which eliminated the
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Table 11 : Early research w ith respiratory tract fluids.
Method Reference
Drying exposed trachea mucus membrane Rossback, 1882%
of dogs and cats with blotting paper. Calvert, 1896%
Collection in calcium chloride tubes Henderson and Taylor.
attached to a tracheal cannula. 1910
Postural drainage and bronchoscopic Jackson and Jackson,
suction. 1934
Tracheal cannula with a glass tube 
attatched.
Perry and Boyd, 1941
^ cited by Boyd, 1954
47
Figure 4 Collection devices fo r re sp ira to ry  tr a c t  flu ids.
(Reproduced from Hilding, 1966 and Adams e t aJ, 1976, 
with permission)
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problem of contamination with oral secretions. It was usually necessary to 
irrigate with a saline solution to obtain the secretions even through the 
bronchoscope because of the small amount of material recoverable. An 
ingenious suction trap device connected to a warmed, humidified 
tracheotomy tube has been described for the collection of human 
tracheobronchial secretions (Toremalm, 1960). Keimowitz (1964) described 
another method. Immediately after induction of anesthesia (Halothane or 
nitrous oxide) a catheter was passed through the endotracheal tube and 
approximately 10 ml of isotonic saline was instilled then suctioned into a 
Luken's collecting tube (about 1 ml was recovered).
During his investigations into the chemical composition of 
secretions from patients with cystic fibrosis, bronchiestasis and 
laryngectomy (Matthews et aJ, 1963). secretions were expectorated onto 
gauze squares and the gauze was then pressed together to absorb the 
saliva. The saliva-free secretions from patients with cystic fibrosis and 
bronchiectasis were then transferred directly into plastic vials. The 
"normal" secretions were aspirated directly from their tracheostomies into 
plastic vials. All samples were kept at 5“C during the collection period and 
then stored at -70 X prior to analysis.
Adams at ^ (1 9 7 6 ) collected airway secretions from dogs on a 
plastic-coated glass fiber screen. This device can be seen in Figure 4. In 
studies on bronchoalveolar lavage fluids from smokers and non-smokers, 
Low at aJ (1978) employed transnasal fiberoptic bronchoscopy with 
pulmonary lavage. Four 60 ml boluses of sterile 0.9 % saline solution were 
instilled and immediately withdrawn through the channel of a 5.2 mm 
fiberoptic bronchoscope gently wedged into a subsegmentai bronchus of 
the right middle lobe or lingula. Transtracheal aspiration was used in only 
the most urgent cases as fatalities have occured (Pratter and Irwin, 1979). 
Oropharyngeal contamination was eliminated with this method. It involved
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insertion of a large-bore needle through the cricoid membrane extending 
only a few millimetres into the trachea. A catheter was then passed via the 
needle into the trachea and the needle removed. Specimens were obtained 
by suction with a 20-30 cc syringe.
Open lung biopsy has been used in compromised hosts where 
differential diagnosis includes infective and noninfective diseases. This 
method allows sampling of different anatomical sites and collection of 
larger specimens than less invasive biopsy proceedures (Yeager, 1971).
In most cases the processing of the secretions was similar; 
centrifugation was followed by décantation of supernates which were split 
into aliquots and stored frozen (-20X or -70X) if not used for immediate 
analysis (Yeager, 1971, Low et a l 1978, Boat and Cheng, 1980). 
Composition.
In the text that follows a distinction will be made, where possible, 
between secretions and washings Respiratory tract secretions (RTS) are 
taken to mean the undiluted fluid collected from the respiratory tract and 
tracheobronchial washings (TBW) to indicate that some kind of lavage 
procedure was used. Where it is not necessary to make this distinction the 
term respiratory tract fluid (RTF) will be employed.
Reviews on the composition of these washings and secretions 
include those by Ramirez, a / (1971), Yeager (1971) and Boat and Cheng 
(1980).
General Composition. The RTS from humans contained 
approximately 95% water and 5% solids (Matthews e t a t, 1963). Some of 
the water was free but much of it /s either bound at one of several levels of 
affinity to macromolecular components or was trapped within the 
interstices of a gel matrix, formed by polymerization and aggregation of the 
mucous glycoproteins and other macromolecular components. The free 
water and soluble components formed an aqueous layer, the periciliary
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fluid, bathing the cilia (Lucas and Douglas, 1934). The mucous gel overlay 
this layer. Recovery of the periciliary fluid alone for analysis was not 
possible, but, the aqueous fraction obtained upon centrifugation was 
thought to be similar in composition to the periciliary fluid (Boat and 
Cheng. 1980).
The solid content of human RTS included 2-3 % proteins (4 % in 
healthy dogs; Reasor, e t a i 1978) and glycoproteins, 1 % lipids and 1 % 
minerals (Matthews e t aJ, 1963). The fluids obtained from the trachea 
were somewhat hypertonic with an os molarity of 359 ± 56 mmole/1000 g 
(Boat and Cheng. 1980). The water in the RTS contained inorganic salts, 
proteins and glycoproteins (Richardson and Phipps, 1981).
5
With regard to the cellular content, degenerating macrophage^were 
most abundantly recovered from RTF (94.8 ± 2.8%) followed by 
lymphocytes (3.5 i  2%) and polymorphonuclear leukocytes (1.7 ±1.6%) 
(Low e t aJ, 1978). These figures were taken for lavage fluids and they may 
therefore be greater in the whole undiluted secretions.
fjaorgaijjc C om ponents, In 1954, Boyd reported chloride levels 
of 5.2 1 2.6 mg/ml in rabbit, cat and dog RTS. He also reported a potassium 
level of 0.76 mg/ml in the cat RTS.
Two studies which concerned themselves with the inorganic 
analysis of human RTS were those by Matthews e ta / (1963) and Potter ei 
aJ (1967). Their results can be seen in Table 12. Matthews et aJ (1963) 
investigated the overall chemical composition of pulmonary secretions 
while Potter et aJ (1967) studied the ionic enviroment of secretions from 
patients with cystic fibrosis, bronchiectasis and laryngectomy ("normal").
Sodium and chloride concentrations were high in " normal " 
secretions compared with potassium and calcium which occurred at much 
lower concentrations. Up to 15 % of the monovalent ions and 30 % of 
calcium were not removed by dialysis, suggesting that considerable ion-
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Table 12 : Inorganic composition^ of human and animal (stated)
respiratory tract secretions.
Reference Inorganic component 
(mean iSD)
Boyd (1954) Cl = 5.2 1 2.6 (rabbit, cat and dog) 
K = 0.76 (cat)
Matthews e /^ /(1963) Ca = 0.06210.02 
P -0 .2 7 i0 .1 6  
Na= 1.65 ±0.42 
Cl= 1.62 10.6 
K: = 0.132 iD.054
Potter e t a / [1967] Na = 211.1 i33 .8  mM/L 
K= 16.6 1 3.4 mM/L 
Ca = 2.45 1 1.11 mM/L 
Cl= 156.71 24,6 mM/L
^ mg/ml unless stated
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-binding to macro molecular components existed (Potter et al, 1967).
P ro tein s. Several studies have reported the protein content of 
human and animal RTF (see Table 13). Matthews et a l (1963) estimated 
that human secretions contained 10.0 i  3 mg/ml (mean ± SD) protein. In 
1978. Low and his co-workers measured the protein concentration of 
"normal" human TBW from healthy volunteers at 0.068 i  0.029 mg/ml 
(mean i  SD), while Davis <?/.2/(1982) reported that human TBW contained 
0.114 1 0.005 mg/ml of protein. The differences between these workers' 
findings and those of Matthews e t a l (1963) could be accounted for by the 
dilution effect during sample collection as previously described.
In animal RTS the protein concentration is variable. Adamson e t ai, 
(1969) reported a protein concentration of 0.3 mg/ml in the alveolar liquid 
from the foetal lamb. An earlier study by Boyd et al (1944) reported 
protein measurements in rabbits, cats and a cockerel of 1.04 + 0.21 mg/ml, 
1.36 1 0.37 mg/ml and 2.6 ± 0.4 mg/ml respectively (all mean tSEM).
The proteins in human and animal respiratory tract fluids include, 
as well as specific secretory products of airway cells, serum proteins which 
may be added by transudation from the vascular spaces of the lung. 
Albumin is the major serum component in the fluids, reported to be 
present in human TBW at a concentration of 1.42 + 0.2 mg/ml (Reynolds 
and Newball. 1974) and 17.4 i  9.0 ug/ml (Low e t a l 1978), and other 
serum proteins identified include the immunoglobulins, 
alpha-1-antitrypsin, alpha-1 -antichy motrypsin, antithrombin III, 
alpha-2 - macroglob ulin, transferrin, prealbumin, alpha-1-acid glycoprotein, 
fibrinogen, ceruloplasmin, hemopexin, haptoglobin, several complement 
components and others (review by Boat and Cheng, 1980). Table 14 shows 
the proteins secreted by airway cells from humans, some of whom were in 
an immunocompromised state.
Masson and Heremans (1973) found that lysozyme and lactoferrin.
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Table 13 : Protein concentrations reported for human and animal
(stated) respiratory tract fluids .
Reference Protein concentration (mg/mi)
(mean ±SEM unless otherwise stated)
Boyd et al ( 1944)^ 1,04 +,0.21 (rabbit)
1.36 + 0.37 (cat)
2.6 i.0.4 (cockerel)
Matthews <?/^(1963)^ 10.0 + 3 (mean + SD)
Adamson e t a l( l969)^ 0.3 (foetal lamb)
Low et al (1978)*^ 0.068 1 0.029 (mean tSD)
Davis e t al[\9% l'^ 0.114 t0 .005 (mean±SD)
 ^ refers to respiratory tract secretions 
 ^ refers to tracheobronchial washings
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Table 14 : Proteins in respiratory tract secretions, (modified from
Boat and Cheng, 1980)
Protein Ceil source
Cone, in 
bronchitic 
secretions 
(mg/ml)
Reference
Mucous glycoproteins Goblet cells 5-10 Matthews H
' Mucous glands (estimated) al, 1%3.
Lysozyme Serous glands 0,16-0.7 Brogan e ta l 
1975.
Lactoferrin Serous glands 0.05-0.05 Brogan etal, 
1975.
Kailikrein Epithelium — M&sson & 
Heremans 1973.
Pro line-rich proteins ? — BailieuI e ta l 
1977
An tipro teases Surface epithelium 
and glands
— Tegner & 
Ohlsson, 1977.
Secretory component Surface epithelium 
Mucous glands
— Reynolds & 
Newball. 1974.
IgA Plasma cells 0.4-0 2
IgG Plasma cells 0.05-0,21 Kaltreider, 1976.
IgM Plasma cells —
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which have antimicrobial properties, were secreted by submucosal glands 
at high concentrations. Several antiproteases appeared to be secreted by 
airway tissues and these inhibited trypsin, chymotrypsin and leukocyte 
proteases (Boat and Cheng, 1980). The majority of antiprotease activity in 
airways was contributed by lung-specific antiproteases while the 
remainder was derived by transudation of serum antiproteases. 
Proline-rich polypeptides have been detected in both bronchial secretions 
(Bailleul et aJ, 1977) and saliva (Carlson et a l, 1970), and these may be 
structural components of secretory granules released during the secretory 
process (Boat and Cheng, 1980).
The glycoproteins, secreted by mucous cells of submucosal glands 
and by goblet cells of the surface epithelium, were largely responsible for 
the gelation of airways secretions. There has been much investigation into 
the glycoproteins but here it will suffice to say that they are indeed 
present in the secretions and have a composition similar to that of other 
mammalian epithelial glycoproteins, and that they give mucus its 
characteristic properties of viscosity and elasticity (Yeager e t aJ, 1971 and 
Reasor e t ai 1978).
Im m u n e sy s te m  com ponents. Specific antibodies associated 
with the external fluids have been identified and characterized, supporting 
the hypothesis that mucous membranes may have their own immune 
system (Yeager, 1971).
Early studies by Keimowitz (1964) and Masson et aJ, (1965) 
detected immunoglobulins in human RTF. Keimowitz (1964) reported the 
presence of ^-globulin and gamma-globulin while Masson et aJ (1965)
identified IgA and IgG.
Reynolds and Newball (1974) reported the presence of three 
immunoglobulins in human TBW (Table 15). They measured IgA 
concentrations of 0.9 / 1 0 .11 mg/ml, IgG concentrations of 0.17 + 0.005
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Table 15 : Iminunogiobuiins detected in human and animal
(stated) respiratory tract fluids.
Reference Immunoglobulin content
(mean iSD)
Reynolds and Newball (1974) IgA = 0.91 ±0.11 mg/mi
' IgG = 0.17 ± 0.05 mg/ml
IgE = 73.2 ±8.2 ng/ml
Reasor ,2/  (1978) IgG and IgM detected (dog)
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mg/ml and and IgE concentration of 73.2 ± 8.2 ng/ml. Reasor et aJ (1978) 
showed the presence of IgG and IgM (not detected in human washings; 
Reynolds and Newball, 1974) in dog TBW and by immunodiffusion IgA was 
also detected. Together with albumin, Reasor et aJ (1978) found that IgG 
made up about 70 % of the total protein in the TBW supernates, IgG has 
been reported as the predominant immunoglobulin in dog pulmonary 
washings (Kaltreider and Chan, 1976).
C arbohydrates. Carbohydrates made up from 20-50% of the 
nondialyzable material in airway fluids (Yeager. 1971). In 1963 Matthews 
e t a l measured the concentration of carbohydrate in human RTS at a level 
of 9.51 ± 2.18 mg/ml (mean ± SD). Other workers confirmed the presence of 
carbohydrates in human washings (see Table 16). Potter et aJ (1967) 
reported a carbohydrate concentration of 19.3 ± 9.4 mM/mi (mean + SD), 
while Low e t aJ (1978) reported a concentration of 0,008 ± 0.004 mg/ml 
(mean + SD). A similar concentration to that reported by Low e t a l (1978), 
in human TBW of 0.01 ± 0.002 mg/ml (mean + SEM) was reported by Davis 
e t aJ, in 1982. Again the differences between concentrations recorded by 
Potter e t aJ (1967) and the latter two workers were probably due to the 
dilution effect encountered by Low, and Davis, during collection of the 
fluids.
In the study by Potter e t a l (1963), a description of the 
carbohydrate content of whole pulmonary secretions was given (Table 17). 
The " normal " secretions were taken from laryngectomized patients and 
the monosaccharides found were N-acetyl hexosamines (N-acetyl 
glucosamine and N-acetyl galactosamine), galactose, manose, fucose and 
sialic acids (Yeager, 1971). No uronic acids were detected, hence no acid 
mucopolysaccharides were present (Schultz and Heremans, 1966).
L Jpids. Human tracheobronchial washings contain relatively large 
amounts of lipid, up to 40 % of the dried, insoluble material (Sahu and
58
Table 16 : Carbohydrate concentration^ in human respiratory  
tract fluids.
Reference Carbohydrate concentration
(mg/ml unless stated)
Matthews e ta l (1963)^ 9.51 ±2.18
Potter et a l W ^ l ^ 19.3 ± 9.4 mM/ml
Low et a l{ \9 1 ^ f ' 0.008 ±0.004
Davis <?/Æ/11982)^" 0,011 ±0.002 (mean±SEM)
 ^ mean + SD unless otherwise stated 
 ^ refers to respiratory tract secretions 
 ^ refers to tracheobronchial washings
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Table 17 : Carbohydrate content of pulmonary secretions from  
normal" patients, (information from Potter e t aJ,1963)^
% of total carbohydrate
Fucose Sialic acid Hexosamine Hesose
21.0 ±3.8 20.7 ±2.8, 31.2 ±2.3 25.5 ±3.8
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Lynn, 1977). A number of studies have yielded different results for the 
concentration of lipids and phospholipids in human and animal TBW (Table 
18). Again the dilution effect may explain this. In 1954, Boyd reported the 
lipid contents of three animal RTS. He found that while cat and rabbit RTS 
had similar lipid contents of 0.22 mg/ml and 0.28 mg/ml respectively the 
concentration of lipids in dog RTS was higher (0.85 mg/ml).
Matthews at al (1963), in his work with human RTS found a total 
lipid concentration of 8.4 ± 2.7 mg/mi (mean t  SD) with Potter et (1967) 
reporting a concentration of 19.3 ± 9.4 mM/L (mean ± SD). Low et ai 
(1978) measured the lipid concentration of human TBW in three parts. 
Mon-polar lipid was present at a concentration of 0.0778 ± 0.0768 mg/ml, 
polar lipid at 0.0441 ± 0.0415 mg/ml and phospholipid at a concentration 
of 0.0011 ± 0.0003 mg/ml (all mean + SD). The lipid in human washings 
measured by Davis et al in 1982 was similar to that reported by Low et a^  
(1978) i.e. 0.167 ± 0.0219 mg/ml (mean + SEM), but less than the reports 
for undiluted RTS.
Table 19 shows the phospholipid analysis of human TBW from 
healthy volunteers in Low's study (1978). Analysis of phosphatidylcholine, 
which is the lung surfactant responsible for surface tension in the lung to 
prevent collapse (Morgan, 1971). revealed large amounts of saturated fatty 
acids (72.5 i 5.8% palmitic acid, 16:0). Other fatty acids present included 
stearic (18:0), oleic (18:1), linoleic (18:2), palmitoleic (16:1) and myristic 
(14:0) (Low et a l , 1978). The presence of fatty acids in RTS has been 
reported elsewhere (Boyd, 1954} for other species i.e. cat, rabbit and dog.
Amino Acids. Only one report has been found which refered to 
the free amino acid concentration of human RTS. In a study by Potter et a^  
(1967) the amino acid concentration of "normal" human RTS was reported 
to be 31.8 1 16.6 mM/L.
Other reports refered to non-protein nitrogen concentrations (Boyd,
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Table 18 : L ipid/phospholipid concentrations^ in human and 
animal (stated) respiratory tract fluids.
Reference Lipid/phospholipid concentration 
(mg/ml unless otherwise stated)
Boyd (1954)^ 0.22 (cat)
0.28 (rabbit) -
0.85 (dog)
Matthews ( 1963)^ 8.4 1 27
Potter 19.3 ±9.4 mM/L
Low et al (1978 )^ 0.0778 ± 0,00768 (non-polar lipid)
0.0441 ±0.0415 (polar lipid)
0.00109 ±0.00033 (phospholipid)
Davis <?/^/(1982)^ 0.167 ±0.0219 (lipid; mean±SEM)
0.00109 ±0.00016 (phospholipid;
mean ±SEM)
^ mean + SD unless stated
^ refers to respiratory tract secretions 
 ^refers to tracheobronchial washings
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Table 19 : Phospholipid content of pulmonary w ashings from  
" normal " patients, (information from Low et al 1978)
Phospholipid % of total lipid
Phosphatidylcholine 83-8 ±7.5
Phosphaiidylglycerol 12.3 ±4.6
Diphosphatidylglycerol 1.1 ± 1.1
Phosphatidylinositol 1.2 ± 1.9
Phosphatidylethanoiamine 0.3 ±0.5
Phosphatidic acid 0.4 ±0.5
Phosphatidylserine 0.7 ±0.8
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1954 and Matthews et al 1963). Boyd's reported concentrations of 
non-protein nitrogen in rabbits, cats and dogs of 0.63 ± 0.25 mg/ml, 0.35 ± 
0,35 mg/ml and 0.3 ± 0.3 mg/ml respectively (all mean ± SD). Matthews et 
aJ (1963) reported non-protein nitrogen levels of about 0.5 mg/ml in 
"normal" human RTS.
An interesting point of note was the change in the composition of 
the secretions with the disease status of the host. In studies with patients 
with cystic fibrosis, bronchiectasis and laryngectomy it was found that as 
the severity of the disease increased so did the content of organic 
constituents, such as DNA, protein, lipid, and carbohydrate, with a 
corresponding decrease in the inorganic content i.e sodium, calcium, 
potassium, etc, (Potter et aJ, 1967). It has also been reported that the 
amino acid content of washings increases with the severity of infection 
(Potter et al 1967). Table 20 shows the relationship of solids, amino acids 
Na, Cl, and Ca in tracheobronchial secretions of various diseases. (Potter ei 
aJ, 1967 and Chernick and Barbero, 1963).
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Table 20 : Relationship of solids. Na, Cl, Ca and amino acids in
respiratory tract fluids in various diseases.
(modified from Chernick & Barbero, 1963)
% solids % Na and Cl % Ca % Amino acids
Respiratory infections 
(e.g. common cold) 
Tuberculosis 
Bronchiectasis 
Cystic Fibrosis
The arrows indicate increasing (downward^ 
or decreasing (upwards) concentrations 
of constituents in respiratory-tract 
fluids in different disease states.
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O B J E C T  OF R E S E A R C H
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Previous studies on the In vitro  growth of the bordeteilae have 
focused almost exclusively on the isolation and cultivation of the bacteria 
in complex or defined media. Hitherto there has been no study of the 
possible growth of the organisms in the fluids of the respiratory tract of 
host species.
The objects of this investigation were therefore :
a) to determine whether each of the four species of BordeteJJa is 
capable of In vitro  growth in tracheobronchial washings (TBW) 
from a variety of host and non-host species.
b) Whether there is any evidence of host/parasite growth 
specificity which might account for the host preferences of the bordeteilae.
During this work there emerged the unexpected observation that 
Bordetella broncAIseptIca could grow in non-nutrient control fluids such as 
phosphate buffered saline and distilled water. This lead to a study of the 
growth and survival of this species in lakewater and seawater.
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M A T E R I A L S  A N D  M E T H O D S
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Part 1. Bacterial cultivation, preparation and standardization.
Organisms, strains and storage
A total of nine strains of bordetella was used in this investigation, 
comprising one strain each of B. pertussis, B, parapertussis and B, avium  
and six strains of B. bronchiseptica (Table 21). Some of the strains such as 
B. bronchiseptica no. 5376 had been in long-term laboratory culture while 
others {B. bronchiseptica strain no. 13325) were recent isolates.
Other organisms used included Escherichia coli strain no. JM S3, 
Lactobacillus piantarum, both from the departmental culture collection 
and Pasturella haem oiytica strains S/C 82/1 and W/D 83/4, provided by 
Mr. Qurban All
For preservation of cultures, a turbid bacterial suspension was 
prepared with growth from a Bordet-Gengou (BG) agar plate in 2 ml, 1 % 
(w/v) casamino acids (Gibco), and 300 ul of this suspension was added to a 
solution of 2.1 ml casamino acids and 0.6ml glycerol and stored at -70X in 
0.3 ml portions. £, co il JM 83 was grown on nutrient agar (Oxoid) and 
frozen suspensions were prepared in a similar manner. The two strains of 
P, haem oiytica were stored at -70X in a 50 %(v/v) glycerol/ brain heart 
infusion broth (BHIB) mixture, while Z. piantarum  was stored in a 
refrigerator (4X) on stab cultures of Micro Assay Culture Agar (Difcoj.
Re agent-grade water (RGW)
RGW was produced from tap water by serial passage through 1) a 
pre-filter (Sparkler Filters GB/LTD); 2) a Milli-RO^^ 4/15 Laboratory 
Grade Water System, comprising a Regard prefilter cartridge followed by a 
reverse osmosis cartridge; and 3) a Milli-Q^^ Reagent-Grade Water System 
(Millipore), consisting of a carbon cartridge and two ion-exchange 
cartridges. The final conductivity was not more than 0.2 uS/cm.
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Table 21 : Organisms and strains used in this research.
Species Strain Obtained from Comments
B. pertussis 18334 Connaught Lab. Ltd. A vaccine strain
Toronto
B. parapertussis 10520 Dr. R. Par to n^ NCTC strain
B. bnmchiseptica 5376 Dr. R. Par ton As used by Eldering 
(1962)
452
10541
6353
NCTC
NCTC
Dr. D. J. Taylor^
Type strain
As used by Lacey 
(1952)
Isolated from a dog 
(1985) with severe 
respiratory disease
13325 Dr. D J. Taylor Isolated from a 
horse (1990) with 
chronic
respiratory disease
B. bivnchiseptica. 11 Dr. D. J. Taylor Isolated from a pig 
(1986) used in 
pathogenicity 
studies
B. avium P4091 Dr. R. Par ton Dr Rimler, USA
Table 21 (continued)
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Escherichia
coli
JMS3 Dr. R. Par ton no information
lactobaciJJus
piantarum
Dr. R. Par ton Standard strain for 
analysis of nicotinic 
acid.
Pasturel/a
haemoiytica.
S/C 82/1 Glasgow University 
Veterinary School
From bovine lungs 
field case of 
pneumonic 
Pasturellosis.
Pastureîîa
haemoiytica
W/D83/4 Glasgow University 
Veterinary School
Healthy animal 
Bovine
Nasopharyngeal
swab.
 ^ Glasgow University. Microbiology Department Culture Collection. 
 ^ Glasgow University
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Single-distilled  water (DW)
DW of conductivity not more than 1.0 uS/cm was collected from a 
Fistreem^*^^ Cyclon (Fisons) distillation apparatus.
Fresh lake and pond water
Samples were obtained from a garden pond, a reservoir and various 
lakes in the Glasgow area (Ordnance Survey map coordinates: pH): garden 
pond (OS 64, 514715; pH 7.6). Milngavie Reservoir (OS 64, 556765; pH 7.1), 
Loch Achray (OS 57, 513064; pH 7.0), Loch Ard (OS 57, 475020; pH 7.1), 
Loch Katrine (OS 57, 495074; pH 7.2), Loch Lomond (OS 59; pH 7.1) and 
Lake of Menteith (OS 57, 588005; pH 6.9). In addition, sea water was 
obtained from the pier of the University Marine Biological Station Millport, 
Isle of Cumbrae (OS 63, 176545; pH 8.4). All samples were sterilized by 
filtration through a 0,45 um membrane filter (Gelman Sciences), the initial 
portion of filtrate being discarded, and stored frozen at -20 X. 
Phosphate-buffered saline (PBS)
PBS was prepared with analytical grade chemicals, by dissolving 7.99 
g NaCl, 1.196 g Na2HP0 ,^ 0.212 g KH2PO4 fall BDH Ltd) and 0.199 g KCl
(Koch-Light Laboratories Ltd), in DW or RGW to a final volume of 1.0 litre. 
By removing small portions of the PBS and testing the pH after the addition 
of alkali or acid the pH was adjusted to 7.2. The solution was sterilized in a 
pressure cooker (12IX  for 15 min) containing DW or RGW as the source of 
steam.
Bordet-Gengou (BG) medium.
BG medium consisted of 40 g BG agar base (Gibco Europe) with 1 % 
(v/v) glycerol, dissolved at lOOX in DW to a final volume of 1 litre. It was 
adjusted to pH 7.6 and sterilized at 121X for 15 min. After cooling the base 
to 5OX, defibrinated horse blood (Becton Dickinson) was added to give 
15-20 % (v/v) and 15 ml portions poured into 50 mm deep-vented petri
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dishes (BDH Ltd.). The plates were stored at +4“C in sealed plastic bags and 
discarded after three weeks if not used.
Cyciodeitrin liquid (CL) medium.
CL medium was prepared as described by Imaizumi et al (1983) by 
dissolving 10.7 g sodium 1-glutamate, 2.5 g NaCl, 0.5 g KH2PO4 0.1 g
MgC1^ .6H20. 0.02 g CaCl2 (all from BDH Ltd), 0.2 g KCl (Hopkin and
Williams), 6.25 8 Tris (Boehringer Mannheim GmbH), 10 g Casamino Acids 
(Gibco), 0.24 g L-proline (Sigma) and 1.00 g cyclodextrin (a gift from J. 
Shimizu, Teijin Ltd., Tokyo, Japan) in DW to a final volume of 1 litre at pH 
7.4. It was sterilized in a pressure cooker at 12TC for 15 min. A 
supplement consisting of 0.01 g FeSO^ (BDH Ltd), 0.04 g L-cysteine, 0.004
g niacin, 0.15 g glutathione and 0.4 g ascorbic acid (all from Sigma) in 10 
ml DW, was sterilized by passage through a 0.45 jJ.m membrane filter 
(Gelman Sciences) and added to the autoclaved components, immediately 
before use, in volumes of 0.1 ml per 10 ml of medium. The supplement was 
stored at -20T  and discarded after two months.
Preparation and standardization of inoculum
Deep-frozen suspensions (-70X) of bacteria were plated onto BG 
medium and incubated for 24h at 37X. The purity of the grown cultures 
was checked by Gram staining, after which the growth was scraped from 
the BG medium, suspended in 3 mi PBS and the optical density at 540 nm 
adjusted with PBS to 0.45 in a 1 cm cuvette. The cell suspension (1 ml) was 
then washed three times in PBS by centrifuging at 10,500 rpm for 15 min 
in a Haemicrofuge (Wifug Laboratory Centrifuges) at room temperature, 
the supernate removed and the pellet resuspended in 1.0 ml of PBS. During 
the centrifugations the temperature in the fluid typically rose to 36X. The 
thrice-washed suspension was diluted in PBS to give an inoculating
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suspension of 1900 ± 850 (SEM) CPU/ml. Figure 5 shows the dilution 
scheme for each of the four bordeteilae.
Special precautions
Glassware in some experiments was cleaned by overnight immersion 
in concentrated nitric acid, after which it was rinsed five times with DW 
and soaked for a further 24h in DW. A final rinse in DW was given and the 
complete removal of acid was verified by showing that the rinsings had the 
same pH as DW straight from the still. Plastic screw caps for the bottles 
were boiled for 15 min in DW, placed in a covered beaker and allowed to 
dry overnight at 37X. Sterile plastic 30 ml universal containers and 7 ml 
bijou bottles were obtained from BDH Ltd. Plastic pipette tips were boiled 
for 5 mill in RGW and sterilized in a pressure cooker ( 12IX  for 15 min) 
containing RGW. Triflex vinyl examination gloves (Baxter) were worn when 
handling the tips before autoclaving.
Growth model for experim entation
Fluids (975 uD to be tested for growth-supporting ability were placed 
in sterile 7 ml plastic bijou bottles (Sterilin) and inoculated with 25 Jil of 
washed bacterial suspension containing approximately 1900 ± 850 (SEM) 
CFU/ml. A sample of 20 |il was taken immediately after inoculation and 
plated on BG medium to give the zero-time viable count. The bottles were 
then incubated at 37X on a Mk IIIB shaker (LH Engineering Co. Ltd) 
rotating at 110 rpm. To monitor the death, survival and/or growth of 
BordeteJJa species at 37X, samples were removed from the inoculated 
fluids at 0, 24 and 48h, and at later times up to 2-3 wk in some 
experiments, and plated (20 ul) on to BG medium. Based on preliminary 
experiments, the samples were plated either undiluted or after a number 
of 10-fold dilutions in CL medium. The BG plates were incubated at 37X 
for 48h, or longer with B, pertussis, when colonies were counted.
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Figure 3 : Dilution scheme for the inoculum preparation of the 
four species of BordeteJJa.
Lawn plate culture
OD54Q - standardized suspension
Washed bacterial suspension
1 in 100 Dilution
1 in 10 Dilution 1 in 100 Dilution
1 in 2 Dilution 1 in 2 Dilution 1 in 1.4 Dilution
B. pertussis B. bronchiseptica B. avium  B. parapertussis
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Dry w eight determ ination of B. bronchiseptica  strain no. 5376.
The confluent growth from four small (50 mm) BG plates was scraped 
into 10 ml of PBS to form a thick bacterial suspension of B. fyronchJseptJcâ 
strain no. 5376. A 1 ml sample of the suspension was diluted to an OD^^q
of 0.45 with PBS (as described above) and the OD of the undiluted 
suspension was thus calculated. Two 1 ml aliquots were placed in tared 
microcentrifuge tubes and cell pellets obtained after centrifugation at 10, 
500 rpm for 15 min in a Haemicrofuge (Wifug Laboratory Centrifuges) at 
room temperature and décantation of the supernate. Two empty 
microcentrifuge tubes were weighed as zero-sample reference controls.
All four tubes were placed in a dessiccator containing P2O5 (BDH) and
dried to constant w^eight at room temperature, over a period of one week. 
The dry weight of the cell pellet was taken as the average weight in the 
two tubes, after subtracting the weight of the empty tubes and accounting 
for any weight change in those tubes. The number of bacteria present in a 
cell suspension of OD^^q = 0.45 was calculated from the initial viable
counts of previous growth experiments and this was used to give the viable 
count for the original thick bacterial suspension. From this figure the 
weight of one CFU of B. bronchiseptica was calculated by dividing the 
weight of the cell pellet by the number of bacteria present in the pellet. 
Long-term survival of B. bronchiseptica  in PBS and fresh  w ater  
B. bronchiseptica strains NCTC 452 (type strain), 6353 (from dog.) and 
No. 11 (from pig) were incubated and sampled over a period of six months 
at dilTerent temperatures in an attempt to assess the longevity of the 
bacteria in PBS and fresh water. The preparation of the inoculum and 
experimental system were as previously described. Each strain was 
inoculated into IS bottles of PBS and 18 bottles of membrane-filtered fresh
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water collected from Loch Lomond. Incubation was at 37X shaken (nine 
bottles) and lOX static (nine bottles) and the caps of the bottles were 
screwed tight. Some of the bottles were weighed before inoculation and all 
were weighed after inoculation in order to monitor, and correct for, 
evaporation  over the incubation period. Two empty bottles (blanks) were 
also weighed and incubated (one at each temperature) to detect weight 
changes in the bottles themselves (e.g. due to variable atmospheric 
pressure). Two uninoculated controls of each fluid were included, one 
incubated at 37X and the other at lOX. With strain No. 11 only 10 bottles 
of each fluid were set up (five at each temperature) although all other 
conditions were as described for the other two strains.
Weighings were taken throughout the incubation period. Bottles 7, 8 
and 9 (strain Nos. 452 and 6353), 4 and 5 (strain No. 11) and the blanks 
were weighed after 1 week and thereafter at the end of each month. Any 
weight loss as a result of evaporation was corrected by the addition of 
sterile distilled water.
Samples from one of the other bottles were taken at 1 week, 1 month, 
three months and six months and plated onto BG agar and incubated at 
37X until growth appeared. Undiluted samples and serial 10-fold dilutions 
were taken to obtain a viable count at each interval.
After approximately three months, one bottle (number 1] from each 
set of conditions was sacrificed for an investigation of wall growth. The 
contents were discarded into a disposal jar, the remaining fluid being 
removed with a pipette. A fresh 975 |il portion of sterile PBS was added to 
the bottles and, after vigorous vortexing, an undiluted 20 ul sample was 
plated onto BG agar and incubated for 24-48h at 37X until growth 
appeared. If no growth had appeared after 4-5 days incubation, the plates 
were discarded.
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Part 2. Collection of tracheobronchial washings (TBW)
Mouse TBW
Adult mice were used to collect the TBW. Each mouse was killed in a 
glass jar containing CO2 and pinned out on its back on a board. The fur and
skin were removed from the throat using a scalpel and folded back. An 
incision was made to expose the trachea and a hole pierced in the trachea 
with dissection scissors. A canula, of diameter approximately 1 mm, with a 
2 mi syringe attatched to the end was inserted into the trachea and tied in 
with fine thread and 1.5 ml of PBS passed into the lungs. After 10-15 
seconds the fluid was sucked out and transferred to a 30 ml plastic 
universal. The TBW collected from 20-30 mice on the same day was pooled, 
except that any with visible blood contamination (pinkish tinge) was 
discarded.
The washings were spun in a laboratory bench centrifuge (MSE minor 
'S’) at lO.OOOrpm for 15 min. The supernate was then filter-sterilized 
through a 0.45 um filter (Gelman Science) into 1.2 ml aliquots dispensed 
into microcentrifuge tubes. The tubes were stored at -20X as were the 
pellets from the centrifugations.
Horse TBW
Approximately 93 ml of TBW was obtained by Professor A.C. Wardlaw 
at Glasgow University Veterinary School from a 16-year old Arab stallion 
with a spinal weakness which had had to be put down. The fluid was 
centrifuged at 10,000 rpm for 15 min. Some of the supernate was stored in 
bulk before sterilization. The remainder was filter-sterilized (as with 
mouse TBW) into 3 x 20 ml portions, in 30 ml sterile plastic universals, and 
in 1.2 ml aliquots in microcentrifuge tubes and stored at -20 X.
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Rabbit TBW
The collection of rabbit TBW was similar to that for mouse TBW. The 
only differences were that the rabbits were killed by an overdose of 
Sagittal (1-1.5 ml). The canula used was larger (diameter of 2-3 mm) and 
40 ml of PBS was used to irrigate the lungs. Centrifugation, sterilization and 
storage were as before.
Sheep TBW
TBW was provided by Glasgow University Veterinary School. The 
lungs from freshly slaughtered normal sheep were removed and rinsed 
with approximately 100 ml of PBS, the first rinsings being separated from 
rinses 2 and 3- The PBS was poured into the sheep trachea and removed 
after 10-15 seconds. Centrifugation, sterilization and storage of the TBW 
and cell pellets were as before.
Chicken TBW
Chickens were provided by The Royal Hospital for Sick Children 
(Glasgow). Two year old black-spotted chickens used for blood harvest 
were used for lung washing. The procedure was similar to that used in the 
collection of mouse TBW and approximately 20-30 ml of fluid was 
obtained. Centrifugation, sterilization and storage of the TBW and cell 
pellets were as before.
Dog TBW
TBW was obtained from a 14 kg mongrel bitch at the Glasgow 
University Veterinary School. The dog was premedicated with 
acetylpromazine. Anaesthesia was induced with 5 %(w/v) sodium 
thiopentone and maintained with halothane/nltrous oxide/oxygen during a 
4h operation. The dog was killed with an injection of barbiturate. The 
trachea had previously been intubated with a leak-proof cannula and 
approximately 200 ml of sterile PBS was poured in within 1-2 minutes of
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death. This was then recovered by tilting the operating table and letting 
the fluid run out under gravity. Processing of the TBW was as previously 
described.
Human bronchial lavage specim ens
A total of six human specimens were provided by Dr. Neil Thompson 
and Dr. Hulk of Glasgow Western Infirmary. These samples were taken 
from elderly male and female patients (by bronchial lavage with sterile 
saline) who had some form of non-infectious lung or bronchial disorder. 
Only three of the six samples were used in this study
The pH of all the TBW was measured with Johnson's test paper and 
found, in all cases to be approximately 7.
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Part 3- Biochemical methods
Blood coatam inatioa
During the collection of the TBW samples it was normal for some blood 
contamination to occur. Since this could lead to additional nutrients being 
supplied by the blood, it was necessary to measure the amount of blood in 
the sample.
The assay employed was a modification of the Sigma kit, procedure 
number 525, used for the quantitative, colourimetric determination of 
whole blood at 530-550 nm. The reaction involves the conversion of all of 
the haemoglobin present in the sample to cyanmethaemoglobin by addition 
of a mixture of potassiun ferricyanide and potassium cyanide (Drabkin 
reagent). This compound is red in colour and can be measured 
spectropliotometrically at 540 nm.
Drabkin solution was prepared by reconstituting Drabkin reagent 
(Sigma Catalogue No. 525-2) with 1000 ml distilled water. To this was 
added 0.5 ml of 30 % Brij-35 solution (Sigma Catalogue No. 430AG-6) and 
the resultant solution was mixed well and stored in an amber bottle at 
room temperature. The haemoglobin standards were dilutions of whole 
mouse blood . The fresh blood was added, immediately upon collection, into 
PBS to give a 2% (v/v) solution and stored frozen until used.
The test was performed as follows. Two or more test tubes were 
labelled BLANK, TEST 1, 2. 3, etc and 2.0 ml of Drabkin solution was added 
to each. The TBW samples (0.5 ml) were added to the tubes labelled TEST, 
mixed and allowed to stand for at least 15 min at room temperature 
(18-26X). The BLANK contained 2.0 ml of Drabkin solution plus 0.5 ml of 
PBS. The absorbance at 540 nm of TEST vs BLANK was recorded for each 
TBW and the concentration of haemoglobin in the sample calculated from
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the calibration curve. The standards for the calibration curve were 
dilutions of whole mouse blood at 1 %, 0.5 %, 0.25 % and 0.125 % (v/v). 
These were treated in the same way as the samples. The haemoglobin 
contents of the unknown samples were interpolated on to the standard 
curve and expressed as mean iSEM % (v/v) mouse blood.
Amino acids
The amino acid content of TBW was measured by a modification of the 
ninhydrin method of Moore and Stein (1948) applied after the 
precipitation of the proteins of TBW with sulphosalicylic acid.
The precipitation of proteins from the TBW was performed as follows: 
500 ul of 4 %(w/v) 5“Suiphosalicylic acid (AnalaR) was added to 500 ul of 
the TBW in a microcentrifuge tube, and left at 4X for at least 4h. The 
mixture was then centrifuged in a Hemicrofuge (WIFUG Laboratory 
Centrifuges) at 10,500 rpm for 10 min after which the supernate was 
decanted aiK^hen used for analysis.
A citrate solution was prepared with 4.3 g citric acid (M&B) plus 8.7 g 
sodium citrate (BDH) in 250 ml of distilled water and adjusted to pH 5.0 
with HCl or NaOH. To this, 400 mg of stannous chloride (BDH) was added 
immediately before use. Gentle heating in a water bath at 40X was 
required to dissolve fully the stannous chloride. A 50 % (v/v) iso-propanol 
solution (Koch-Light Laboratories Ltd) was prepared (500 ml). A 
ninhydrin solution, consisting of 1 g ninhydrin (Sigma) dissolved in 25 ml 
methoxyethanol (BDH), was prepared immediately before use and added to 
the stannous chloride solution in a 1:1 ratio (colour development reagent). 
Boiling tubes (14 i  150 mm) were used for the reaction mixtures which 
consisted of 100 ul of sample or standard made up to 0.5 ml with distilled 
water plus 1.5 ml of the colour development reagent. The mixture was 
boiled for 5 min in a water bath, the tubes removed and allowed to cool,
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before 8 ml of the propanol solution was added to each tube. The contents 
were mixed on a vortex and left at room temperature. The absorbance was 
read at 570 nm after 30 min on a SP6 550 UV/Visible spectrophotometer 
(Pye Unicam). A calibration curve was constructed using L-leucine (Sigma) 
as the standard amino acid dissolved in PBS. The concentration of the 
standards were 0.25 mM, 0.5 mM. 1 mM and 2 mM leucine. A water blank 
was treated in the same way as the standards and samples as a 
comparison. The amino acid content of the unknown samples was 
calculated by interpolation from the curve. The mean and the SEM were 
calculated from a number of observations on the same TBW sample.
Nicotinic acid (NA)
A microbiological assay was used to determine the concentration of 
nicotinic acid in the various TBW samples tested. The test organism was 
LacîobadJIus pJanîarum  which, like the bordeteilae, has an essential 
requirement for NA. The extent of growth of the bacterium in the culture 
medium was in direct correlation with the concentration of NA present. 
During growth, L  pJaniarum  produced lactic acid which was titrated with 
NaOH, the volume of which required for neutralisation was directly 
proportional to the growth of the bacterium and hence to the NA 
concentration added to the medium.
An initial inoculum of L  piantarum  was made from a stab stock 
culture on Micro Assay Culture Agar (Difco). After activation at 30X for 
24h a loopful was transferred to 10 ml of Micro Inoculum Broth (Difco) and 
incubated at 30X for 24h or until a silky turbidity developed. The cell 
suspension was then pelleted at 9,000 rpm in a MSE minor S' bench 
centrifuge and washed twice in 0.85 % (w/v) sterile saline to avoid the 
possibility of nutrient carryover from the broth. Niacin Assay Medium
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(Difco) was prepared (200 ml) and 5 ml of this was transferred to 15 ml 
test tubes. A stock NA solution (100 ug/ml) was prepared with 0.05 mg of 
NA (niacin, Sigma) dissolved in 500 ml of distilled water. This was diluted 
to 0.1 jig/ml by adding 0.1 ml stock solution to 99.9 ml distilled water, and 
added to the test tubes to give 0, 0.05, 0.1, 0.2, and 0.4 iig/ml NA (i.e. 0, 
0.5. 1. 2 and 4 ml respectively). TBW samples (0.5 ml) were added to the 
sample tubes and all tubes were made up to a final volume of 10 ml with 
distilled water.
The assay medium was sterilized at 1 2 rc  for 10 min and cooled. Each 
test tube had 50 ul of L  pJajitarum  inoculum added and was incubated at 
30X for around 24h. Once turbidity had developed in the media the tubes 
were removed. The contents of each tube was transferred to a 100 ml 
conical flask and 50 ml of distilled water and 30 ul of bromothymol blue 
indicator added. Sodium hydroxide (0.1 M) was used to titrate the acid 
produced by the L  pJantarum  in the medium. The volume of NaOH 
required for neutralization was equivalent to the acid produced, which in 
turn, was directly related to the concentration of NA in the medium.
Total protein determ ination
The method used was the Lowry protein estimation (Lowry e t aJ, 
1951 ). A series of bovine serum albumin (BSA, Sigma) standards were 
prepared in boiling tubes in concentrations ranging from 50 ug/ml to 50 
Ug/ml. The samples tested in duplicate, were prepared undiluted and at a 
1 inlO dilution in distilled water. To 0.5 ml of sample and the standard BSA 
solutions and 0.5 ml water (blanks), 0.5 ml of IN NaOH was added and the 
tubes were then placed in a boiling water bath for 5 min.
The experimental protocol was as follows: 50 ml of 5 % (w/v) Na^CO-
plus 2 ml of 0.5 % (w/v) CuSO  ^ 5H2O in 1 \  (w/v) sodium potassium 
tartar ate (all BDH) were prepared immediately before use. When the tubes
S4
from the water bath had cooled, 2.5 ml of this reagent was added, mixed 
and the tubes were allowed to stand for 10 min. To each of the tubes 0.5 
ml of IN Folin reagent (Folin-Ciocalteaus phenol reagent diluted 1:1 in 
distilled water) was added and mixed. After 30 min at room temperature 
the absorbance at 750 nm in a cuvette of path length 1 cm was read in a 
Shimadzu UV 240 spectrophotometer. The protein concentrations in the 
unknown samples were calculated and presented in the read-out from the 
spectrophotometer.
83
Part 4. Characterization of B. broüchisepticâ strains
Cultural characteristics
A 25 Lil sample from each of sii B. broncAiseptJca strains, which had 
been stored as previously described, was spread onto two BG agar plates to 
give single colonies after incubation at 37°C for 24-48h. Purity of the 
resultant plate culture was determined by colony morphology and Gram 
stain.
A single colony from each plate was suspended in about 0.3 ml of PBS 
and mixed vigorously. A 10 pi sample was taken for Gram stain by the 
method described in Mackie and McCartney (1989). A further 10 pi sample 
was taken for motility testing by the "hanging drop" method (Mackie and 
McCartney, 1989).
All six strains of B. bronchjseptlcs tested Gram negative and were 
actively motile.
API tests
The six strains of B. broncAIseptJcs used in this research were tested 
for their reactions on an API 2ONE identification strip (API Laboratory 
Products Ltd).
A saline suspension was prepared from the 24-48h growth, on BG 
agar, of each B. broncAjseptjca strain ; A single colony from each BG plate 
was suspended in an ampoule of NaCl (0.85 %) and mixed vigorously.
An API strip for each strain was placed in an incubation box, and 
about 5 ml of distilled water was added to the box, to create a humid 
enviromem. The tubes, but not the cupules, of the tests NO^  to PNPG isee
Appendix la) were inoculated with the saline suspension of the 
corresponding B. brancAJseptJca strain. Sterile mineral oil was then added 
to the cupules of the tests GLU, ADH and URE.
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To an ampoule of AUX medium, 200 pi of the remaining saline 
suspensions was added and mixed, avoiding excess bubble formation. The 
tubes and cupules of tests GLU through to PAG were filled with the 
corresponding AUX suspension. The incubation boxes containing the API 
strips were closed and incubated for 24h at 30*C.
After incubation the results were recorded as either positive or 
negative, based upon the test interpretation table (Appendix la). Each 
strain was then allocated an identification number which was 
cross-checked with the identification table in Appendix lb (this table listed 
results for 66 different non-fermentative, Gram negative bacteria). 
Filamentous haem agglutlnln (FHA)
The six strains (20-30 lil of a thawed deep-freeze culture) of B. 
broncAjseptIca were grown on BG plates for 24-48h at 37"C, and the 
resultant growth was scraped into 3 ml of PBS. The optical density at 450 
nm was adjusted to 1.9-2.0 with PBS.
A 5 ml volume of horse red blood cells (Becton-Gibson) was washed 
three times in PBS by centrifugation in a bench centrifuge (MSE minor S') 
at 3,500 rpm for 10 min. A 2 % (v/v) solution of the cells, in PBS, was 
prepared by adding 1 ml of washed cells to 49 ml of PBS.
A 50 lil sample of bacterial suspension was added to the first well of a 
round-bottomed microtitre plate (Gibco). To the successive wells was added 
50 jil of PBS. Serial 2-fold dilutions of the bacterial suspension were made 
in the PBS and then 50 pi of the washed erythrocytes was added to all 
wells. A semi-purified preparation of FHA from B. p ertu ssis (provided by 
Miss Far hat Mirza), and PBS, were each mixed (50 pi) with the red blood 
cells and used as positive and negative controls respectively.
The microtitre plate was incubated at 37°C for l-2h  after which the 
results were recorded. A positive agglutination was indicated by the
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non-formation of a red button of erythrocytes at the bottom of the well. 
Heat Labile Toxin (ELI)
The six strains of B. bronchisepU ca were assayed (by Professor A.C. 
Wardalw) for heat labile toxin (HLT). Each strain was plated onto four BG 
plates and incubated for 24h at 37“C. The confluent growth was scraped 
into sterile plastic universals (Sterilin) and stored frozen overnight. After 
thawing, the bacterial pellets were resuspended in PBS to give 30 mg/ml 
and kept on ice (see Table 22).
The resuspended pellets were sonicated on ice in 5 x 1 min bursts 
with 1 min. cooling in between. For testing, the preparations were diluted 
to 10 mg/ml. Dilutions of the adjusted bacterial suspensions (4-fold) were 
made over the range 1/4 - 1/64 and a control heated at 56°C for 30 min to 
inactivate any HLT activity was also included. As a positive control a crude 
preparation of HLT from B, p ertu ssis strain no. 77/18319 (provided by 
Professor A.C. Wardlaw) was diluted to give 10 mg/ml and then treated in 
the same manner as the test samples.
Two mice were tested at each dose point in a mouse toxicity test and 
the animals were monitored for adverse reactions over a period of five 
days.
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Table 22 ; Preparation of B. bronchlseptica  suspensions for use 
in HLT analysis.
Strain number Moist weight (mg) PBS for 30 mg/ml (ml)
5376 338 11.3
452 383 12.6
10541 292 9.7
11 283 9.4
13325 287 9.6
6353 368 12.3
39
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Part 1 : Characterization of stock B. broochiseptJca strains.
It is convenient to introduce the results of these investigations by 
describing the six strains of B. broncbJseptJca with which much of the 
work was done. In fact, this characterization was performed mid-way 
through the study, after the surprizing observation had been made that B. 
bronchiseptica strain 5376 could grow in PBS without nutrient 
supplementation.
All six strains were small Gram-negative coccobacilli. Hanging drop 
preparations of colonies from BG plates suspended in PBS showed 
convincing motility with each of them. Biochemical tests with API 20 NE 
strips gave the results summarized in Table 23 (see also Appendix la), 
which include the API identification numbers. It will be noted that all six 
strains were positive for urease and oxidase and for assimilation of adlpate, 
malate, citrate and phenyl-acetate. All six strains were negative for indole 
production, acidification of glucose, arginine dehydrolase, B-glucosidase, 
protease, B-galactosidase and assimilation of glucose, arabinose, mannose, 
mannitol, N-acetyIglucosamine, maltose and gluconate. Differences between 
strains were observed with nitrate reduction and caprate assimilation.
According to the API scheme, the interpretation code (last line 
within Table 23) for typical' broncb/sept/ca  is 11 000 23. This was 
exhibited by strain nos, 5376, 6353, 1 1 and 10541. Strain No. 13325, a 
recent isolate from a horse with respiratory disease, differed in one test 
(caprate assimilation) and had the code 11 000 33. The type strain 452, 
which had been isolated in 1920, differed in two tests, caprate assimilation 
and nitrate reduction and had the code 01 000 33. All six strains fell within 
the limits of variability for typical and atypical B.broncJiJseptlca as defined 
by API tests (Appendix lb).
Additional confirmation of identity was sought by assaying the
Table 23 : API identification of B. broncJtiseptica strains
Test
Strain no. (API 20 NE code)
5376 6353 11 13325 452
NO^  TRP GLU "t" — + --  + — + — - —
ADH URE ESC - + - - + - - + - - + - - + - - + -
GEL PNPG GLU —  —  - - - - — —  —
ARA MNE MAN —  —  —  —  —  —
NAG MAL G NT —  —  —  —  — - —
CAP ADI MLT - + + - + + -++ -++ + + + +-h +
CIT PAC OXI + + + + + + + + + +■ + + -t- + + + + +
Code (11 000 23) (11 000 23) (11 000 23) (11 000 23) (11 000 33) (01 000 33)
For description of tests see API 20 NE interpretation table (Appendix la)
11 000 23 is the API code for B. bwachiseptJca (Appendix lb)
11 000 33 and 01 000 33, from the API identification table, are atypical of B. 
broachjsepü'cii although they fall within the range of variability
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strains for ability to produce filamentous haemagglutinin (FHA) and 
heat-labile toxin (HLT), both of which virulence factors are regarded as 
characteristic of this bordetella (Pittman and Wardlaw, 198 1 ). As shown in 
Table 24 (see also Appendices 2 and 3), the six strains varied considerably 
in ability to produce these two factors. Four of the strains produced FHA in 
readily detectable amounts, whereas two strains, one of which was the 
type strain and the other a recent isolate, did not. However all six strains 
produced HLT although the amount varied over a 250-fold range.
The overall conclusion from these biochemical and other tests was 
that all six strains were confirmed as as B. broncAiseptJca
93
Table 24 ; Characteristics of B. broncAJseptica strains.
Strain
Investigator,or 
Source, and date
API 20 NE 
number
FHA
activity^
HLT
activity^
5376 Eldering, 1962 11 000 23^ 1.6 6.2
6353 Dog, 1985 11 000 23 12.5 100
11 Pig, 1986 11 000 23 3.1 100
13325 Horse, 1990 11 000 33 < 0.1 0.4
10541 Lacey. 1952 1 1 000 23 0.8 12.5
452 Ferry, 1920 01 000 33 < 0.1 1.6
 ^ expressed as a percentage of HA activity of a semi-purified preparation 
of FHA from B. p ertu ssis
^ expressed as a percentage of the activity of a semi-purified preparation
of HLT from B, p ertu ssis
 ^ 1 1 000 23 is the number which is assigned to B. bronchiseptica strains.
See Appendices 2 and 3 for FHA and HLT data
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Part 2 : Growth of B ordetella  species in TBW 
Developm ent of the test method
The main initial object of this research was to determine whether 
the tracheobronchial washings (TBW) from various vertebrate species 
could support the growth of the four species of Bordetella, and if so, 
whether evidence to explain host-parasite species specificity might emerge.
Initial experiments involved establishing a suitable protocol for the 
growth experiments with the four species. A different dilution scheme had 
to be developed for each organism (Figure 5) in order to obtain the desired 
count of approximately 50 colonies from a 20 pi sample of inoculated TBW 
at time zero. Once established, the protocol was used, with minor 
variations, throughout the research.
The first fluid tested was mouse TBW, with cyclodextrin liquid (CL) 
medium and PBS as the positive and negative control fluids respectively. 
Initial results of the growth-supporting properties of these three fluids are 
presented in Table 25. These indicated that mouse TBW supported growth 
of B. parapertussis, B. bronchiseptica and B. avium., as shown by the 
confluent growth given by undiluted 20 pi samples taken after incubation 
for 48h at 37“C and plated onto BG medium. B. p ertu ssis failed to give any 
colonies when tested in parallel, indicating greater than 98 % loss of 
viability in TBW. All four species grew in the CL medium used as a positive 
control. Surprisingly, B. bronchiseptica and B. avium  grew also in PBS. 
However, the two human-pathogenic bordeteliae failed to survive in this 
fluid.
Growth of the bordeteliae was then studied with better 
quantitation and with various sampling times over one week. In addition, 
the samples were serially diluted before plating so as to yield countable 
number of colonies on at least some of the BG plates. Results of a typical
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Table 25 Qualitative observation of growth of B ordetella 
species during 48h at 3 7 ’C in CL medium, mouse 
TBW and PBS.
Qualitative observation of growth of :
Fluid
B. p ertu ssis B. parapertussis B. bronchiseptica B. avium
CL medium ++ ++ ++
Mouse TBW - ++ ++ ++
PBS
++ and - refer respectively to confluent growth and no growth when a 20 pi 
sample was spread on a BG plate after the period of incubation.
With each organism, the inoculum contained an initial viable count such 
that 30-50 colonies developed from 20 pi of the inoculated fluids spread 
on BG plates.
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experiment with B. bronchiseptica strain 5376, with sampling times of 48h 
and 1 wk are given in Table 26.
The Table shows that from an average inoculum of about 40 
CFU/20 pi (equivalent to 2 x 10^ CFU/ml) the viable counts increased to 
3.6 X 10^ CFU/ml in CL medium, to 5.7 x 10^ in PBS, and to values between 
8 x 1 0 ^  and 1x10^  CFU/ml in TBW from three mammalian species. It was 
therefore apparent that this strain of B. bronchiseptica was capable of 
extensive growth in TBW samples from horse, sheep and rabbit.
The sections that follow deal with the detailed examination of 
growth of the four species of bordetella on each of seven species of TBW. 
Figures 6 to 9 summarize the results which are recorded in detail in 
Appendices 4a to 7c.
B. bronchiseptica.
Figure 6 shows the viable counts recorded over 1 week when B. 
bronchiseptica strain no. 5376 was incubated at 37°C in PBS, in CL medium 
and in TBW samples from man. horse, sheep, dog, mouse, rabbit and 
chicken. The viable counts were presented as mean log^Q CFU/ml + SEM,
calculated from viable counts similar to those in Table 26.
The Figure shows that in most of the fluids, the growth of B. 
bronchiseptica reached its maximum value within two days, after which 
the viable count was generally stable for at least a further five days. In 
PBS, a 2500-fold increase in viable count was recorded at seven days, i.e. 
the initial log|Q viable count of 3.3 i  0.05 CFU/ml (N = 15) increased
progressively and reached 6.7 +0.1 (N = 5) at the end of 1 week. This 
2500-fold increase corresponded to about 11 cycles of cell division.
In CL medium, from the same initial logjQ CFU/ml of 3.3 i  0.04 (N
= 21), the B. bronchiseptica reached a maximum logjQ viable count of 9.4 + 
0.1 (N = 14) after 48h incubation at 37°C. This level was maintained for a
97
Table 26 : Typical experim ent (Expt III 1) on the growth of B.
bronchiseptica  strain no. 5376 at 3 7 *C in three species 
of TBW as compared to CL medium and PBS. The data are 
presented as actual colony counts at the different sample 
dilutions.
Fluid
No. of colonies from 20 iil at CFU/ml
Zero
time
48 h 
(dilution)
7d
(dilution)
48h 7d
Undiluted 103 10^ 10^ 105 10®
CL medium + 44 + + 73 2.2 X 109 3.6 X 10*
102 10^ 102 103
PBS 43“ + 26 + 115 1,3x10® 5.7.x 10®
10“^ 105 102 103 lO"* 105
Horse TBW 39“ + 32 + + + + + 209 1.6x10® 1 X 109
10^ 105 1Q2 103 ioi
Sheep TBW - 23 + + + 209 1.1 X 10® 1.1x10®
10^ 105 1Q2 103 lO'*
Rabbit TBW + 12 + + + 159 6 X 10^ 8.0 X 10'
 ^ The average of these three values gives a zero time average count of 2 x 10^  CFU/ml 
in the samples
.. signifies not tested: ++ indicates confluent growth; + indicates almost confluent 
growth and +, indicates too many colonies to count,
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Figure 6 : B. bronchiseptica  growth in TBW : Tracheobronchial 
washings (TBW) from various vertebrate species 
w ere compared w ith CL medium and PBS. B.
bronchiseptica strain no. 5376 was incubated at 37^ C and 
the error bars represent SEM. With the human TBW, three 
separate specimens were tested.
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further 24h, after which the count decreased slightly to 8.8 + 0.4 (N = 5) at 
1 week. The maximum increase in viable count corresponded to about 20 
cycles of cell division.
Each of the species of TBW tested supported the growth of B, 
bronchiseptica over the 1 week incubation and gave final logjQ viable
counts within the 16-fold range of 7.8 + 0.1 CFU/ml (sheep and chicken 
TBW) to,9.1 + 0,1 CFU/ml (horse TBW), The counts with the other species of 
TBW were intermediate. With horse, mouse and two of the human TBW, 
these maximum counts were close to those recorded for CL medium and 
corresponded to about 18 cycles of cell division. Although dog TBW gave 
the same 7-day viable count as sheep and chicken TBW, the rate of growth 
was significantly less.
The majority of the TBW samples gave very similar growth 
patterns, with one exception. This was one of the human samples (TBW No. 
2) which not only failed to support growth, but caused a decrease in viable 
count such that after incubation for 48h the culture appeared to be sterile, 
B. avium.
B. avium  strain P4091 gave results qualitatively similar to those 
obtained with B. bronchiseptica strain 5376 but with definite quantitative 
differences (Figure 7). Thus in PBS, there was only an 80-fold increase in 
viable count (N = 4) compared with the 2500-fold seen with B. 
bronchiseptica. In CL medium, the maximum logjQ viable count was 9.4 +
0.1 CFU/ml (N = 6) which was indistinguishable from that obtained with B. 
bronchiseptica.
In the various species of TBW the maximum viable counts attained 
by B. avium  were quite similar to those of B. bronchiseptica except that 
there was no plateau between day 2 and day 7. Typically, the B. avium  
counts showed an average 33-fold decline over this interval. As with B.
00
Figure 7 : B. avJum growth in TBW : Tracheobronchial
w ashings (TBW) from various vertebrate species 
were compared w ith CL medium and PBS. B.
avium  strain no. P4091 was incubated at 37^  ^ C and 
the error bars represent SEM. With the human TBW, three 
separate specimens were tested.
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0bronchiseptica, the dog TBW supported slower growth of B. avium  than did 
the other species, although the final viable count was just as high, and 
human TBW no. 2 also failed to support the growth of the bacterium. With 
the exception of the human TBW each of which was only tested once, all of 
the other samples were examined with between three to seven 
observations. The detailed viable counts with the various fluids are 
recorded in Appendices 5a to 5e.
As with B, bronchiseptica  the maximum viable counts in TBW 
from horse, mouse and human no. 1 were close to (within a factor of five) 
those obtained in CL medium. Sheep and chicken TBW gave least growth 
with both of the Bordetella species.
B. psrapertussJsL
Figure 8 shows that the results with B. parapertussis strain no. 
10520 were markedly different from those with the two species of 
B ordeteiia described above. In CL medium, growth was much slower, 
although at 1 week there was the same iog^Q viable count (9.5 ± 0.1; N = 3).
With PBS in contrast, B. parapertussis showed no evidence of growth; the 
viable count had declined by 97 % at 24h and by 99 % at 48h (N = 3 and 4 
respectively). By three days there were no viable cells detectable.
B. parapertussis showed four patterns of response in the various 
TBW samples but in each case the maximum viable count was substantially 
lower than with B. bronchiseptica or B. avium . The most common pattern 
with B. parapertussis was growth that reached a peak of log |q  viable
count between 5 5 and 6.7 around days 2-3 and then declined slightly. This 
was shown by TBW from sheep, rabbit, mouse and chicken. With the 
human samples 1 and 3, there was a similar peak at day 2 but thereafter 
the viable count decreased to undetectable numbers by day 7.
The dog and horse TBW which had supported good growth of B.
0 2
Figure 8 : B, parspertu ssis  growth in TBW ; Tracheobronchial 
w ashings (TBW) from various vertebrate species 
w ere compared w ith  CL medium and PBS. B.
parapertussis strain no, 10520 was incubated at 37® C and 
the error bars represent SEM. With the human TBW, three 
separate specimens were tested.
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bronchiseptica and B. avium  were not growth-supporting for B. 
parapertussis \ the viable count declined slowly but steadily in the dog 
TBW and very rapidly in that from the horse. The human TBW sample 2 
which had been unable to support the growth of the other two species of 
Bordeteiia  was similarity lethal for B, parapertussis. The detailed viable 
counts with the various fluids are recorded in Appendices 6a to 6e.
B, pertussis.
B. p ertu ssis strain no. 18334 failed to grow in any of the seven 
TBW tested (Figure 9 and Appendices 7a to 7c). PBS was also unable to 
support growth of this species. However in CL medium the viable count 
increased to 5.4 + 0.2 (N = 6) in 48h from an initial iogjQ CFU/ml of 3.5 t
0.2 (N = 5) and reached 10.0 ± 0.2 (N = 5) after 1 week at 37X.
Although none of the TBW supported growth, there were 
differences in the time taken for the viable count to reach zero. In horse, 
dog, mouse, chicken and the three human TBW no culturable bacteria were 
recovered from a 48h sample, whereas with sheep and rabbit TBW and PBS 
the log IQ CFU/ml values at 48h were 2.5 ± 0.2 (N = 2), 1.5 1 1.5 (N = 2) and
0.7 1 0.7 (N = 4) from initial values of 3 4 + 0.5 (N = 2), 3.4 + 0.5 (N = 2) and 
3 5 t  0.3 (N = 3) respectively. Thereafter no culturable bacteria were 
recovered from the 1 week sample.
Supplem entation of rabbit TBW for the growth of B. p ertu ssis
An experiment was done to investigate the effect on the growth of 
B, p ertu ssis of supplementing rabbit TBW with the nutrients in CL medium 
and with MeBCD. The latter was added to the rabbit TBW to give 1 mg/ml, 
the same concentration as in CL medium. The results in Table 27 show that 
adding this ingredient to TBW did not permit growth, although it retarded 
slightly the loss of viability which B, p ertu ssis underwent in rabbit TBW. A 
1:1 mixture of CL medium and rabbit TBW supported more growth than CL
0 4
Figure 9 : Æ p ertu ssis  growth in TBW : Tracheobronchial
w ashings (TBW) from various vertebrate species 
w ere compared w ith CL medium and PBS. B.
p ertu ssis strain no. 18334 was incubated at 37^ C and 
the error bars represent SEM. With the human TBW, three 
separate specimens were tested.
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Table 27 ; Effect of supplem enting rabbit TBW w ith  the 
nutrients of CL medium (1:1 ratio) and w ith Me BCD 
(1 m g/m l) on the growth of 3. p ertu ssis  strain no. 
18334 at 37-C.
Fluid
CFU/ml after incubation (h)^
0 48 168
CL medium 800 4 X 10^ 7 x  lO"^
Rabbit TBW + CL medium 1450 14.4 X 105 16.5 X 10^
Rabbit TBW + MeBCD 950 50 <50
Rabbit TBW b < 50 <50
PBS •• <50 < 50
 ^ average zero time count was 1.1 x 10^+196 (N=3) CFU/ml 
^ not tested
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medium alone, suggesting that the rabbit fluid was contributing nutrients 
which compensated for dilution of the CL medium and did not have 
intrinsic bactericidal or other activities that might reduce the apparent 
viable count.
B, parapertussis gave qualitatively similar results, when incubated 
for 48h at 37“C, in a 1:1 mixture of horse TBW and CL medium, again 
showing that the loss of viable count with this organism and horse TBW 
was not due to bactericidal or agglutinating effects.
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Part 3 Chemical Analysis of TBW
The TBW samples tested above for ability to support the growth of the four 
species of BordeteJJa were analyzed for known BordeteJla nutrients, viz 
amino acids, fatty acids and nicotinic acid. In addition, the samples were 
assayed for haemoglobin, as an index of blood contamination and also for 
total protein.
Blood contamination.
The majority of the TBW samples at the time of collection were 
colourless turbid liquids and only a few of them showed red cells in the 
pellet obtained by centrifugation. However, the possibility that small 
quantities of blood with or without haemolysis may have contaminated the 
TBW during collection could not be discounted. Therefore a sensitive assay 
for haemoglobin with the Drabkin reagent was done on the pellets 
resuspended to original TBW volume and also on the membrane-filtered 
supernates from the centrifugation.
Figure 10 (see also Appendix 8) is the standard curve from the 
Drabkin test for absorbance at 540 nm against haemoglobin concentration 
expressed as the % (v/v) equivalent of mouse blood. This assay had a 
detection limit down to about 0.001 % (v/v) of blood In the diluent. Table 
28 summarizes the results on 13 samples of TBW from the seven 
vertebrate species (Appendices 9 to 11), each sample being analyzed for 
haemoglobin in both the pellet and the supernate.
The Table shows that all samples of TBW contained some 
measurable haemoglobin, but even the highest level of contamination was 
below 1 % (v/v) equivalent of blood. The TBW sample with the most blood 
in it was human No. 1 with 0.86 % (v/v) blood equivalent. On the other 
hand, the least contaminated sample in the series was one of the other 
human specimens with 0.02 %(v/v) blood equivalent. In the non-human
0 8
Figure 10 Estimation of blood contamination in TBW.
Standard curve for the Drabkin assay of 
haemoglobin calibrated in term s of the percent 
(v /v )  w hole mouse blood.
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Table 28 : Blood contammation^ of TBW (based on a minimum of 
three observations). Each TBW was centrifuged to deposit 
unhaemolysed erythrocytes (and other cells). This "TBW 
pellet" was resuspended in PBS to the original volume of the 
TBW and analysed for haemoglobin. The " TBW supernate " was 
membrane-filtered before testing.
Blood contamination 
(expressed as % v /v  whole mouse blood)
TBW TBW Pellet TBW Supernate Total
Horse 0.12 + 0.01 0.12 ±0.01 0.24 ±0.02
Rabbit 1 0.13 + 0.01 0.08 ±0,01 0.21 ±0.02
Rabbit 2/3 0.05 ±0.01 0.07 ±0.004 0.12±0.014
Sheep 1 0,13±0.01 0.03 ±0.01 0.16 ±0.02
Sheep 2 0.05 + 0.01 0.007 ±0.002 0.057±0.012
Mouse (157) 0.26 + 0.03 0.22 ±0.01 0.48 ±0.04
Mouse (158) 0.16 + 0.004 0.13 ±0.01 0.29±0.014
Mouse (165) 0.31 ±0.04 0.15 ±0.01 0.46 ±0.05
Chicken 0.03 ±0.01 0.01 ±0.005 0.04±0.015
Dog 0.12 ±0.01 0.01 ±0.002 0.13±0.012
Human 1 0,86 ±0.02 < 0.001 0.86 ±0.02
Human 2 0.50 ±0.03 0.16 0.66 ±0.03
Human 3 0.02 ±0.003 < 0.001 0.02 ±0.003
 ^ Expressed as percent (v/v) whole mouse blood + SEM 
For full details see Appendices 9, 10 and 11
TBW samples, the blood contamination extended over a 10-fold range from 
0.04 %(v/v), in chicken TBW, to 0.48 %(v/v) in mouse TBW 157. The 
haemoglobin levels in the other animal TBW samples were intermediate.
In most cases, the majority of the haemoglobin measured was 
located in the resuspended cell pellet, particularity with the human TBW 
samples, while in the membrane-filtered supernates the values recorded 
ranged between 0, in human TBW Nos. 1 and 3, to 0.22 % in mouse TBW 
157. These data suggested that although some blood had leaked into the 
TBW during collection, little haemolysis had occurred.
Variations were observed in different batches of TBW from the 
same species; an 8-fold range was seen in the three human TBW, a 3-fold 
range in the two sheep TBW and a 2-fold range in both the mouse TBW and 
rabbit TBW samples,
Amino acids.
The average dose-response curve for amino acid determination by 
the ninhydrin method, with leucine as standard, is shown in Figure 11 
which summarizes the results of seven calibration curves (Appendix 12). It 
shows that there is a linear relationship between concentration of leucine 
and absorbancy at 570 nm, at least up to 2 mM of the amino acid. The 
lower limit of detection was at approximately 0.017 mM (equivalent to 
where 1 SEM below the standard curve intersects zero absorbance).
All 13 assayed samples of TBW from seven species had measurable 
levels of amino acids, within the 8-fold range from 0.10 to 0.81 mM (Table 
29 and Appendices 13 to 15). With four of the species - rabbit, sheep, 
mouse and human - there was more than one sample available for assay 
which permitted investigation of within-species and between-species 
variation. The Table shows that there was little convincing evidence of 
between-species variation after the within-species between-sample 
differences had been taken into account. For example, there was a 3.5-fold
Figure 11 ; Standard curve of amino acid concentration by the  
ninhydrin method. Results are expressed as mM 
leucine equivalents (LE).
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Table 29 ; Amino acid content^ of TBW (based on at least three 
observations). The TBW had been centrifuged and 
membrane-filtered and deproteinized before analysis.
TBW A mino acid content 
in leucine equivalents 
(mMiSEM)
Horse 0.74 + 0.08
Rabbit 1 0,20 + 0.03
Rabbit 2/3 0.12+0.0
Sheep 1 0 .15 i0 .02
Sheep 2 0.09 + 0.01
Mouse 157 0.81 + 0.09
Mouse 158 0.47 + 0,01
Mouse 165 0.39 + 0.09
Chicken O.lOzO.03
Dog 0,23 + 0.02
Human 2 0.73 ±0.04
Human 3 0.21 + 0.01
 ^expressed as mM leucine equivalents (LE) + SEM 
For full details see Appendices 13,14 and 15
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variation between two of the human samples and differences of the order 
of 2-fold between the two rabbit specimens, the two sheep samples and 
the three TBW pools from mice. It was concluded that the observed 
differences had arisen mainly through unintended variations in the process 
of collection.
Nicotinic Acid (NA).
The mean standard curve, based on three tests (Appendix 16), for 
the assay of nicotinic acid (NA) by the promotion of growth of Lactobacillus 
pJantarum  is presented in Figure 12, The graph was linear up to 0.16 ug 
NA/ml and the limit of detection was approximately 0.001 [ig NA/ml.
Application of this microbiological method to the assay of NA in 
TBW yielded the results presented in Table 30 (see also Appendices 17 to 
18). All samples of TBW had readily detectable amounts of NA within the 
5-fold range from 0.2 to 1.06 pg/ml. The human samples which were from 
different patients gave closely similar values at around 0.65 }ig NA/ml. 
Contribution of blood amino acids to TBW amino acids
Having found that the TBW supernates which were used for the 
bacterial growth experiments had between 0.001 %(v/v) and 0.22 %(v/v) 
equivalent of blood, it was of interest to determine the quantity of amino 
acids which might be contributed by these measured levels of blood 
contamination. To provide a calibration scale, the ninhydrin assay was 
therefore applied to mouse blood which had been diluted in PBS to give 
0.25, 0.5 and 1.0 %(v/v) mixtures and the protein precipitated with 
sulphosalicylic acid. The results in Table 31 show that the deproteinized 
supernates of mouse blood that had been diluted to 1 %(v/v) in PBS 
contained amino acids equivalent to 0,24 mM leucine.
Based on this value for the amino acid content of mouse blood, and 
assuming it would be the same for other species, the proportion of the 
amino acids which had been contributed to the various TBW samples by
4Figure 12 Standard curve of nicotinic acid by the
LadobaciJlus method. The concentration of nicotinic acid 
(Mg/ml) is plotted against the volume of NaOH (ml) required 
for acid neutralization.
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Table 30 ; Nicotinic acid (NA) concentration^ of 
m em brane-filtered TBW.
TBW NA concentration ; 
p g /m il SEM (N)
Horse 1.06 10.05 (4)
Rabbit 2/3 0.2310.03 (4)
Sheep 1 0.33 10.08 (4)
Mouse (157) 0.8410.08 (4)
Chicken 0.20 + 0.00 (2)
Dog 0.5410.00 (3)
Human 2 0.63 10.09 (3)
Human 3 0.67 + 0.08 (3)
 ^ measured in |ig/ml
For full details see Appendices 17 and 18
Table 31 : Amino acid concentration^ of whole mouse blood at 
different dilutions in PBS, expressed as mM leucine 
equivalents (based on two observations).
Mouse blood Amino acid concentration
% (v/v) (mM LE)
individual values (mean)
1 0.25,0.23 (0.24)
0.5 0.20,0.16 (0.18)
0.25 0.11,0.10 (0.10)
 ^ (mean + SEM)
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blood contamination was then calculated. For this calculation, the data on 
blood contamination were taken from Table 28 and on amino acids from 
Table 29 with the results presented in Table 32 . Of the eight samples 
examined in this way, the majority had less than 10 % of the total amino 
acids contributed by blood contamination, while two samples showed 16.7 
and 20 %. It therefore appeared that although blood contamination 
contributed some amino acids to TBW it was not a major source relative to 
that which could not be accounted for by blood contamination (i.e. the 
amino acids endogenous to the TBW).
Total Protein.
The protein concentrations of the various TBW samples (Table 33 
and Appendices 19 to 20), as determined by the method of Lowry e t a i 
1951, lay within the range 88 jig/ml (chicken) to 2172 ug/ml (human No. 
1). The protein concentrations in the other TBW tested were intermediate.
8Table 32 : Estimation of the concentration of amino acids^ in 
m em brane-filtered TBW contributed by blood 
contamination. The data in columns 2 and 3 are from Table 
and 28 respectively.
Total amino acids 
TBW (leucine equivalents 
mM)
Blood contamination 
%(v/v) mouse blood 
equivalents
% of total amino 
acids contributed 
by blood 
contamination (%)
Horse 0.74 0.12 3.9
Mouse 157 0.81 0.22 7,1
Rabbit 2/3 0.12 0,07 16.7
Sheep 1 0 15 0.03 6.7
Chicken 0.10 0.01 20.0
Dog 0.23 0,01 1.0
Human 2 0.73 0.16 5.3
Human 3 0,21 > 0.001 >0,1
 ^ expressed as the percent (v/v) of the total amino acids present
Table 33 : Protein concentration^ of m em brane-filtered TBW
TBW Protein concentration 
( jig/ml 1 SEM)
Horse 1294 ±119
Rabbit 2/3 318 + 23
Sheep 1 769 + 72
Mouse (157) 1010 + 33
Chicken 88+16
Dog 599 + 163
Human 1 2172 + 98
Human 2 1865 i7 7
^ measured in jig/mi 
For full details see Appendices 19 and 20
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Part 4. Growth of B. broncàJseptica in PBS and natural waters
The observation that B, bronchJseptIca strain no. 5376 could 
survive and grow in PBS without any other added nutrients was the basis 
for the studies described in this section. Various batches of PBS and 
samples of fresh waters from lakes in proximity to the laboratory were 
tested for growth-supporting properties towards B. bronchiseptlca strain 
5376. In all, a total of six strains of B. broncJiJseptlca were tested in both 
PBS and lake water, and rough estimations of the amount of nutrient in 
these fluids were made.
Dry w eight determ ination of B. bronchJsepticx strain no. 5376
In an attempt to estimate the amount of nutrient required for the 
observed growth of B. bronchlsepU ca strain 5376 in PBS and the lake 
waters, the dry weight of a single ceil of B. bronchiseptJca was calculated 
(Figure 13)
Assuming that one CFU corresponded to a single viable cell of B. 
bronchiseptlca, it was estimated that the dry weight of one bacterial cell of 
B. bronchiseptJca was equivalent to 105 fg.
Growth of B. bron cbiseplicx, strain no. 5376, in PBS and RGW
PBS prepared from analytical grade salts dissolved in either DW or 
RGW supported the growth of B. bronchiseptJca 34). In PBS made
with DW (expt 1) the initial viable count of 1.6 x 10^ CFU/ml increased to 
8.4 X 10^ CFU/ml in 24h and to 3-5 x 10^ CFU/ml at 48h. Thus, over 48h, 
there was an increase in viable count of approximately 2200-fold, 
coresponding to 11 cycles of cell division. Essentially the same results were 
obtained with PBS made in RGW (expt 2), where the viable count increased 
by a factor of 2700. In neither case was there development of visible 
turbidity in the PBS.
In CL medium which was inoculated in parallel as a positive control
12
Figure 13 Dry w eight determ ination of Æ broochiseptJca 
strain no. 5376,
Confluent growth from four BG plates was scraped into 10 ml distilled 
water to give a thick suspension. This was diluted 60X with PBS to reach an 
OD^^q = 0.45. Thus the original suspension had an 0D= 27
Tube No.
Weight of tubes (g) 
Initial Final
Increase
(§)
Average Increase 
(mg)
Blank 1 0.8893 0.8901 0.0008
0.5
2 0.8863 0.8865 0.0002
Sample 1 0.9030 0.9147 0.0117
11.5
2 0.9415 0.9528 0.0113
Increase in weight of tubes due to the bacteria = 11 mg
Therefore an OD^^q equal tO 0.45 contains 11/60 x 1000 pg/ml of B.
bronchiseptJca i.e. 183 hg/ml
From previous viable count data the CFU/ml at an OD54Q of 0.45 = 1.7356 x 
10  ^which is equivalent to 183 jig/ml (from above)
Therefore if ; 1.7356 x 10^ CFU/ml =183jig/ml
1.7356 X 10^ CFU = 183 x 10'^ g
and 1 CFU - 183 x 10 '^ / 1.7356 x 10^
= 105 fe
2 2
TABLE 34 : Typical resu lts showing growth of B. bronchiseptlca
strain no. 5376 in PBS and in CL medium during 
incubation for 48h at 3 7 "C.
Expt
no.
Fluid Incubation 
time (h) 10®
CFU/2Û pi from dilution
lo' lo2 Io3 10“^ lo5 10®
CFU/ml
1 PBS 0 32,33^ . * 1 • 1. , ( ,1 ,1 , l.ôïioî
in DV 24 ac '^ 168 15 ................... 8.4 % 105
48 ac 70 3.5 X 10®
a 0 30,38 1.7x10^
medium 24 ac 65 3.2 X 10®
48 •• ac 31 1.3x10®
0 15, 16 775
2 PBS 24 c^ ac ac 13 5.5X 105
inRG¥ 48 c ac 424 2 2.1 X 10®
CL 0 18, 19 925
medium 24 c 16 1 8x10®
48 c " 48 2.4 X 10®
 ^Duplicate samples:  ^ not tested; '^almost confluent growth; ^confluent growth.
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, the same initial inocula produced respectively, viable counts of 1.5 x 10*^  
and 2.4 x 10*^  CFU/ml at 48h for experiments 1 and 2 i.e. about 430 and 
1100 times higher than the respective counts in PBS. Here, however, visible 
turbidity developed in the medium.
In repeat experiments (n=42, see appendix 14), the initial viable 
count on different days had a standard deviation of 850 around the mean 
value of 1900 CFU/ml. To facilitate comparisons between experiments, it 
was therefore convenient to express the extent of growth on a common 
basis as the logarithmic (base 10) increase from the initial viable count. For 
this purpose, the Growth Index (GI) defined as log^Q (count at time t/count
at time zero) was used. The several repeat experiments with PBS in DW 
and RGW presented in this fashion (Figure 14 and Appendix 21) show 
average GIs of around 3.0, corresponding to a 1000-fold increase in viable 
count during 48h.
In an attempt to remove the presumed traces of nutrient from PBS, 
50 mi of the buffer made with RGW was passed slowly through a 1 x 10cm 
column packed with coarse-grade charcoal (NORIT) and then sterilized by 
membrane filtration. Figure 14 shows that the growth-promoting property 
of PBS for B, bronchiseptJca was not impaired by the charcoal treatment; if 
anything, it was slightly enhanced.
RGW without added salts was also tested for ability to support 
growth of the bacteria by the same method. The mean GI at 48h was 0.7 
(Figure 14), corresponding to a 5-fold increase in viable count i.e. 2.25 cell 
divisions. It therefore appeared from these experiments that the main 
source of nutrients in PBS was one or more of the analytical grade salts 
used to prepare the buffer, rather than the water itself or the atmosphere 
of the laboratory.
Serial transfer in PBS (made in DW)
Serial transfer experiments, with a 40-fold dilution at each step.
2 4
Figure 14 : Growth of B, bronchiseptlca  strain no. 5376 during 
24h and 48h incubation in water and PBS at 37®C.
The dots represent individual values and the bars the SEM.
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were made to investigate the possibility that the previously observed 
growth of B. bronchiseptlca strain no. 5376 in PBS might have been due to 
nutrients carried over from the original BG medium. A thrice-washed 
inoculum (25 fil) of the bacteria was therefore added to 975 |il of PBS, and 
also to 975 III of CL medium as a nutrient-positive control. Samples for 
viability counting were taken from both media at zero time and after 
incubation for 24h at 37°C. The first of the serial transfers consisted in 
inoculating fresh 975 ill aliquots of PBS or CL medium with 25 hi from the 
corresponding 24h cultures. These in turn were incubated for 24h at 37“C 
and then subjected to a second round of serial transfer, with counting at 
zero time and 24h. Figure 15 shows that B. bronchiseptlca grew up to the 
same viable count of around 10^ CFU/ml after the third serial transfer as it 
did from the initial inoculum (see also Appendix 22). This indicated that 
the source of nutrients was not the initial washed inoculum. In CL medium, 
the 24h viable count in each serial transfer was about 10^ CFU/ml (Figure 
15).
When E. coll JM 83 was subjected to the same serial transfers, it 
failed to grow in the same batch of PBS which gave positive results with B. 
bronchiseptlca, and did not survive to the second or third transfers (Figure 
16 and Appendix 23). Viable counts of K coll in CL medium reached 
approximately 10^ CFU/ml in each of the three transfers (Figure 16). Thus 
the B, bronchiseptlca strain was able to survive and grow during serial 
transfer in PBS under conditions in which the B.coII strain failed to persist.
Dilutions of CL medium
To compare roughly the level of nutrients in PBS (made in DW) 
with those in CL medium, the growth of B. bronchiseptlca was measured in 
a series of ten-fold dilutions of CL medium in PBS. In two independent 
experiments (Figure 17 and Appendix 24), a 10^ dilution of CL medium
26
Figure 15 : Changes in log % g viable count during three serial
transfers of B, bronchisepiicM  strain no. 5376 in a) 
PBS and b) CL medium. Each serial transfer involved  
a 1 in 40 dilution. The dots represent individual values 
and the bars the SEM.
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Figure 16 : Changes in lo g |o  viable count during three serial
transfers of £. co li strain no. JM 83 in a) PBS and 
b) CL medium. Each serial transfer involved a 1 in 
40 dilution. The dots represent individual values and the 
bars the SEM.
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Figure 17 : Estimation of the concentration of nutrients in PBS 
by determining the dilution of CL medium which  
failed  to stim ulate growth of £. broncAJseptlcM  
strain no. 5376 above the level achieved in PBS. The
dots represent individual values.
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gave a slightly higher GI at 48h than PBS alone, and in one experiment a 
small increase in growth was detected with a 10^ dilution. Since undiluted 
CL medium contains amino acids at about 22 g/1, the growth in PBS alone 
could be explained by nutrient impurities in the range 0.2-2 mg/1.
Growth in natural w aters
In an attempt to discover if B, bronchlseptica strain 5376 could 
survive in waters from the natural enviroment various samples of fresh 
water and sea water were tested for their growth-supporting properties.
Figure 18 shows that B, bronchJseptica grew and survived in 
natural fresh water and sea water at 37T  (see also Appendices 25 to 26). 
In the various fresh water samples from a garden pond, a reservoir and 
five lakes in the vicinity of Glasgow, the 48h GI values ail lay within a 
narrow range from 2.7 to 3.2, corresponding to between 8 and 10 cycles of 
cell division from the inocula of approximately 1900 CPU/ml. At 24h 
however, the GI values varied between 1.2 and 3.0, indicating larger 
differences in initial rate of growth in the various fluids. These latter 
differences appeared to be correlated with the amount of particulates in 
the water samples before membrane filtration. Thus the highest 24h GI of 
3.0 was obtained with the garden pond water, which was the most turbid 
sample prior to membrane filtration. This was followed by two similarity 
turbid waters, from Loch Lomond and the Lake of Menteith, which yielded 
24h GIs of 2.1 and 1.7 respectively. In contrast, the clearest waters 
produced the lowest GIs after 24h. In this category were Loch Katrine and 
Milngavie Reservoir, the source and storage lake respectively for Glasgow's 
drinking water. With further incubation of both waters to 48h respective 
GI values of 2.7 and 3.1 were recorded. Continued incubation at 37*C 
beyond 48h, showed that all of the fresh water samples supported 
approximately three additional generations within 1 wk, after which the 
viable counts changed little for at least 3 wk.
30
Figure 18 ; Grovtli of Æ bronchiseptica  strain no. 5376  in a 
variety  of natural lake and pond w aters during 24h 
and 48h incubation at 37®C. The dots represent 
individual values and the bars the SEM.
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In sea water, although the growth of B. bronchlseptica was much 
less than in the fresh water samples, the average GI of 0.9 corresponded to 
an 8-fold increase in viable count during 48h at 37°C (Figure 18 and 
Appendix 25).
Other strains of B. broncJbisepticM
To investigate the possibility that the ability of B. bronchiseptlca 
to grow in low-nutrient fluids was specific for strain 5376, five additional 
strains of this species, including the type strain 452 and a number of 
recent isolates from a pig, horse and a dog, were tested for their ability to 
grow in PBS (made in RGW) and fresh water from Loch Lomond. Figure 19 
shows that all five strains resembled strain 5376 in their viable count 
increases in the two test fluids (see also Appendices 27 to 28).
Incubation of PasteureJJa hMemoJytJca in PBS and Loch Lomond 
water
Another bacterium which is an obligate pathogen of ruminant 
species and, like the BordeteJJa usually in the respiratory tract is 
PasteureJJa baemoIytJca. This organism was also tested for the ability to 
grow in PBS and fresh water from Loch Lomond.
It was found that when a growth experiment of the type described 
above was set up using two P. haem oJytIca strains (S/C 82/1 and W/D 
83/4) inoculated into PBS, Loch Lomond water and BHIB only the latter 
supported the growth of both organisms (Table 35). From an initial viable 
count of around 200 CFU/ml, both strains of P. hem oIytJca showed visible 
turbidity in BHIB after 48h incubation at 37“C. The viable count in PBS and 
the fresh water was zero after the same time period.
Long-term survival of B. bronchiseptJca in low -nutrient fluids
Having established that the B. broncbiseptJca strains tested above 
all posessed the ability to grow in PBS and fresh water samples, a study 
was done to establish how long B. bronchJseptlca would survive under the
32
Figure 19 : Comparison of six strains of Æ bronchJseptJcs for 
their ability to grow in PBS (A) and Loch Lomond 
water (B). The dots represent individual values and the 
bars the SEM.
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Table 35 : Colony count changes with PssteurelJa haem oJytlcs in  
PBS and Loch Lomond water, as compared to those in 
Brain Heart Infusion Broth (BHIB).
Fluid
CFU/20 ul after incubation (h)
P haemoIytJca S/C 82/1 P. haemoJytJca W/D 83/4
Oh 48h Oh 48h
BHIB 4 ■f + 4 + +
PBS 4 0 3 0
Loch Lomond 3 0 8 0
: confluent growth
3 4
low-nutrient conditions.
Three strains of B. broncJiJseptlca (452, 6353 and 11) were 
incubated in closed, screw-cap bottles containing PBS and Loch Lomond 
water and incubated at temperatures of 37'C and 10“C. Samples (20 jJii) 
were taken at zero time and after 1 week, 1 month, three months and sis 
months at each incubation temperature. These samples were plated either 
undiluted or after a number of 10-fold dilutions onto BG agar. The viable 
counts are summarized in Table 36 with the actual counts presented in 
Appendix 29 .
All three strains of B. broncAiseptJca remained viable for at least 
three months at both 37“C and 10“C. With strain 11, no viable count was 
recorded in the fluids incubated at 37T after six months. In the other 
fluids incubated at 10°C, although slight decreases were recorded after six 
months, the viable count remained considerably higher than the zero time 
count.
Growth in the fluids incubated at 10“C was slower than at 37'C 
with all three species. However the stationary phase counts were similar. 
No obvious differences were observed between growth and survival in PBS 
as compared to that in Loch Lomond water with any of the strains tested.
In most cases, viability was maintained even after incubation for 
six months, maximum counts were reached at between 1-3 months and the 
viable count remained steady or decreased slightly thereafter. An 
exception was with strain 452 incubated in PBS at both 37“C and 10"C 
where the viable count continued to rise slightly after six months.
Colony m orphology. An interesting observation was made with 
all strains over the six month incubation period. It was observed that as 
the incubation period proceeded the colony size on BG agar decreased, with 
a mixture of small and large colonies observed on the plates. Photograph 1 
shows four plates containing B. broncAJseptIca strain 6353. Plates A and B
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Table 36 : Long-term survival of B. bronchiseptica  strain nos.
11, 6353 and 452 in PBS and Loch Lomond water when  
incubated at 37*C (shaken) and lO'C (static) over s i i  
months.
Strain Fluid
CFU/ml after incubation (wk)
0 1 4 12 24
PBS 300 9.5 X lo3 5.5 X 105 25.5 X lO) 0
PBS 300 2,15 xl05 63 X 105 36 .5 X 1Q) 16.5 X 10“*
11 LLA^ 350 30 X 1q5 9.5 X 105 14.7 X 10® 0
LLB*^ 400 8.5 X 10“* 36.5 X 1q5 28 X lO) 83.5 X lO)
PBS A 300 52 X 105 19 X 105 9.5 X lO) 6.5 X 1Q)
PBSB 2.05 X 103 14x 105 50 X lO) 2.05 X 10®
6353 LLA 450 27.5 X 103 1.75x10) 12 X 10® 12.5 X lO)
LLB 8 X 105 17.5 X 105 36.5 X lO) 35 5 X lO)
PBS A 2.3 X 10^ 2.7 X 10? 11.5x10) 5.5 x io ) 6 x l0 )
PBSB 4.1 X 103 4.5 X 10* 6.5 X lO) 12 I lO)
452 LLA 2.9% 10^ 15 X 105 2.5 X lO) 5.5 x lo ) 55 X 10*
LLB 4x10'* 3.45x10) 7x lO) 9.5 X 10*
 ^ phosphate-buffered saline, incubated at 37’C 
 ^ phosphate-buffered saline, incubated at 10'C
 ^ Loch Lomond water, incubated at 37* C
 ^ Loch Lomond water, incubated at 10’C
.. not tested
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Photograph 1 : Variation in the colony moi^hology of B.
bronchiseptJca strain no. 6353 on BG agar, when a 
20 ill sample was taken from PBS and Loch Lomond 
water after incubation at 37®C and 10°C for 1 month.
C sec Lne oÇ por (defence "b> omci
DC B
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are 1 month samples from PBS at 37'C and 10“C respectively and plates C 
and D are those from the respective Loch Lomond samples at 37“C and 
10“C The differences in the colonial sizes can be clearly seen and both 
types of colonies are evident on plate D.
Photograph 2 is a close-up of a plate containing B. bronchJseptJca 
strain 6353 incubated for 1 month in Loch Lomond water at 10“C. It shows 
two very distinctive colony sizes. As time passed the predominant 
phenotype was the small-form. Both types of colony were tested on the 
API 20 NE strip and both gave the identical code, characteristic of a ^  
bronchlseptica strain i.e. 1 1 000 23.
W all grow th In the study described above the possibility was 
considered that during the incubation of the B. bronchlseptica strains, 
attatchment to the sides of the culture vessel might have occurred. A 
qualitative estimation of this possible wall growth from each of the three B. 
bronchlseptica strains used in the long-term survival study was therefore 
made. The fluid from one culture vessel (PBS and Loch Lomond water) at 
10“C and 37“C was discarded and replaced with a fresh 1 ml of PBS. The 
contents were then mixed vigorously and a 20 jil sample was plated onto a 
BG plate.
All three strains showed an apparent degree of wall growth or 
adherence in PBS at both 37“C and 10“C (Table 37). In the Loch Lomond 
water at lO'C, both strains 452 and 6353 showed considerable evidence of 
wall growth while that seen with strain 11 was much less. In the same 
fluids at 37“C there appeared to be less adherence than at 10°C with all 
three species.
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Photograph 2 : Detail of colony morphology of B. bronchlseptica  
strain no. 6353 on BG agar, when a 20 jil sample 
w as taken from Loch Lomond w ater incubated at 
37®C for 1 month.
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Table 37 Qualitative assessm ent of w all growth of B. 
bronchiseptJca strain nos. 11, 6353 and 452 in PBS 
and Loch Lomond w ater after incubation for three
months at 3 7 ’C and lO’C.
Strain no.
CFU/20 III from 1 ml rinsing after three months at :
37“ C in : 10“C in:
PBS Loch Lomond 
water
PBS Loch Lomond 
water
11
6353
452
++ 42 
++ 0
+ 4"
++ + 
++ ++ 
++ ++
+ and ++ indicate almost confluent and confluent growth on a BG plate from 
a 20 hi sample
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Part 1. Growth of BordeteJJa species in TBW
Despite the early recognition that in  vJvo growth of the 
bordetellae was confined to the respiratory tract of animals and birds, 
there appear to have been no studies prior to the present work on the 
growth of these organisms in TBW in  vitro. Yet the harvesting of fluids 
from the respiratory tract for a variety of experimental and diagnostic 
purposes goes back at least 40-50 years. For example, in 1944 Boyd and 
co-workers reported on the lipid, sodium, chloride and nitrogen content of 
the respiratory tract fluid of normal animals. Moreover lack of usage of 
TBW for growth of respiratory pathogens is not restricted to the BordetelM  
In fact, extensive searches of the literature have failed to uncover any 
recorded use of TBW or bronchial lavage fluids for In vitro  growth of any 
respiratory-tract pathogens e.g. Haemophilus, Pneumococcus, Legionella, or 
Candida. In contrast, there is a substantial body of literature dealing with 
the growth of bacteria in other body fluids, such as saliva, breast milk and 
urine (Table 38). Experience gained in the present work suggests that such 
investigations might be fruitful in the context of defining growth in such 
media which arguably are more natural than conventional culture media.
One of the initial hopes in this investigation was that the four 
species of Bordetella might show growth patterns in TBW from different 
vertebrate species which would be in accordance with their known 
patterns of host specificity. In fact, the results did not work out this way. B. 
p ertu ssis failed to grow in any of seven species of TBW (including human); 
B. parapertussis grew in five of the seven, while B. bronchlseptica and B. 
avium  grew in all of the TBW species tested (except human TBW no. 2). 
Rather than revealing any host specificity within the bordetellae for TBW, 
the results indicated more the degree of fastidiousness of each of the four 
organisms, a point which has long been known.
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Table 38 : Growth of microorganisms in body fluids as reported  
in the literature.
Fluid Micruorganism Reference
Saliva
Acl/noûiyœs r/si'oas Aerobacter chacae, 
Bavlllus c&reus, Bacillus subtJlus, Candida 
albicans Corynebactcrium diptheriae, 
laclübacillus Staphylococcus aureus. 
Streptococcus faecalls. Streptococcus pyogenes
Williams and Povlen, 
1959
Cowman etal. 1977 
De Jong etal. 1984
Serum Streptococcus spp. Sukroongreung etal. 1988
Breast-milk Staphylococcus, StJ'eptococcus E. coli Roberts and Severn, 1978 
Nwankwo etal, 1988
Urine
£. coli Proteus. Klebsiella. Enterococci Kaye, 1968
Staphylococcusepidermidis, Aerobacter Stamey and Kaufman, 1975 
aerogenes, Pseudomonas aeruginosa. Greenwood and O' Grady,
Staphylococcus aureus. Streptococcus albus 1978
Stamey and Mihara, 1980
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Table 39 shows the maximal log^Q CFU/ml recorded for each of
the four bordetellae in the TBW samples and compares them with those for 
CL medium. With all four organisms, the viable count was always highest in 
CL medium (as was expected) due to the nutritious nature of this medium. 
However, the counts recorded for B. bronchlseptica and B. avium  in horse 
and mouse TBW were similar to those for CL medium. In most cases, B. 
bronchlseptica gave the most growth in the TBW samples, although B. 
avium  was similar. This was as expected considering the fact that these 
two organisms are the least fastidious of the bordetellae. With B. 
parapertussis the maximum log^Q CFU/ml in all six TBW samples was
similar suggesting that a nutritional deficiency prevented B. parapertussis 
from emulating the viable counts of B. bronchlseptica and B. avium ,. 
Although B. p ertu ssis failed to grow in any of the TBW samples without 
supplementation, the viable counts recorded in the CL medium were the 
highest of the four species. A surprizing observation was that rabbit TBW 
supplemented with CL medium gave an approximately 2-fold greater 
viable count with B, p ertu ssis than did CL medium alone. This suggested 
that the rabbit TBW may contain a stimulant for B. p ertu ssis which is 
lacking in the CL medium. The reasons for the quantitative differences in 
the viable counts recorded for the different bordetellae in the TBW was 
thought to reflect the nutritional content of the TBW and the 
nutrient-scavenging abilitiy of the organisms. The ability of B. 
bronchlseptica and B. avium  to use alternative carbon and energy sources 
would also help explain the larger viable counts recorded with these two 
bacteria.
The fact that members of the Bordetella can even grow in TBW 
from different animal and bird species presents a number of future areas 
of research. A study of the infectivity and pathogenicity of the bacteria
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Table 39 : Viable counts^ of the four species of B ordetella  in 
various sam ples of vertebrate TBW after two and 
seven days incubation at 37*C.
Fluid Day
LogiQCFH/ml (N)of
B. bronchiseptica B. m um  B. paru pertussis B, pertussis
PBS 2 5.9i0 ,l(12) 5 .2 1 O.4 (5) 1.3iO,S (5) 0.7i0.7(4)
7 6.7i0.1 (5) 5 .3 1 O.5 (4) 0(6) 0(4)
CL 2 9.410.1 (14) 9.1 + 0.2(10) 6.2 ±0.2 (11) 5.4 1 0.2 (6)
medium 7 S.8 1 O.4 (5) S.ZiO.l (4) 9.5i0.1 (4) 10,0i0.2(5)
TBW
Horse 2 8.8i0.2(4) 8.8 1 0.1 (5) 0(3) 0(2)
7 9 .I1 O.I (3) 7.4i 0.03(3) 0(3) 0(2)
Sheep 2 7.91 0.2 (5) 7.5i 0.3(5) 5.7i 0.4(3) 2.5 ±.0 .2(2 )
7 7 .8 1 O.I (4) 6.1i0.2(3) 5.4i0.2(3) 0(2)
Dog 2 5.5i0.2(3) 5T i0 .2(3) 2,9i0.1 (6) 0(3)
7 7,9i0.2(3) 7.9i 0,2(3) 0(6) 0(3)
Mouse 2 8.7i0.2 (4) 8 .8 1 0 .2  (3) 6 .3 1 O.5 (5) 0(3)
7 8 .8 1 O.I (3) 6.5i0.1 (3) 5.1 (1) 0(3)
Rabbit 2 7.9iO,2 (4) 7.6iO,2 (5) 5.6i0.4(3) i .5 i l .5  (2)
7 8.2±0.2(3) 6.6iO,l (4) 5.7±0,5(3) 0(2)
Chicken 2 S.4i0.2(3) 7.5i0.03(3) 5 .5 ±.0.2 (3) 0(3)
7 7 .S1 O.I (3) 5>4i0.1(3) 5 .I1 O.2 (3) 0(3)
Human 1 2 8.9(1) 8.5(1) 6.5(1) 0(1)
7 8.7(1) 7.3(1) 3.3(1) 0(1)
Human 2 2 1 .2 il .2 (2 ) 0(1) 0(2) 0(2)
7 0(2) 0(1) 0 (2) 0(2)
Human 3 2 8.3(1) 7.8(1) 6,1 (1) 0(1)
7 8.7(1) 6.1 (1) 3.2(1) 0(1)
 ^ expressed as log 10 CFU/ml
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grown in TBW as compared to the conventionally-grown bacteria would 
perhaps reveal more information on phenotypic modulation and provide us 
with an organism for study,which is more like the one involved in the 
natural infection. A model system using tissue culture with TBW as the 
bathing fluid would provide a model similar, if not better than the current 
animal models. Another area of research could concentrate on 
supplementation studies with B. p ertu ssis and B. parapertussis to 
investigate the question of which essential nutrients are missing from the 
TBW. This could lead to the development of a new artificial medium, solid 
or liquid, based upon the different TBW and tested as an isolation and 
cultivation medium for each of the four bordetellae. Further studies to 
reveal which alternative energy sources are being exploited by B. 
broncJiIseptlca and B, avium  would also be a potential area of research. 
Thinking laterally, this work could be extended to other respiratory tract 
pathogens such as PasteureIJa and HaemopAIJus species.
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Part 2. Chemical analysis of TBW
It is known that the BordeteJJa require amino acids and nicotinic 
acid for growth and that since three of the four species grew in the TBW 
then these nutrients must be present. The fact that there were differences 
in the extent of growth in the different fluids and between species of 
BordeteJJa suggested that nutritional differences, in terms of amino acids 
and nicotinic acid, within the TBW existed. To verify these assumptions a 
series of chemical analysis were employed to quantify the amino acid and 
nicotinic acid contents of the different TBW samples. Some of the nutrient 
in the TBW could have come from blood contamination and the 
haemoglobin content of the TBW was measured as an indicator of this 
contamination. Despite extensive searching, no relevant literature dealing 
with analysis of TBW for these particular nutrients has been reported. 
There is vast literature on analysis of human and animal TBW for proteins, 
lipids and immunoglobulins as was presented in the Introduction. 
Therefore this section will focus only on the amino acids and nicotinic acid 
present in the TBW.
Amino acids were found in all of the TBW tested although the 
concentrations were much lower than those in CL medium (Table 40). In 
terms of amino acids, and with respect to CL medium, the TBW could be 
regarded, on average, as a 1 in 500 dilution of the laboratory medium. The 
nicotinic acid content of the TBW also varied but was again less than that of 
CL medium (on average, a 1 in 7 dilution). Table 41 shows a comparison 
between the maximal viable counts recorded for each of the four BordeteJJâ 
and the amino acid contents of the culture fluids. There was a significant 
relationship between nutrient concentration (both amino acids and 
nicotinic acid) and growth of B. broncAJseptJca and B. avium . Comparing 
amino acid concentrations of the various TBW samples with the growth
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Table 40 : BordeteJla nutritional factors in CL medium and TBW
TBW/Media
Average amino acid 
concentration 
(mg/mi)
Average nicotinic 
acid concentration 
(Ug/mi)
CL medium 20.94 4
Horse TBW 0.10 1.06
Mouse TBW 0.07 0.84
Rabbit TBW 2/3 0.02 0.23
Sheep TBW 1 0.02 0.33
Chicken TBW 0.01 0.20
Dog TBW 0.03 0.54
Human TBW 0.06 0.65
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Table 41 : Comparison of the amino acid concentrations of TBW 
w ith  the maximum viable counts® recorded for B. 
broncAiseptica, B. avium  and B. parapertu ssis
Fluid
Maximum log^Q CFU/ml of ;
Amino acid 
(mg/ml)
B. broncbiseptica B. avium B. parapertussis
CL medium 20.94 9.4 9.4 9.5
TBW
Horse 0.10 9.1 8.8 < 1.7
Mouse 0.07 8.8 8.8 6.3
Human^ 0.05 8.8 8.2 6.3
Dog 0.03 7.9 7.9 < 1.7
Rabbit 0.02 8.2 7.6 6.6
Sheep 0.02 7.9 8.0 6.7
Chicken 0.01 8.4 7.5 5.5
® expressed as log 10 CFU/ml 
^ average of two different samples
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achieved by B. broncbiseptica in each fluid a Kendall correlation statistic of 
0.667 was recorded. For B. avium  the correlation statistic was 0.950, 
indicating a closer relationship. A similar pattern was seen when the 
growth of each organism was compared to the amount of nicotinic acid 
present. Kendall correlation statistics of 0.551 and 0.927 were recorded for 
B. broncbiseptica and B, avium  respectively.
B. parapertussis did not show any relationship between the 
amino acid or nicotinic acid content of TBW and the viable count. The 
counts recorded for this bacterium, in all of the TBW, were similar and no 
visible turbidity was observed. This suggested that certain essential amino 
acids may not have been present at the correct concentrations to give as 
good growth as in the CL medium. Also, B. p ertu ssis failed to grow in any 
of the TBW, thereby strengthening the argument made for B. parapertussis.
Therefore there appears to be a definite relationship between the 
amino acid content of the TBW and ability to support the growth of B. 
broncbiseptica and B. avium  but not for B. parapertussis or B. p ertu ssis 
The possibility that the two animal and bird pathogens are growing on both 
amino acids and organic acids cannot be discounted.
Preliminary experiments using a technique of Isotachophoresis 
(SKo.rv e t aJ, 1985 and Andrews, 1988) revealed the presence of 
compounds in some of the TBW which could be fatty acids. However no 
detailed study was made and it would be unwise to assume that these 
results were valid without replication.
It was concluded that the level of blood contamination in the 
TBW samples was insufficient to affect its overall nutritional content (Table 
32). In the literature there was some information on the amino acid and 
nicotinic acid content of whole blood. In the Documenta Geigy (1970), blood 
is regarded as having an amino acid content of 60 mg/1 and a nicotinic 
acid content of 6.3 mg/1. The amino acid values are similar to those
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recorded for the TBW samples tested in these studies, while the nicotinic 
acid values are about 6-fold greater in blood. Also documented is the fact 
that whole human adult blood contains fatty acids at a concentration of 80 
mg/1. This would suggest that the TBW may also contain levels of fatty 
acids similar to those in blood providing more encouragement for further 
investigations with the Isotachophoresis. Both amino acids and fatty acids 
have been reported in other body fluids such as breast-milk, saliva and 
urine (see Documenta Geigy, 1970). There also appears to be species 
differences in the nutritional content of the TBW samples. However in 
order to verify this, extensive sampling would have to be completed and 
factors such as the age of animals, enviroment, health and diet considered.
An important factor to consider is that the TBW being dealt with 
in this study are a dilute form of the natural fluid of the respiratory tract. 
Table 42 shows estimated dilution factors for dog, human and chicken TBW 
in terms of protein concentrations. The protein concentration of each TBW 
species calculated in this study, was compared to those reported for 
undiluted secretions in the literature. The TBW used in this study could be 
regarded as a 1 in 3 (chicken), 1 in 5 (human) and a 1 in 68 (dog) dilution 
of their respective whole respiratory tract secretions. Therefore it is 
possible that the undiluted form of TBW could support the growth of the 
BordeteJJa species to a greater extent than is reported. It may also be the 
case that B. p ertu ssis will grow in these secretions without the need for 
supplementation. However, the concentration of amino acids reported by 
Potter e t a i (1967) of 31.8 i  166 mM/L for whole human secretions, was 
less than that recorded for one of the human samples used in this research 
(i.e. human TBW no. 2 contained 0.73 mM LE). This suggests that 
within-species variation may occur, with regards to the nutritional content 
of secretions, although extensive sampling would be necessary before any 
definite conclusions could be made.
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Table 42 : Estimation of dilution factors for TBW sam ples based 
upon reports, in the literature, for undiluted  
respiratory-tract secretions (RTS).
Protein concentration (iig/ml) of :
RTS^ TB^b Dilution factor
Dog Reasor e t aJ, 
1978
41, 000 599 1 in 68
Chicken Boyd e t aJ, 
1944
260 88 1 in 3
Human Matthews e t aJ, 
1963
10, 000 2018 1 in 5
 ^from the literature 
^ from this research
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This work has shown that a range of TBW species contained 
sufficient nutrients to support the growth of three of the four BordeteJh 
species. Supplementation of these fluids improved growth and, in the case 
of B. pertussis, resulted in a greater viable count than in CL medium alone. 
Future elucidation of the amino acids present in the TBW and of the fatty 
acid content are necessary to establish which amino acids are missing or 
not present in sufficient concentrations to support the growth of all four 
BordeteIJa species, and whether B. broncbiseptica and B. avium  are 
utilizing an alternative energy source as is suggested.
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Part 3. The growth of B. bronchiseptJca in PBS and natural
w aters
This study has shown that B. bronchJseptJca, despite its generally-accepted 
role as an obligate respiratory-tract parasite, is able to increase in viable 
count and survive in a variety of natural waters, in RGW and in PBS. 
Although most of our observations were made with strain, no. 5376, which 
had been subjected to long maintenance in the laboratory, similar growth 
in lake water and in PBS was seen with fresh isolates from domestic 
animals and with the type strain NCTG 452. It seems, therefore, that the 
ability of B. broncbiseptica to grow in these several types of low-nutrient 
fluids is a species characteristic and is not restricted to particular selected 
strains.
The extent of increase in viable count in the various fluids to 
which no nutrients had been added could be separated into two categories, 
viz in the region of 5- to 8-fold, as observed in RGW and sea water, and 
around 1000-fold, as recorded with PBS and all the samples of lake and 
pond water. It seems likely that this distinction reflects 
order-of-magnitude differences in the nutrient concentrations in the 
respective fluids. Such quantitative differences may also be accompanied 
by qualitative differences in the actual nutrients present.
With other species of bacteria there is an extensive literature on 
increases in viable count under starvation conditions ( Postgate and Hunter; 
1962 Jones and Rhodes-Roberts, 1981; Morita, 1982; Harder and 
Dijkhuizen, 1983). For example, Morita and Novitsky (Morita, 1982; 
Novitsky and Morita, 1977, 1978) reported 4-fold increases, over 1 week, 
in the CFU/ml of a marine vibrio in a starvation menstruum. Various 
authors have used terms such as starvation-survival (Morita, 1982), 
cryptic growth (Postgate and Hunter, 1962), re-growth (Strange e t ai.
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1961) and cannibalism (Harrison, 1961), to describe the observed increases 
in viable count of bacteria in environments with very low concentrations of 
nutrient. It is possible that a variety of mechanisms may be involved, such 
as extremely efficient scavenging of trace nutrients, including those such as 
ammonia which may be absorbed from the atmosphere (Jones and 
Rhodes-Roberts, 1981); reductive division, i.e. cell division with a reduction 
in cell size (Morita, 1982); endogenous respiration (Pine, 1980); and death 
of part of a population, with re utilization of leaked nutrients by the 
survivors (Postgate and Hunter, 1962). Any or all of these mechanisms 
may have been involved in the 5-fold and 8-fold average increases in 
viable count of B. broncbiseptica observed in RGW and sea water, 
respectively. With regard to the biological significance of growth and 
survival of these organisms in the sea water, it may be noted that B. 
broncbiseptica has recently been isolated from seals (Tewes, 1989)
The greater increases in viable count, in the order of 1,000-fold, 
observed in PBS and lake and pond water presumably reflect the much 
greater level of nutrients in these fluids than in the fluids just considered. 
However, even these higher levels are probably only in the region of 
1/10,000 to 1/100,000 of those present in a normal B ordeteiia culture 
medium, such as CL medium. With PBS, it seems that one or more of the 
analytical-grade salts, rather than the water supplies or the laboratory 
atmosphere, was the main source of nutrients.
Over 30 years ago, Garvie (1954) reported the growth of E. cob 
and A erobacter aerogenes in PBS made from purified ingredients. Other 
bacteria either failed to grow or died out. In our studies, the nature of the 
nutrients in PBS or lake water has not been determined; they may be 
different from those in conventional media for BordeteIJa species. In this 
connection it may be noted that B. broncbiseptica can grow on ammonia 
plus lactate or citrate (Proom, 1955), although conventional media for this
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species usually supply amino acids as the carbon, nitrogen and, energy 
source.
The stationary-phase population of B. broncbiseptica in PBS and 
lake or pond water was never greater than about 7 x 10^ CFU/ml, a 
concentration insufficient to give visible turbidity. By drying and weighing 
pelleted cells of B. broncbiseptica of known CFU from growth on BG 
medium for 24h, the mass of an individual bacterium was established as 
about 0.1 pg. This is assuming that 1 CFU represents a single viable cell of 
B. broncbiseptica. On this basis, the dry weight of 10^ CFU would be 0.1 
pg, and the amount of major nutrients needed to yield this number of cells 
would be about 0.3 tig. While we have not attempted to analyse or 
measure the nutrients in the lake or pond water samples, it may be noted 
that 0,3 [ig/ml is 0.3 mg/L and would represent the very low biological 
oxygen demand expected for the unpolluted waters sampled. Also, the 0.3 
mg/L is nutritionally equivalent to a 1/73,000 dilution of the amino acids 
of CL medium, and is within the range estimated (0.2-2 mg/L) by the 
experiment in which CL medium was diluted in PBS to the point where it 
gave no more growth than PBS alone.
The ability of B. broncbiseptica strains to survive in the 
low-nutrient fluids tested was maintained over a period of six months at 
both 37“C and 10“C. This raises the question of whether it is feasible to 
assume that B. broncbiseptica, and even B. avium  which shares similar 
properties, exist in the natural enviroment and may cause infection when 
ingested by the host species. The ability of other bacteria, particularly in 
the marine enviroment, to maintain viability over long-term starvation has 
been well documented although this is the first report of a similar action of 
B. broncbiseptica. In 1970 Ensign reported that A rtbrobacte/ 
crystaiJopoietes maintained 100 % viability under starvation conditions for 
30 days and after 60 days remained 65 % viable. In another study
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involving 16 marine isolates Amy and Morita (1983) studied their 
starvation survival patterns and reported survival times of at least eight 
months. Also in relation to the marine enviroment, work with the marine 
vibrio Ant 300 revealed survival times of 70 weeks (Novitsky and Morita, 
1978 and Morita 1982) and over 1 year ( Novitsky and Morita, 1977). 
Jones and Rhodes-Roberts (1981) reported that a marine Pseudom onat 
species remained viable for 40 days in a starvation menstruum. Other 
non-marine organisms include Campylobacter fe tu s  subs p. jejunJ which 
showed the ability to survive in a number of different biological milieu 
(Blaser e t aJ, 1980) such as bile (two months), faeces (three weeks), urine 
(five weeks) and water (four weeks). Survival of B. broncbiseptica  in soil 
may be for as long as 45 days (Mitscherlich and Marth, 1984), while B, 
p ertu ssis in the same report, survived for shorter periods on various 
materials; baby food (four days), air (20 h). paper (two days) and plastic 
(3-5 days).
A more recent investigation generated by the initial findings of 
this study was undertaken by McCaig (1991). The work involved an 
investigation into the effect of supplementation of PBS and lake and sea 
water (LW and SW) on the growth of B broncbiseptica. Initially the findings 
of this thesis were verified, although the viable counts recorded for growth 
of B. broncbiseprica in sea water were greater than those reported 
originally. This could be explained by the fact that the two samples in 
question were taken from different locations resulting in possible different 
organic contents. Supplementation of LW and SW with nicotinic acid, lactate 
and ammonium chloride was investigated. Of the three potential nutrients 
nicotinic acid was found to be most limiting and in the presence of all three 
the final viable count recorded with B. broncbiseptica was 40-fold greater 
in LW alone and 20-fold greater than in SW alone. Even with this 
supplementation and increased viable count visible turbidity was never
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achieved. McCaig (1991) also showed, by means of the BOD test, that LW 
contained at least 0.8 ug/ml dissolved organic carbon per ml; more than 
enough to support the reported growth of B. broncbiseptica.
During the long-term incubation of B. broncbiseptica in PBS and 
fresh water, the 20 )il platings on BG exhibited two distinct colony forms 
(Photographs 1 and 2). As the time of incubation in the dilute-nutrient 
fluids progressed, the large-form colonies of B. broncbiseptica on BG agar 
tended to switch to the smaller form. This could be a response to the lack 
of nutrients in the PBS or lake water and may represent a method of 
energy conservation by the bacterium. Further study would be needed to 
see if the smaller colonies cot aine d smaller cells e.g in line with the 
phenomenon of miniaturization of cells which has been reported 
extensively elsewhere (Amy and Morita, 1983; Morita, 1982; Baker e t aJ, 
1983 and Marden e t ai, 1985). It may also be the case that a form of 
antigenic modulation or phenotypic variation is in effect, where B. 
broncbiseptica may switch off expression of its virulence factors and adopt 
a more economical morphological form in response to the low-nutrient 
conditions. This method of energy conservation under stressed conditions, 
such as starvation, has been observed in other bacteria. For example, 
Morita (1985) reported this phenomenon in marine bacteria in response to 
a lack of energy source, and Marden and co-workers (1985) showed similar 
response with three marine isolates.
The effect of temperature on the survival of B. broncbisepticti 
could be important. Towards the end of the observation period the viable 
counts for B. broncbiseptica  in the fluids incubated at 37“C decreased and 
in some cases no viability was recorded. This was in contrast to those 
incubated at 10°C where the viable count, generally, remained constant 
over the final three months. Initially, as was to be expected, B. 
broncbiseptica grew more slowly in the fluids incubated at the lower
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temperature although the maximum counts, when reached, were similar to 
those at 37“C. McCaig (1991) presented similar findings when she 
incubated the bacterium at 18*C. During these long-term starvation studies 
B. broncbiseptica could be recovered from the walls of the culture vessels. 
This suggests that the viable counts recorded in the experiments reported 
in this study, and perhaps in other investigations with B. broncbiseptica 
may be lower than the true value if wall growth or adherence is taken into 
account.
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Part 4. Conclusions and future areas of research
This study, as far as is known, is the first to report on the growth of 
BordeteJJa species in the natural host fluid from the site of infection. It has 
been noted that the two less fastidious species, B. btonchJseptJca and B. 
avium , grew in all TBW samples tested while the two human pathogens 
either did not grow {B. p ertu ssis ) or showed a variable response (B  
parapertussis). No species specificity was demonstrated . Chemical analysis 
of the TBW showed that at least some of the appropriate nutrients (amino 
acids and nicotinic acid) were present, although these may not be in the 
most suitable concentrations for growth of Bordeteiia.
From this work a number of possibilities for future research have 
emerged. The work with the TBW could be extended to other respiratory 
tract pathogens such as H aem opiiiius and Legioneiia species. A study of 
the Bordeteiia cell properties i.e. virulence factors, when grown in TBW 
compared to those in CL medium would reveal whether or not antigenic 
modulation occurred in the TBW samples. Preliminary studies of gel 
profiles and of FHA activity of B. broncbiseptica strain no. 11 grown in dog 
TBW (results not presented), suggested that the bacterium does possess 
toxin activity, while a number of differences between cells from TBW and 
those from CL medium were observed in the gel profiles. Supplementation 
of the TBW would reveal which nutrients were missing and whether when 
added, the TBW would then be growth-supporting for B. p e rtu ssis. Also 
there could be an investigation of possible alternative energy sources being 
utilized by B. broncbiseptica and B. avium . Perhaps a new medium could 
be developed, based upon TBW composition and could be tested in both 
liquid and solid form for isolation and cultivation purposes.
The other area in which novel discoveries have been made is 
perhaps more challenging : The ability of B. broncbiseptica to grow and
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survive over long periods in fresh water. We concluded from these 
observations that it should be possible for B. broncJiJseptlca to survive in 
ponds and lakes and hence create a reservoir of infection. From this could 
emerge an investigation to isolate B. bronchlseptJca from enviroments in 
which it is prevalent. For example, in a dog kennel where there is a 
naturally occurring infection. If B. broncbiseptica could be isolated from, 
say, infected drinking water and this water could be used to initiate 
infection in other animals, then the evidence for a new mode of 
transmission would be very strong. Another study could focus on the 
question of antigenic modulation under the low-nutrient conditions. We 
found that during long-term incubation of B. broncbiseptica in fresh water 
a smaller morphological form developed. The investigation could focus on a 
comparison of the two morhological cell types, looking at virulence factors 
such as HLT and FHA. If it was found that B, broncbiseptica is avirulent in 
these low-nutrient fluids it might help explain why it has never been 
isolated from other enviromental sources. Another area of research 
stimulated by this work could be an investigation into the 
starvation-survival strategies employed by B. broncbiseptica. It could be 
that the efficient scavenging ability of the organism is due to the presence 
of amino acid binding proteins, similar to those used in iron acquisition, or 
to dormancy, miniaturization of cells and/or cannibalism. Also, nothing is 
known about the pathogenicity of this organism when it is grown in these 
natural fluids. For example, is it possible that B. broncbiseptica grown in 
lake water can initiate an infection when introduced into an appropriate 
host species and, if so, is this infection similar to that caused by organisms 
grown in conventional culture media ? A major difficulty encountered here 
would be the problem of scaling-up to obtain sufficient numbers of cells for 
the study, particularity for electron microscopy studies.
A further study which has already been described earlier in the
previous section (McCaig, 1991), is the supplementation of the low-nutrient 
fluids and their chemical examination and could also include B. avium  
which has been shown to possess this self-same ability as B. broncbiseptica. 
It is interesting to note that both B. broncbiseptica and B. avium  were 
formerly assigned (Pittman and Wardlaw, 1981 ) to the AicaJlgenes, a genus 
of soil and fresh water bacteria with which they share many properties. In 
fact, the main differential characters additional to habitats are the 
virulence factors possessed by these bordetellae. This also suggests a new 
look at the taxonomy of the B ordeteiia and A icaiigenes and supports the 
opinion of De Ley e t a i (1986) who proposed a new family, 
Aicaiigeneaceae, encompassing both genera.
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Appendix la  : API interpretation table.
1 1 RESULTS
TESTS SUBSTRATES j REACTIONS/ENZYMES NEGATIVE POSITIVE
1 reduction of nitrates | NIT 1 ^ NIT 2 / 5 min
NO. potassium |
to nitrites j colourless pink-red
1 nitrate reduction of nitrates Zn ; 5 minj to nitrogen pink colourless
f JfiM€S immediate
TAP triptophan indole production pale green-yellow Pink
G LU glucose acidification blue or green yellow
ADH arginine arginine aihydroiase yellow orange/ pink/ red
URE urea urease yellow orange/ pink/ red
ESC aesculin hydrolysis ,3-glucosidase) yellow grey/ brown/ black
GEL gelatin hydrolysis iprotease)
no pigment 
diffusion
diffusion of 
black pigment
PNPG p-nttrophenyl-3D-galactopyranoside l3-galactos;dase colourless
yellow
:GLU| glucose assimilation transparent ! opaque
: ARA 1 arabinose assimilation transparent ! opaque
MNE; m annose assimilation transparent opaque
! MAN 1 mannitoi assimilation transparent
!
opaque
; NAG ] N-acetyt-glucosamine assimilation transparent j opaque
1
i MALI maltose assimilation transparent j opaque
GNT| gluconate assimilation transparent 1 opaque
;CAPl caprate assimilation transoarent j opaque
i ADI 1 adipate j assimilation transparent ! opaque
■ MLTj malate
1
[ assimilation transparent j opaque
GIT! citrate
1
1 assimilation
1
1 transoarent 1 ooaque
1
; PAG i ' phenyl-acetate 1 assimilation i transparent opaque
o x 1 tetramethyl-o- j phenylene diamine I cytocnrom e oxidase
i
j colourless violet
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Àppeadix lb  : API identification codes.
.... r N03 I TttP 1 ^ Uj i AOH 1 uAE; ESC OËL jPNpqllQLU *nA,i' MHei VAHljl HXOli! UAL, 11 ONT |'5AE'i .ADui’Mii;li_2CL,l'.PAiLi ox
^ sa u o o m o n a s  a e ru g in o sa  j 96{ 0 1
4
3oi 201 1 90l 1 1 99 21 A 84 72! 3f 97 96) 751 901 98 1 t ! 38
P se u d o m o n a s  a u rso ra c ie n s  | s o l oi 801 01 0 901 301100 391100) 99 90 0 1100 90) 3 0 l t 0 0 | t 0 0 | 90) 70
P se u d o m o n a s  o e o a c ia  ( 39 01 30 j 1 i Zi 50 70 1 72)100 721 38 35 37 3 l  37 , 39 ) 93|tOO{ 99! 39 1 39
P se u d o m o n a s  cn io ro raon is 7 01 0 7] 0 i 27 7 1 0 1100 801 93 60 7 | 0 1 90 73 0)100 )100 ) 7 1 AO
P se u d o m o n a s  dim inuta 6 01 0 01 01 0 331 Oi 1 11 1 1 1 0) 1 j 0 35 121 24 1 1 1 0 1 94
P se u d o m o n a s  ‘lu o ra sc en s 31 01 0 S31 1 t 1 391 A| 99 701 90) 35 31 1 7 98 99 a l 93 j 391 10 1 39
P se u d o m o n a s  maiiei :to o 0 t 0 30 1 331 3 01 0 1100 01 37 7 lOO) o ito o 0 991 0 ) 0 1 0 I10O
P se u d o m o n a s  m en d o c in a 100 31 o i 94 1 1 i 0 4
01100 01 01 0 01 01 94 too 1 ) io o ( io o ) 0 11(30
P se u d o m o n a s  m eso o n ih ca 24 01 o | 01 73 1 0 01 3) 29) 431 01 0 0 1 Of 29 0 12) ao 191 01 90
P se u d o m o n a s  oaucim odiiis 101 01 0 | 01 1 1 39 2 ) 90 95 781 73 i 15 59 1 93 46 13 e l 01 46 1 1 ! 73
P se u d o m o n a s  oioKettii 35 01 o i 31 3 1 0 3 l 0 ) 95 701 1 4 6 0)100 87) 30)100 34.[ 3)100
P se u d o m o n a s  o seudom aile i too- o t 3 I 961 01 12 to o l 0 )100 O i 96)100 100 0)100 100 9 8 f100 97) 39! 100
P se u d o m o n a s  ou iida 31 01 11 701 1 1 0 1 j 1 i 96 361 371 5 2 [ 0 92 96 1 1100 99) 30 1 38
P se u d o m o n a s  o u tre tac ie n s 92 01 A) 01 1 ! 71 951 01 3 11 1 0 0 95 9 1 71 1 ) 90 21 0 1100
P se u d o m o n a s  stutzeri 34 01 oi 51 i l 0 1| o l 95 4 i 10 1 87 89 91 86 2 95 34) 2 ilOO
P se u d o m o n a s  vesicu iaris 23 01 4 1 1 01 98 13! 40 72 01 Ol 3 101 721 1 a 1 i 40 01 Oi 99
C a m a m o n a s  testosterom y P s.a ica tiqenes ■30. 01 0 21 0 4) 1 3 31 31 A 11 2 f 42 35 38 1 90 321 2 1 36
C a m a m o n a s  ac id o v o ran s 97 01 0 01 0 1 0 31 0 1 1 1 0 1 73 o l 0) 991 53 1 91) 96 331 31 IlOO
X an th o m o n as m aitoonilia 371 01 o i 01 1 ! 39 9 9 ) 87 84 31 93 1 I 93 96 1 1 11 1 ! 98 981 01 a)
G hrv seo m o n as lu teo ia S7I 01 13 71 1 1 !100 30 1 99 9 9 99) 99) 90 121 65 35i 82 1 ) 90 341 3 | 2
P 'av im onas a ryzihao itana 01 O i 0 Oi 1 1 0 11 1 11 100 9 9 |1 0 0 |l0 0 0! 30 f 99j 38 2 | 99 99 1 01 3
G firom ooactenum  vio iacaum 951 111 39 391 01 o i  3 9 | 1 99 0 1 66 1 221 381 1 99! 36 1 IlOO 44 1 1 t 95
B ordetella  o ro n cn iseo tica 721 01 0 01 97) 0 91 Ol 0 01 Ol 0 01 0 0 7 a z 53 76 t 77-100
, B o rce ten a  avium 01 0 1 0 01 01 0 01 13 01 0 1 0 01 Ol 0 0 )1 0 0 |1 0 0 100)100! 75
Oliqeila areoiy tica 1 0 1 0 01 99 i 0 01 Oi 0 0 1 01 0) 0) 01 0 01 11 95 9S | 26 I 30
Oligalla urettirans 01 01 3 01 01 0 0 01 1 0 | 0 1 0) 01 0 1 0 0 0 ( 96 30 1 0 1100
CQC qrlV C-2 1 1 01 0 o i 261 0 1 0 1 0 01 01 0) 01 1 SO 00 i 7 4 ) 90 751 121 96
A lcaligenes 'a ec a iis 201 0 1 0 21 0 t 0 1 2) 01 01 0 | 1 1 01 12 38 1 2 t 99) 321 36) 95
A lcaligenes xviosoxidans sso  aen iin fican s 9 s i 0 1 0 o i 21 0 0 ol 1 01 ol 0 0 1 1 80 20 9 0 j 08 061 331100
A lcaiiqenes xvtosoxidans sso xviosoxidans 35 1 o i 0 0 1 0 1 0 3 0 1 99 01 29 1 3 31 0I1OO 79 1 38)100 to o l 37 1 99
A cn ro m o o ac ter  CDC grVO 30 t 0 1 0 0 1 341 0 0 31 34 791 30 1 23 831. 3 0 1 39 35 41 39 s o l 1 1 33
A qrooactertum  m o io o a c te r 9 9 j 01 0 01 30) 39 1 ■ 98)100 991100)100 36) 90) 90 2 1 ) too 11 a 1 30
p 'av o o ac ten u m  oreve 21 51 0 0 1 1 1 3 93 Ol 10 1 1 1 1 0 0 1 10) 0 0 1 | 0 “ 1 101100
p 'avoD acterium  n d o io q en e s 201 35 | 2 0! 441 98 99 31 05 27 1 821 3 01 821 3 Ol 3) 8 171 17 1 36
Fiavooacterium  m eningoseo tioum t { 83) 2 0 1 51 96 94 63 77 71 75) 76 70) 61 i J 0 11 0 251 O i  99
P lavooactartum  o o o ratu m 1 i 101 0 0 1 33 1 2 97 1 1 1 01 1 1 0 51 1 1 0 Ol 1 5 0 1 9 1 30
B oningooacterrum  m uitivorum 1 1 01 16 0 1 33 1100 1 I10O 90 ! 91 1 381 01 961 96 1 0 0 ! 1 0 01 3 t 90
S o n in q o o acteriu m  soirittvorum 01 0 1 0 01 1 !100 0 |1 0 0 |1 0 0 1 ilOOi 19 ilQ O ilO O l 0 ol 0 0 ol 3 n o o
W eeK seiia virosa At 51 0 01 0 1 1 9 9 0 1 0 1 1 01 0) 01 01 2 01 0 0 0 1 t : 39
W eeK sena zooneicum 01 0 I 0 0 1 39 I 0 87 01 0 Oi 1 0 ) o l 0 I 0 01 1 0 01 0! 39
A cinetoD acter oaum anm i 1 1 01 20 01 ‘ 1 0 1 01 32 1 791 0! 0 01 01 30 9 9 )  9 Q j l « ) 90) 961 9
A cm eto o ac ter c a ic o a c e tio u s o( 01 0 0 t 0 | 0 0 | 0 0 01 o l 0 01 Ol 0 t o o l  1 0 to o l 1001 0
A c in e io o ac te r  n aem oiy ticus 21 01 24 01 01 0 0 0 01 ol 0 o i 01 0 ■ 38 I 2 38 731 1 1 ]
A cm eto o ac te r  onnsonn 01 01 0 01 0! 0 01 01 0 01 01 0 01 Ol 0 to o  I 33 0 1001 Ol 3
A cm eto o ac te r  |unii 21 01 3 0! 31 0 01 01 19 241 11 1 0 1 0 t 3 331 38  IlOO: 081 01 3
A c m eto o ac te r  'woffii 1 1 0 I 1 i J i 31 0 01 I 3 Ai 11 1 11 0 1 1 70 1 20 48 01 36 ' 1
M oraxaila tacu n a ta 90 1 01 0 01 01 0 99 3 01 01 0 0 1 o l 0 01 0 9 71 0 1 ICO
M oraxeiia onenyiovruvica 1 601 0 1 0 Oi 96i 0 01 0 0 01 01 0 0 1 0 | 0 0) 1 3 11 t'IC O
Vioraxeiia so o I 45 1 01 0 01 21 0 5 0 1 ) 31 01 0 ol 01 0 4 1 2 3 1 1 3 11(30
P asteu re ila  a e ro g e n e s 1-001 o i 97 0 ! 991 0 0 | 99 95 i 75 i 95 I 3 3o! 93 95 0 |  1 95 11 01 77
p asteu re iia  n aem oiy tica 1 01 2 0 1 0 | 2 01 82 01 0) 01 0 1 0) 0 0 0 ( 1 0 01 0! 30
P asteu re ila  m uitooida I 39 t 96) 5 01 01 oj o l 10 3 Oi i 5 1 5) 2 2 o l 1 3 01 0 1 79
P asteu re ila  o n eu m o tro o ica jto o i 3 0 | 20 0! 3 5 1 0 Oi 75 3 31 5 1 Ol 61 3 a 0 a 6 01 31 34
P asteu re ila  s o d j 961 11 1 161 01 0 3 A! SO) 61 2l 5 ) 1 1 2 0 1 50 11 01 37
A erom onas nvoroonila/ cav iae 1 98 j- 361 98 73 1 0 | 94 97 - 99) 99
1
79 1100 ) 98 )100 93 89 01 99 37) 3! 39
A erom onas soorta jto o j 36) 96 30 i 0 | 1 99) 97 too 29Î 99) 97 I 391100) 100 90 0 98 75! 3 100
A erom onas îa im o n ic ia a  saim onicica {too 1 ! 37 i 391 0 t 99 9ft 18! 73 1 11 t 1 32 6 2 ) 99 39 0 4 39 A ; } too
Aeromonas saim onicioa m asoucida/ acnrom ooenes ito o i 21 1 ; 7 |  31 o t 27 42 a 33 i Al 24 1 25 1 A1 19 3 0 1 ) a 11 ; too
p iesio m o n as snm eiio ides i i o o h o o i 97 ) 961 01 0 Oi 86 68 1 01 15 1 o ; 4 2 : 421 «8 88 t 0 1 73 0 1 30:
viOfio siginolyticus i 97 1 331 93 01 0 ! a s )  3 t 10 741 21 381 75 I 57) 74} 72 2 1 ° 93 10 3- 97
Vibrio ono ierae 1 96 11001100 3 1 Oi 7 i 94 t 39 38 1 1 ! 30 73 1 7 n 35) 39 5 1 1 1 90 951 2 to o
/ ib n o  c a m se ia 34  1 0 1 94 94 1 94 i 13 1 01 13 13 1 0 131 0 ) a 1 13 0 0 1 0 1 63 0 3 100
Vibrio noilisae 100)100) 35 01 01 01 0 1 3 10 ) 39! 53 1 0 1 24 1 41 01 Ot 94 0 3-100
Vibrio m etscnm kovii 0 ) 301 1 0 1 0 i 30 to o 0 100 0 f 30 ilOO 100)100 100 50 j 0 [100 Ot 0 . 0
Vibrio o a ran aem o iy ticu s sT T 9 a l 100 41 31 2 97 94 79 71 81) 9 4 [  51 1 93 90 i t  2 |  M 21 3 1 99
Vibrio vulniticus lo o j 9 6 | 95 4 =>i 95 99 95 3 0 10 9 M a 26 0 1 ° |0 5 91 m o o
Vo of positive reactions after 24-43 h at 30'^C)
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Appendix 2 : Results of FHA tests on the six strains of B. 
bronchiseptica
Fluid HA at sample dilution
Strain no. 1/2 1/4 1/8 1/16 1/32 1/64 1/128 1/256 1/512 1/1024
PBS - - - - - - - - - -
FHA + - - -
5376 + + - - - - -
6353 - -
11 - - - -
10541 - > - - - - ~ - -
452 - ■* - - - - - - - -
13325 - - - - - - - - - -
and - indicate haemagglutination and no haemagglutination respectively
8 6
Appendix 3 : HLT toxicity results in mice with the six strains of 
B. b ro n ch isep tica
Source
of
HLT
48h (dead and very sick mice)/no. infected 
of lOmg/ml crude HLT diluted
: after with 0.5ml i.p.
Undiluted 
(heated at 56*0
Undiluted 1/4 1/6 1/64
B. broûchiseptJcii
5376 0/2 2/2 1/2* 0/2 0/2
452 0/2 2/2 0/2 0/2 0/2
10541 1/2 2/2 2/2 1/2* 0/2
11 0/2 2/2 2/2 2/2 2/2 *
13325 0/2 0/2 0/2 0/2 0/2
6353 0/1 2/2 1/1 1/1 2/2 *
B. pertussis
crude HLT 0/2 2/2 2/2 2/2 2/2
indicates region of LDjq endpoint
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Appendix 4a ; Growth of B, bronchiseptica strain 5376 in PBS
Accumulated colony count data.
Expt no.
No. of colonies from 20 ul at
Zero time 24h 48h 72h 7d
Undiluted 10^ 10^ 10^ 10^ 10^ 10^ 10^  103 10^  10^
ÎI4 32
i n 16. 15 50 3 48 4
119 48 10 1 0 216 18
II 12 21 20 2 72 6
II 15 60 62 4 1 31
II 16 45,42 50 7 1, 49
II 18 34 85 8 1 21
II 19 21 3 0 1 21
II 42 14 7 0 13 1 12 3
III 1 43 1 26 - 115
III 6 68 1 30 1 52
III 19 62 48 2 + 134
III 20 84 1. 70
III 39 41 39 3 + 158
; not tested; 
accurately
growth almost confluent; jl : too many colonies to count
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Appendix 4b : Growth of B. btoachiseptica strain 5376 in CL
medium : Accumulated colony count data.
Exptno.
No. of colonies from 20 ul at
Zero time 24h 48h 72h 7d
Undiluted 10  ^ 105 10& 10^  io5 10^ 105 10^  10^  105 10^
195 42,46 + 5
196 36.35 19
II 1 27. 40 46 3
112 15,27
113 27,36
114 59. 43
115 18. 19 16 1 + + 48
119 44 283 .. 73
II 12 25 + 67 + 27
II 14 30.38 + 65 31
I I 15 81 + 54 24
II 16 48 64 1 53 2. 72
II 17 47 1 74 + 237 .. 95, 108
II 18 23 235 30 40
II 42 21 + 169 47 ± 22 .. ..
III 1 39 + 44 . . . .  + 1 . 73
III 6 51 118
III 19 66 107 . . .  1 21 1
III 19 39 ■ ■ ■ + 1 50
III 20 65 . .   ^ t 42
IV 3 20 - 51 39 1
.. : not tested; ++ : confluent growth;  ^ : growth almost confluent; +, : too many
colonies to count accurately
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Àppeadix 4c : Growth of B. bronchiseptica strain 5376 in horse.
sheep and dog TBW : Accumulated colony count
data.
No. of colonies from 20 ul at
TBW species Zero time 24h 4Sh 72h 7d
and
Expt no. Undiluted 10^  10^  105 103 10“* 1q5 lO'* 105 10^ lO'* 105 10°
Horse
II 42 20 "  1 92 1 S3 9
III 1 39 1 32 1 209 ..
III 6 57 - 275 • ( 1 234 ..
III 19 + 368 + 1 32
10^  10^  105 10^  105 lO'^  1Q5 10^ lO l^O'IlO^
Sheep 
II 42 19 23 4 0 24 5 22 3 1
III 1 ± 23 + 226 -,
III 6 ± 22 . .  ± 14
III 19 71 1 23 - A 14
III 19 1 20 .. 1 5
10^  10^  10^  10^ 10^  103 10^
Dog 
III 48 125 - 36 5 1 + + -r_ 144
III 48 + 107 5 0 ++ 1 307
III 48 T 190 1 0 + f 88
.. . not tested; ++ ; confluent growth; + : growth almost confluent; ; too many 
colonies to count accurately
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Appendix 4d : Growth of B. bronchiseptica strain 5376 in mouse,
rabbit and chicken TBW : Accumulated colony
count data.
TBW species 
and
Expt no.
No. of colonies from 20 ill at
Zero time 24h 48h 72h 7d
Undiluted 10^ 10“* 10® 10“* 10510° 10^  10“* 10® 10^  105 10^
Mouse
172 30.24 different dilutions tested
188 54.41 + ± 28 1 30 „ 2. 37
III 20 * * .. 1 68 13 + 1 13
III 20 60 .. 1 49 6 + i. 10
III 20 1. 62 10 + 1 16
103 lO^ioS 1Q4 io3 10“^ 1Q5 10® 103 10^  105
Rabbit
II 42 26 35 2 70 8 54 4
III 1 t .  12 * 159
1116 2 42 2. 64
III 19 .. ,. 151 7 ± 31
1q2 103 lO** 105 10° 102 103 lO'^  105 10^
Chicken
III 39 53 +* i  i  82 .. + + + 160 9 ..
III 39 40 + ■*■ 2. 89 t + + 199 16 ..
III 43 46 ^  28 4 + + + 1 20 1
.. ; not tested: ; confluent growth;  ^ ; growth almost confluent; i, : too many
colonies to count accurately
Appendix 4e : Growth of B. bronchiseptica strain 5376 in human
TBW ; Accumulated colony count data.
TBW species 
and
Expt Û0.
No. of colonies from 20 ul at
Zero time 48h 7d
Undiluted 10*^ 10^ 10^  10^ 10^ 10^ 105 10^
Human 1
III 62 52 + 146 + 55 8
IV 3 26 — 110 5 1- 50 5
Human 2
III 62 0 0
IV 3 47 0 0
Human 3
IV 3 21 40 3 - 109 11
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Appendix 5a : Growth of B. avium  strain P4091 in PBS :
Accumulated colony count data.
Expt no.
No. of colonies from  20 ul at
Zero time 24h 48h 72h 7d
Undiluted 10^ 102 10^ 10^ 103 10^  102 10^ iq2 io3
1142 65 8 0 + 43 1 62
II 49 13 10 0 1 0 1 1
III 6 27 22 9 1 37
III 17 140 22 3 0 0
III 17 10 1 12 1
III 20 25 15 0
: not tested; 
accurately
growth almost confluent; too many colonies to count
93
Appendix 5b : Growth of B, avium strain P4091 in CL medium
Accumulated colony count data.
No. of colonies from 20 jil at
Zero time 24h 48h 72h 7d
Expt no.
Undiluted 102 103 iq4 iq5 lO^  1q3 10^  10^  10° 10"^  lo5 10^ 10^  105 10^
172 26,21 -other dilutions used—
177 26. 37 + + ++ 138 .. 529 80 .. + 11
ISO 18. 16 ++ t. ■.  ^ .. 52
IS5 18, 9 46 4 0 1. 27 1- .. 49
I S9 43.43 + + ++ ,, + + .. 125 - .. 113
193 26. 19 . .  ++ + 16 .. ,. + 70 .. ± 87
II 42 78 .. - 1 13 ...................  7 0 .. 1 23
II 49 20 .. > 303 .. + 561 .. .. 1 31
III 6 40 42 .. 31 3
III 17 38 .................... 1 39 ± 47 5
III 17 > » 1 1 II ± 41 1 26 1
III 20 27 . 32 4
: not tested; + ; growth almost confluent; t  ; too many colonies to count
accurately
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Appendix 5c ; Growth of B. avium strain P409Î in horse, sheep
and dog TBW : Accumulated colony count data.
TBW species 
and 
Expt no.
No, of colonies from 20 ul at
Zero time 24h 48h 72h 7d
Undiluted 10^  10^  lo5 1Q2 10^  10^  1q5 10^  105 10® 102 103 10^  1q5
Horse
II 42 56 67 2 0 ++ + 238 i  1 40 • t ,, • •
II 49 21 13 0 .. 1 117 36 1
III 6 24 1 157 „ 48 4
III 17 1 59 .. 50 4
III 17 1 96 .. 64 10
Sheep
II 42 57 66 4 1 1 63 1 38
II 49 14 38 5 74 9 89 13
in  6 24 2 ' ' <1 < ¥ 7 1
III 17 1. 24 3 96 9 0 ..
III 17 57 — 42 3 - 20 0 ..
Dog
III 48 100 90 2 0 + + i  319 ..
III 48 22 0 0 .. + + 1 79 ..
III 48 " 13 3 0 „ 1. 128
: not lested: 
accurately
growth almost confluent: '■ too many colonies to count
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Appendix 5d ; Growth of B. avium  strain P4091 in mouse, rabbit
and chicken TBW ; Accumulated colony count data.
TBW species 
and 
Expt no.
No. of colonies from 20 |il at
Zero time 24h 48h 72h 7d
Undiluted 103 lO"* 105 103 lO'^ 105 10® lO^ l 1Q5 10^ 1q2 10^  10"^
Mouse
172 39. 32 — different dilutions used..........
185 17,11 » 893 .. .. 11 106 0 0
189 58.49 + + .. 168 + + 127 13 80 14 .. ■ f '  f
II 49 13 * 389 64 ,. . 19 2
III 20 4
III 20 7
III 20 32 11
Rabbit
II 42 68 1 65 0 .. 113 10 2 1 15 0
II 49 21 1 30 .. 26 3 27 2 ,.
IIIo 20 0
III 17 84 7 .. 14
III 17 45 7 .. 1 33 5
III 20 +  + 9
Chicken
III 42 13 1 77 10 ,. . ,  . .  ' I 44 10 1
III 42 1 70 7 .. 64 3 0
III 42 ± 61 9 ,. 66 6 0
.. . not tested;
accurately
growth almost confluent; i  too many colonies to count
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Appendix 5e : Growth of B. avium  s i t P4091 in human TBW : 
Accumulated colony count data.
No. of colonies from 20 jil at
TBW species 
and
Zero time 48h 7d
Expt no. Undiluted 10^ 10^  1q2 10^  10^  10^ 10^ 102 10^  10^ 105
Human 1 
IV 4 
IV 4
49
32
+ + + + + + .................
. . . .  + 1 13
+ + - i  39 6
Human 2 
IV 4 0 ........................  0 0
Human 3 
IV 4 
IV 4
52
30
++ ++ .................
. . . .  + 13
- 27 2 0
: not tested: * : ,growth almost confluent; ± : too many colonies to count
accurately
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Appendix 6a : Growth of B. parapertussis strain 10520 in PBS
Accumulated colony count data.
Expt no.
No. of colonies from 20 ul at
Zero time 24h 48h 72h 7d
Undiluted Undiluted Undiluted Undiluted Undiluted
II 28 42 0 0 0 0
1144 31 5 0 0 0
II 49 32 10 3 0 0
III 11 31 20.26 0 0
III 21 28 0
III 45 35 0
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Appendix 6b : Growth of B. parapertussis strain 10520 in CL
medium : Accumulated colony count data.
No. of colonies from 20 ul at
Zero time 24h 48h 72h 7d
Expt no.
Undiluted 10^  10^  10% 10^  10^  1q2 1o3 10“* 10® 10^  lo3 10"* 10“* lo5 10®
I S3 97,52 1 .. 6 + .. 43 .. 0 + + 351 .. 4
186 22,21 — contaminated-------------
187 30.19 .. 2 i  .. 9 . . . .  + 79 .. 1
190 38, 37 1 42 2 -  1 171 .................
II 28 45 1 34 1 1 20
II 44 38 i  66 6 + 401 ................
II 49 45 .. 102 14 78 .. ± 183
III 11 47 r 123 12
III 21 45 . . 39
III 21 66
III 45 44 ..  ^ ± 17 .. +  +  + 101
III 49 55 t  244 ..
III 60 100 . . . .  1 1 25 ..
IV 4 71 .. 147 12 ..
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Appendix 6c : Growth of 3. parapertu ssis strain 10520 in horse, 
sheep and dog TBW : Accumulated colony count 
data.
No. of colonies from 20 ul at
TBW species 
and
Zero time 24h 48h 72h 7d
Expt no. Undiluted 10^  10^ 1Q2 10  ^ 10^  10  ^ 10^  10*^  10^  103 104 10^ 10^  10^
Horse
II 44 34 0 0 0 0 0 0 . .  0 0 . . . . 0
II 49 21 0 * • 1 • ■ t '1 > t • • 0
III 11 37 0 .. If , 0
Sheep
II 44 28 + 19 0 + i  25 .. ++ 627 ,. .. + 72 ..
II 49 44 1 27 2 56 2 17
III 11 .. .. 5^ 1 .. 28 ..
III 11 46
Dog
III 45 41 . . 0  0 0 ...................... 0
III 45 . . 4 1 0  ........................ 0
III 45 . 0  0 0 ...................... 0
III 49 31 12 ............................................ 0
III 49 23 ........................................... 0
III 49 1 3 '. .. .. .. .. .. .. 0
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Appendix 6d : Growth of B. parapertu ssis strain 10520 in mouse. 
rabbit and chicken TBW : Accumulated colony 
count data.
No. of colonies from 20 ul at
TBW species Zero time 24h 
and _______ _ _______
48h 72h 7d
Expt no. Undiluted lO^loho^ 10^  10^  loho^ 10^  10^  10^  10^  10^  io^'ioho^ 10^
i n  11
III 21
M ouse
183 79, 78 .. 75 5 t  ..
186 10, 16 .. 153 15
187 27. 18 + .. 92 7
II 28 47 + 66 5
II 44 29 140 14 1 • * ++ +
II 49 40 - 332
III 21 72 ----------1
III 21
Rabbit
II 44 50 25 5
II 49 38 30 ..
12 0 0
1 .. 19
1 •• 34
i  19
68
8 1 0
.. 19 0 
1 56 0 
++ 213 .. 
+ + 409 ..
 contaminated-
contaminated-----------
contaminated-----------
+ 24 1
.. 14 4 ..
++ 418 .. + .. 39 ..
1 ^1^5
......... 24 4
.......................... 46 2
Chicken 
III 45 
III 45 
III 45
49 24 2
68 3
124 14
1 12 0
± 2 1  2
± 46 3
:o
Appendix 6e : Growth of B. parapertussis strain 10520 in
human TBW : Accumulated colony count data.
No. of colonies from 20 lil at
TBW species 
and
Zero time 48h 7d
Expt no. Undiluted 10° 10^  10  ^ 10^ 10^ 10^ 105 10®
Human 1
IV 4 + + i  70 0 0 0
IV 4 64 43 0
Human 2
III 60 117 0 0
IV 4 Û 0
Human 3
IV 4 75 1 26 0 0 0
IV 4 54 36 0
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Appendix 7a : Growth of B. pertussis strain 18334 in PBS and CL
medium : Accumulated colony count data.
Fluid 
and 
Expt no
No. of colonies from 20 ul at
Zero time 48 7d
Undiluted 10^ IQl 102 10^ 10^ ) 10^  io5 10® lO"
PBS
III 37 9 0 0
III 46 163 2 0 * « 11
III 50 0 0
IV 4 25 0 0
CL
III 37 10 + 104 10 +  +  4* 270
III 46 178 99 5 39
III 46 4* 4- + 1 22 102 6
III 50 71 34 3
III 56 78 + + 1 99 13
IV 4 37 60 6
- — 18
2 0 3
Appendix 7b : Growth of B. p ertu ssis  strain 18334 in TBW from  
various vertebrate species : Accumulated colony 
count data.
Fluid 
and 
Expt. no
No. of colonies from 20 ul at
Zero time 48 7d
Undiluted 10^ ) 10^  1Q2 Undiluted
Horse
II 46 0 0
II 46 0 .. .. 0
Sheep
II 37 20 4 0 0 0
II 46 19 0 0 0
Dog
II 46 139 0 0
II 46 0 .. .. 0
II 50 85 0 0
Mouse
II 37 20 0 0 0 0
II 46 0 .. .. 0
II 50 71 0 .. 0
Rabbit
II 37 22 0 0 0 0
II 46 19 .. 0
Chicken
II50 74 0 .. .. 0
II50 0 .. 0
II50 0 0
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Appendix 7c : Growth of B. pertussis strain 18334 in human
TBW : Accumulated colony count data.
Fluid 
and 
Expt. no.
No, of colonies from 20 ul at
Zero time 48 7d
Undiluted Undiluted Undiluted
Human 1
III 56 98 0 0
IV 4 0 0
Human 2
III 56 92 0 0
IV 4 0 0
Human 3
IV 4 11 0 0
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Appendix 8 : Absorbance at 540 nm, in the Drabkin test, of
dilutions of mouse blood (X, v /v )  in PBS as
recorded in 11 assays.
Assay no,
Absorbance at 540 nm with mouse blood (%, v/v) of :
0.015625 0,03125 00625 0,125 0.25 0,5 1.0
1 0.003 0.007 0.011 0,022 0,047 0,095 0.198
2 0.003 0,007 0.015 0,020 0.045 0.086 0.183
3 0.002 0,004 0,008 0.022 0.042 0,090 0,181
4 0,005 0.011 0,022 0,040 0.079 0,165
5 0.005 0.012 0.023 0,079 0,184
6 0,044 0,090 0.183
7 0,011 0.021 0.042 0.081 0,159
S 0.003 0,005 0.016 0,021 0.050 0.091 0,189
9 0,017 0,035 0.081 0,182
10 0.042 0,104 0,194
11 0,016 0.038 0,082 0,172
Mean 0.003 0,006 0,011 0.019 0,041 0,087 0,181
SD 0.0005 0.001 0,004 0,003 0.007 0.008 0-012
SEM 0.00025 0.0006 0,001 0,001 0.002 0.002 0,004
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Appendix 9 : Blood contamination of the cell pellet from  
centrifuged horse, rabbit and sheep TBW and the 
m em brane-filtered supernates. Results are 
expressed as % (v/v) mouse blood equivalents.
Exptno. Fraction % (v/v) mouse blood equivalent (mean + SEM) 
Horse Rabbit 1 Rabbit 2/3 Sheep 1 Sheep 2
I lls Pellet 0.19 0,06 0,14 0,07
I lls Pellet 0.14 0,07 0,16 0.06
III 9 Pellet Oil 0,02 0.10 0.02
III 9 Pellet 0.10 0,01 0,12 0.04
III 12 Pellet 0.11 0,12 0,08
III 12 Pellet 0.10 0,15 0.03
III 13 Pellet 0.11 0,14 0 07
III 13 Pellet 0.12 0,13 0.07
III 13 Pellet 0.13 0.14 0,05
III 14 Pellet 0.13
III 14 Pellet 0.10
III 14 Pellet 0,12
(0.12i0,01) (0 12 + 0 01) (0,12^0.01) (0,12i0.0l) (0,12i0.01)
I lls Supernate 0.09 0.07 0.02 0.01
III 8 Supernate 0,09 0.07 0,04 0,01
Ills Supernate 0.10 0.08 0.09 0.01
III 12 Supernate 0.12 0.07 0.07 0,02 0,00
III 12 Supernate O.Il 0.08 0,05 0,01 0,01
III 12 Supernate 0.13 0,05 0.06 0.01 0,00
III 14 Supernate 0.09
III 14 Supernate 0,10
III 14 Supernate 0,11
III 15 Supernate 0.14
III 15 Supernate 0.15
III 15 Supernate 0,13
(0.12i0,01) (0.08 + 0.01) (0,07 + 0.004) (0,031.0.01) (0,007 + 0.002)
2 0 7
Appendix 10 Blood contamination of the ceil pellet from  
centrifuged mouse, chicken, and dog TBW and 
the m em brane-filtered supernates. Results are 
expressed as % (v/v) mouse blood equivalents.
Exptûo. Fraction % (v/v) mouse blood equivalent (mean + SEM) 
Mouse (157) Mouse (158) Mouse (165) Chicken Dog
Ill 7 Pellet ' 0.20
III 7 Pellet 0.23
III 8 Pellet 0,31 0.34
III 8 Pellet 0,31 0.38
III 9 Pellet 0.20 0,15
III 9 Pellet 0,20 0.22
III 13 Pellet 0,15
IIÎ13 Pellet 0,15
III 13 Pellet 0,15
III 13 Pellet 0.16
III 13 Pellet 0.17
I I 13 Pellet 0,17
III 14 Pellet 0.43
III 14 Pellet 0.40
III 14 Pellet 0,46
III 28 Pellet 0.04
III 28 Pellet 0.04
III 28 Pellet 0.05
III 30 Pellet 0.006
III 30 Pellet 0,006
III 54 Pellet 0,12
III 54 Pellet 0.12
III 54 Pellet 0.12
III 54 Pellet 0,14
III 54 Pellet 0,12
III 54 Pellet 0.09
(0.26^0.03) (0,16 + 0.004) (0,31 i0,04) (0,038 lO.Ol) (0 12 ^0,01)
2 0 8
Appendix 10 (continued)
Expt no. Fraction % (v/v) mouse blood equivalent (mean + SEM)
Mouse (157) Mouse (158) Mouse (165) Chicken Dog
Ill 7 Supernate 0,14
III 7 Supernate 0,17
III 8 Supernate 0.16
III 13 Supernate 0.13 0,14
III 13 Supernate 0,14 0.17
III 13 Supernate 0.12 0.13
III 13 Supernate 0.11
III 13 Supernate 0.14
III 13 Supernate 0,11
III 15 Supernate 0.19
III 15 Supernate 0.24
III 15 Supernate 0.19
III 15 Supernate 0.25
III 15 Supernate 0.21
III 15 Supernate 0.25
III 28 Supernate 0.01
III 28 Supernate 0,03
III 28 Supernate 0.02
III 30 Supernate 0.00
III 30 Supernate 0.00
III 54 Supernate 0.012
III 54 Supernate 0.012
III 54 Supernate 0,012
III 54 Supernate 0.017
III 54 Supernate 0.023
III 54 Supernate 0.005
( 0 , 2 2 i 0 . 0 1 )  ( 0 . 1 3 i 0 . 0 1 )  (0,15 l O , 04) (0.01 ^ 0 , 0 0 5 )  ( 0 , 0 1 4 ^ 0 . 0 0 2 )
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Appendix 11 : Blood contamination of the cell pellet from  
centrifuged human TBW and the 
m em brane-filtered supernates. Results are 
expressed as % (v/v) mouse blood equivalents.
Expt no. Fraction % (v/v) mouse blood equivalent (mean + SEM) 
Human 1 Human 2 Human 3
IV 6 Pellet 0.S8 0.44 0.02
IV 6 Pellet O.Sl 0.50 0.02
IV 6 Pellet 0.88 0.56 0,03
(0.86 + 0.02) (0.50 + 0.03) (0.02 ±0.003)
IV 6 Supernate 0.00 0.16 0.00
2 1 0
Appendix 12 : Absorbance of standard leucine concentrations 
(mM) at 570 nm for 7 assays of amino acid 
content of TBW.
Absorbance at 540 nm with leucine mM of :
0.25 0.5 1.0 2.0
0.052 0.100 0.199 0.430
Î 0.032 0.097 0.208 0.413
0.036 0.103 0.186 0.430
2 0.054 0.071 0.188 0.413
3 0.045 0.107 0.209 0.400
4 0.02S 0.059 0.132 0.286
0.031 0.056 0.132 0.283
5 0.050 0.092 0.185 0.365
6 0.038 0.102 0.162 0.387
0.052 0.070 0.190 0.364
7 0.046 0.084 0.174 0.336
0.044 0.088 0.178 0.330
Mean 0.042 0.086 0.178 0.370
SD 0.009 0.018 0.026 0.052
SEM 0.003 0.005 0.007 0.015
9Appendix 13 : Amino acid content of horse, rabbit and sheep
TBW expressed as mM leucine equivalents (based 
on at least 3 observations). The TBW supernate was 
membrane-filtered before analysis.
Expt no.
Amino acid concentration as mM leucine equivalents (mean ± SEM) in
Horse Rabbit 1 Rabbit 2/5 Sheep 1 Sheep 2
11 37 0.83 0.11 0.19
II 41 0.69
II 51 0.54
III 5 0.88 0.25 0.15 0,22 0.07
III 16 0.26 0.08 0.13 0.11
III 16 0.19 0,05 0.11 0.11
III 16 0.14 0.08
(0.74±0.08) (0.20 ±0.03) (0.12±0.03) (0.15±0.02) (0.09±0.01)
2 1 2
Appendix 14 : Amino acid content of mouse, chicken and dog
TBW expressed as mM leucine equivalents 
(based on a least 3 observations). The TBW
supernate was membrane-filtered before analysis.
Expt no.
Amino acid concentration as mM leucine equivalents (mean ±SEM) in
Mouse (157) Mouse (158) Mouse (165) Chicken Dog
II 37 0.42
II 41 1.08
III 16 0.70 0.49 0.39
III 16 0.72 0.44 0.38
III 16 0.74 0.46 0.38
III 16 0.50
III 29 0.07
III 29 0.16
III 29
IV 12
0.07
0.26
IV 12 
IV 12
(0.81 ±0.09) (0.47±0.01) (0.39±0.09)
0.25
0,18
(0.10±0.03) (0.23±0.02)
2 1 3
Appendix 15 : Amino acid content of human TBW expressed as
mM leucine equivalents. The TBW supernate was
membrane-fiitered before analysis.
Expt no.
Amino acid concentration as mM leucine equivalents (mean ±SEM) in
Human 2 Human 3
IV 7 0.68 0.20
IV 7 0.80 0.22
IV 7 0.72 0.22
(0.73 ±0.04) (0.21 ±0.01)
9 1 4
Appendix 16 : Nicotinic acid assay : Volume of NaOH (ml)
required for acid neutralization, in relation to 
standard concentrations of nicotinic acid in 
43h Lactobacillus cultures.
Assay no.
Volume of NaOH for acid neutralization at 
nicotinic acid concentrations of (ug/mi) :
0.01 0.02 0.04 0.08 0.16
1 1.5 2.1 6.2 11.4 18.5
1.5 1.9 5.7 11.0 19.9
2 1.0 2.7 4.7 8.9 16.6
1.2 3.0 4.5 9,2 16,7
3 1.4 2.9 5.6 12.0 23.7
1.5 2.9 6.0 12.0 24.3
Mean 1.35 2.58 5.45 10.75 19.95
SD 0.21 0.47 0.69 1.37 3 37
SEM 0,08 0,19 0,28 0.56 1.38
2 1 5
Appendix 17 : Nicotinic acid content^ of various vertebrate TBW
(based on at least 2 observations). The TBW was
centrifuged and membrane-fiitered before analysis.
Expt no.
Nicotinic acid concentration expressed as ug/ml (mean ±SEM) in
Horse Rabbit 2/3 Sheep 1 Mouse (157) Chicken Dog
Ill 26 0.96 0.16 0.48 1.04
III 26 1.04 0.28 0.44 0.88
III 32 1.20 0.20 0.20 0.72 0.20
III 32 1.04 0.28 0.20 0.72 0.20
IV 12 > t <1 '* 0,00 0.54
IV 12 0.54
IV 12 0.54
(1.06±0.05) (0.23±0.03) (0.33±0.08) (0.S4±0.08) (0,20±0.00) (0.54±0.00)
 ^ expressed as iig /m i
Appendix 18 : Nicotinic acid content^ of Human TBW (based on at
least 2 observations). The TBW was centrifuged and
membrane-filtered before analysis.
Nicotinic acid concentration expressed as ug/ml (mean ±SEM) in
Expt no
Human 2 Human 3
IV 12 0.54 0.54
IV 12 0.54 0,80
IV 12 0.30 0,66
(0 63 ±0 09) (0.67±0.08)
 ^ expressed as dg/ml
6Appendix 19 : Protein content^ of various vertebrate TBW
(based on at least 2 observations). The TBW was
centrifuged and membrane-fiitered before analysis.
Protein concentration expressed as jig/ml (mean ±SEM) in
Horse Rabbit 2/3 Sheep 1 Mouse (157) Chicken Bog
III 34 1360 264 890 970 , 116
III 34 1520 296 894 1102
III 35 1338 356 679 1016 62
III 35 957 358 613 952 85
IV 5 762
IV 5 436
(1294±119) (318±23) (769 ±72) (1010±33) (88 ±16) (599±113)
^ expressed as ug/ml
Appendix 20 : Protein content^ of human TBW (based on 2
observations). The TBW was centrifuged and 
membrane-filtered before analysis.
Expt no.
Protein concentration expressed as ug/ml (mean ±SEM) in
Human 1 Human 2
IV 5 2074 1788
IV 5 2270 1942
(2172 ±98) (1865 ±77)
 ^ expressed as ug/ml
2 1 7
Appendix 21 : Growth of B. broüchJseptica strain no. 5376 in 
PBS: a) prepared from analytical grade salts in 
distilled  water (PBS/DW); b) prepared from  
analytical grade salts in reagent grade water 
(PBS/RGW) and c) passed through a charcoal filter  
(PBS/CH), and reagent-grade water (RGW) alone 
during 24 and 48h at 37"C.
Expt no. 
and 
Fluid
Zero
time 10^
Colony count and GI from 20 ul sample at
10^
24h
102 10^
GI
10^
48h
10^  1q2 103
GI
10^
RGW
II 14 21,28 269, 252 1.0 560 1.4
I I 15 70 102 12 0.2 165 21 .. 0.5
II 16 42,41 118 12 0,5 123 15 .. ,. 0,5
PBS/DW
195 39, 40 + + + 1 18 2.6
196 28,46 + + 1 21 2.8
II 1 39, 35 + + 4* 27 3 1.9
II 14 33,32 + 168 15 2.7 70 3 3
II 15 58 35 2 1,8 39 .. 2,8
II 16 45, 42 50 7 2.1 49 .. 3.0
PBS/RGW
II 5 16,15 50 3 2.5 + 48 4 3.5
II 9 48 10 1 0 0.3 216 18 2.6
II 12 21 10 2 0.9 72 6 . 2.5
II 15 60 62 4 1.0 ± 31 .. 2,7
I I 18 34 85 8 1.4 21 2.8
PBS/CH
II 12 22 + 629 3.4 + 137 3.8
II 15 50 4 78 3.2 + 178 17 3.5
2 1 8
Appendix 22 : Effect of serial transfer of B. broncàiseptJca
strain no. 5376 in PBS and CL medium at 3 7 ’C.
Expt no. 
and 
Transfer no, Fluid
Colony count per 20 ul at
Zero
time loO 10^ 1Q2
24h
10^  10  ^ 105 10®
195
1 PBS 39, 40 + * • 18
1 CL 42,46 5
2 PBS 450 + + + 28
2 CL 125 X 1Q5 4- + ±
3 PBS 700 + + + 85
3 CL + + + + 117
4 PBS 2125 + t 50
4 CL 2925 X 10^ + + 61
196
1 PBS 28,46 + + 21
1 CL 36,35 + + 4* 19
2 PBS 525 + 4- ± 47
2 CL 4750 +
3 PBS 1175 + + ± 47
3 CL * " + + < 4 +
4 PBS 1175 4- + ± 63
4 CL ■ * +■ + +
II 1
1 PBS 39, 35 + + 27 3
1 CL 27,40 46 3
2 PBS 73 + 7
2 CL 11500 + 95
3 PBS 175 ± 55
3 CL 2375 -X 10- ■* 92
4 PBS 1375 1 33
4 CL 23 X 105 96
The Oh counts for transfers 2-4 were calculated as a l/40th of the previous 24h count.
2 1 9
Appendix 23 : Effect of serial transfer of Æ colJ strain no. JM 83 
in PBS and CL medium at 3 7 ‘C.
Esptno. 
and 
Transfer no,
Colony count per 20 ul at
Fluid
Zero
time 10*' 10^ 1Q2
24h
103 10^ 105 10°
195
1 PBS 7,7 10 0 0 , ,
1 CL 10,6 + + 1 1 + 29
2 PBS 0,0 0 0 f * 0
2 CL 7.25 X 105 + + + 32
3 PBS 0,0 0 0 0
3 CL Sx 105 +  + + + 11 68
4 PBS 0,0 0 0 0
4 CL 17s 105 + + 70
196
1 PBS 9,14 7 0 0
1 CL 24,12 + 32
2 PBS 0,0 0 0 0
2 CL Sxl05 + 27
3 PBS 0,0 0 0 0
3 CL 675 X 10^ 11 i * r t  « « + 33
4 PBS 0,0 0 0 0
4 CL 825 X 10^ • > , 1 + 20
II 1
1 PBS 47, 32 36 4 0
1 CL 39,41 + + 15
2 PBS 0,0 0 0 0 0 11
2 CL 375X10^ + 11
3 PBS 0,0 0 0 0 0
3 CL 275 X 10^ + + 248
4 PBS 0,0 0 0 0 0
4 CL 62 X 105 13
The Oh counts for transfers 2-4 were calculated as a l/40th of the previous 24h count.
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Appendix 24 : Growth of B. bronchJseptics strain no. 5376 in
dilutions of CL medium during 24 and 48h at 3 7 ’C.
Exptno.
and
Dilution
Colony count and GI from 20 ul sample at
Zero
time 10® 10^ 102
24h
103 10“* 1q5
GI
102 10^
48h
10^ 10^ 10°
GI
119
10^ 44 + + ■ 1 254 4.8 + -¥ 430 5 6.0
102 40 + + 1 283 4.8 + + 73 53
lO'^ 43 2 0 0 0.7 t 239 4 3.7
10° 49 4 1 0 0.9 + 30 0 2.8
10& 40 3 1 0 0.7 25 0 2.8
10 0^ 43 3 0 0 0.8 1. 30 0 2.8
lolz 54 2 0 0 0.8 1 35 0 2.8
I I 12
10^ 25 1 67 5.4 + 27 6.0
IQ2 16 t 32 5.3 96 5.8
lO'^ 21 166 1.9 r 28 11 4.1
105 18 80 1.6 42 3.4
10° 27 1 100 1.6 1 32 3.1
10% 22 - 14 0,8 139 14 2.8
Information for PBS was taken from previous experiments.
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Appendix 25 : Growth of B. bronchi sep tics strain no. 5376 in
pond and sea water during 24 and 48h at 37* C
Exptno. 
and 
Water type
Colony count and GI from 20 ul sample at
Zero
time 10® loi
24h
102 10^
GI
10®
48h 
10^  1Q2 10^
GI
Pond
113 33.29 + + + 286 18 2.8
115 21,29 + 13 2.7 + 424 3.2
II 12 25 + + 49 3.3 + 74 3.5
I I 15 58 - 118 3.3 1 155 3.4
Sea
113 31.34 79 4 1 2 0.4 * <
115 34,22 1. 9 2 0.5 + 78 5 1.4
I I 12 20 134 12 0.8 + 27 1.1
I I 15 61 57 1 0 156 10 0.4
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Appendix 26 : Growth of B. bronchlseptJcs strain no. 5376 in 
fresh  water sam ples from various lakes during 24 
and 4Sh at 37* C
ExpL no. 
and 
Water type
Colony count and GI from 20 jil sample at
Zero
time 10®
24h
10^ 10^
GI 48h
10^ 10^
GI
Milngavie
Reservoir
II 17 39 + 109 10 1.4 209 25 2.8
I I 19 41 32 0 0.9 - IS 2.6
Loch Katrine
II 17 26 + 117 6 1.4 292 34 3.1
II 19 42 38 2 0.9 f 88 3.3
Loch Achray
II 17 46 131 10 1.4 39 2.9
II 19 14 28 0 1.3 - 46 3.5
Loch Ard
II 17 54 + 26 1.7 190 33 2.8
II 19 25 58 0 1.4 + 30 3.1
Loch Lomond
II 17 53 101 2.3 1 45 2.9
II 19 31 290 9 2.0 - 88 3.4
Lake of Menteith
I I 17 43 + 31 1.8 1 37 2.9
II 19 25 S3 0 1.5 - 56 3.4
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Appendix 27 : Comparison of Æ bronchiseptica  strains 5376,
452 and 10541 for their ability to grow in PBS 
and fresh  water from Loch Lomond over 48h at 
37'C.
Strain
and
Exptno.
PBS Loch
Lomond
Colony count from 20 ul at
Zero 48h 
time 10® 10^  1Q2 103
GI
5376
115 Yes 16, 15 + 48 3.5
II 9 Yes 48 216 18 2.6
II 12 Yes 21 72 6 2.5
II 15 Yes 60 31 2.7
II 18 Yes 34 1 21 2.8
II 17 Yes 53 45 2.9
II 19 Yes 31 - 88 3.4
452
11 36 Yes 53 32 2.8
II 36 Yes 58 1 19 2.5
II 36 Yes 61 23 2.6
II 36 Yes 71 26 2.6
10541
II 36 Yes 31 1 20 2.8
II 36 Yes 26 1 53 2.8
II 36 Yes 23 65 3.4
II 36 Yes 25 - 45 3.2
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Appendix 28 : Comparison of B. broocAJseptJca strains 11, 6353  
and 13325 for their ability to grow in PBS and 
fresh  water from Loch Lomond over 48h at 37"C.
Strain 
and 
Expt no.
PBS Loch
Lomond
Colony count from 20 ul at
Zero 48h 
time 10® 10^  10^ 10^
GI
11
II 30 Yes 7,7 + + 4 4 40 3.8
II 38 Yes 15 60 7 2.9
II 30 Yes 10,6 +  + + + 50 3.8
II 38 Yes 26, 17 1 64 3.5
6353
II 30 Yes 9,6 + 4 18 3.4
II 38 Yes 15 35 6 2.4
II 30 Yes 6,4 + + 4 4 69 4.1
II 38 Yes 9 1 23 35
13325
II 30 Yes 23,20 44 42 3.3
II 38 Yes t * 15 32 2.6
II 30 Yes 30,30 4 4 87 3.5
II 38 Yes 71.77 1 56 2.9
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Appendix 29 : Long-term survival of three strains of B. 
bronchiseptica  in PBS and fresh  w ater from Loch 
Lomond at 37*C (A) and 10“C (B) over a period 
of six months.
Colony count from 20 ul at
Strain Zero time 
and _______
Iwk Imth 3mth 6mth
Fluid Undiluted 10® 102 10^ 10® 1q2 10^ 10® 102 iq3 10® 1Q1 102 10^
452
PBS A 46 +  + 54 8 + + 4 23 44 + 11 4 4 4 12
PBSB 82 1 0 + 9 1 4 4 + 13 4 4 + 4 24
LLA 58 4 + + 30 + + 52 6 4 4 + 11 4 + 11 1
LLA - 8 0 69 2 4 4 14 2 4 19 2 1
6353
PBS A 6 44 + 124 4 4 4 38 44 4 19 4 4 4 4 13
PBSB 4 + 41 9 4 4 4 28 44 4 100 44 4 4 41
LLA 9 4 4 4 55 - 35 4 44 4 24 4 4 4 4 25
LLB + + 4 16 4 4 35 4 4 4 73 44 4 4 71
11
PBS A 6 + + 4 19 4 4 4 11 44 4 51 0 0 0 0
PBSB 6 4 4 43 6 44 4 126 4 4 4 73 4 4 t . 33 11
LLA 7 4 4 + 60 44 4 19 44 4 294 0 0 0 0
LLB 8 4 17 4 44 4 73 44 4 56 ++ + + 167
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1445 GROWTH OF 50RDETELLA SPECIES IN MAMMALIA.^  TRACHEOBRONCHIAL 
WASHINGS.
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Glasgow G12,30Q.
Although thoro have been aumcrous studies on the growth of bordeteiiae 
la 1  variecy of artificial culture media, there appears to be ao report oa the la  
growth of the bacteria la respiratory-tract secretions of host species.
We have therefore examined tracheobronchial washings (TBW) from a 
variety of animais and one bird species for abiiicy to support bordetella growth from 
washed inocula of 10^  CFU/ml. 3. broachlsepticz and 3. zvium  grew in ail six species 
of TBW and 3 pzatpertussis in most of them. 3  pertussis failed to grow in any.
Phosphate-buffered saline (PBS) was used as a aon-autrieat control fluid 
in these experiments. To our surprise, it supported some growth of 3, broucAisepcicz 
and 3. jvi'aja. but not 3. parspertussis or 3. pertussis. The trace nutrients La lake and 
pond water also supported growtù of 3. broucAisepticz wnich suggested that this 
species may not be an obligate respiratory-tract parasite, but may have the capacity 
to exist in aquatic enviromcnts.
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